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Abstract 
Background and purpose:  
In vivo dosimetry is one of the quality assurance tools used in radiotherapy to 
monitor  the  dose  delivered  to  the  patient.  The  digital  image  format  makes 
electronic portal imaging devices (EPIDs) good candidates for in vivo dosimetry. 
Currently  there  is  no  commercial  transit  dosimetry  module,  which  could 
facilitate routine in vivo dosimetry with the EPID. Some centres are developing 
their in house packages, and they are under assessment before introduction into 
routine clinical usage. The main purpose of this work was to develop the EPID as 
an in vivo dosimetry device. 
 
Materials and methods:  
Knowledge  of  a  detector’s  dose response  behaviour  is  a  prerequisite  for  any 
clinical  dosimetric  application,  hence  in  the  first  phase  of  the  study,  the 
dosimetric characteristics of eleven Varian a Si500 EPIDs that are in clinical use 
in  our  centre  were  investigated.  The  devices  have  been  in  use  for  varying 
periods and interfaced with two different acquisition control software packages, 
IAS2  /  IDU II  or  IAS3  /  IDU 20.  Properties  investigated  include:  linearity, 
reproducibility, signal uniformity, field size and dose rate dependence, memory 
effects and image profiles as a function of dose. In the second phase, an EPID 
was calibrated using the quadratic method to yield values for the entrance and 
exit  doses  at  the  phantom  or  patient.  EPID  images  for  a  set  of  solid  water 
phantoms  of  varying  thicknesses  were  acquired  and  the  data  fitted  onto  a 
quadratic equation, which relates the reduction in photon beam intensity to the 
attenuation  coefficient  and  material  thickness  at  a  reference  condition.  The 
quadratic model was used to convert the measured grey scale value into water 
equivalent  path  length  (EPL)  at  each  pixel  for  any  material  imaged  by  the 
detector.  For  any  other  non reference  conditions,  scatter,  field  size  and  MU 
variation  effects  on  the  image  were  corrected.  The  2D  EPL  is  linked  to  the 
percentage  exit dose  for  different  thicknesses  and  field  sizes,  thereby 
converting the plane pixel values at each point into a 2D dose map at the exit 
surface of the imaged material. The off axis ratio is corrected using envelope 
and boundary profiles generated from the treatment planning system (TPS). The 
method was extended to include conformal and enhanced dynamic wedge (EDW)   iii 
fields. A method was devised for the automatic calculation of areas (to establish 
the  appropriate  scatter  correction)  from  the  EPID  image  that  facilitated  the 
calculation of EPL for any field, and hence exit dose. For EDW fields, the fitting 
coefficients  were  modified  by  utilizing  the  Linac  manufacturer’s  golden 
segmented  treatment  tables  (STT)  methodology.  Cross  plane  profiles  and  2D 
dose distributions of EPID predicted doses were compared with those calculated 
with  the  Eclipse  8.6  treatment  planning  system  (TPS)  and  those  measured 
directly with a MapCHECK 2 device. 
Results:  
The image acquisition system influenced the dosimetric characteristics with the 
newer version (IAS3 with IDU 20) giving better data reproducibility and linearity 
fit than the older version (IAS2 with IDU II). The irradiated field areas can be 
accurately determined from EPID images to within ± 1% uncertainty. The EPID 
predicted dose maps were compared with calculated doses from TPS at the exit. 
The gamma index at 3% dose difference (DD) and 3mm distance to agreement 
(DTA) resulted in an average of 97% acceptance for the square fields of 5, 10, 15 
and 20 cm thickness solid water homogeneous phantoms. More than 90% of all 
points passed the gamma index acceptance criteria of 3% DD and 3mm DTA, for 
both conformal and EDW study cases. Comparison of the 2D EPID dose maps to 
those from TPS and MapCHECK shows that, more than 90% of all points passed 
the gamma index acceptance criteria of 3% dose difference and 3mm distance to 
agreement, for both conformal and EDW study cases. 
Conclusions:  
The quadratic calibration can effectively predict EPL and hence exit dose. Good 
agreement  between the EPID predicted and TPS calculated dose  distributions 
were  obtained  for  open  fields,  conformal  and  EDW  test  cases.  There  were 
noteworthy deviations between EPID, TPS and MapCHECK doses on field edges. 
But it should be emphasised that, for practical in vivo dosimetry, these areas of 
reduced accuracy at the field edges are much less important.  It is concluded 
that the EPID Quadratic Calibration Method (QCM) is an accurate and convenient 
method  for  online  in  vivo  dosimetry  and  may  therefore  replace  existing 
techniques. 
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1  CHAPTER ONE: INTRODUCTION AND AIM OF THIS 
RESEARCH 
1.1 Radiotherapy 
Radiation  has  been  used  in  medicine  for  diagnostic  and  therapeutic  purposes 
since the discovery of x rays over one hundred years ago. Radiotherapy is the 
use  of  high  energy  x rays  and  other  ionising  radiation  such  as  gamma  rays, 
electrons, protons, etc to treat diseases.  The radiotherapy process is complex 
and  involves  a  series  of  procedural  steps  beginning  with  patient  diagnosis, 
disease  staging  and  lastly  the  treatment  of  a  specified  target  volume  with 
predetermined radiation energies and beam parameters. Currently 80% of cancer 
patients will require radiotherapy as part of their treatment (Janaki et al, 2010), 
complementing other cancer treatment modalities like surgery, chemotherapy, 
hormonotherapy or immunotherapy.   
Radiotherapy  is  subdivided  into  two  major  branches:  internal 
(Brachytherapy) and external (Teletherapy). In internal radiotherapy the sources 
are  placed  in  contact  with  the  patient.  Mainly  sealed  sources  of  radioactive 
nuclides  such  as  Ir 192,  Cs 137,  Co 60,  Au 198,  I 125,  etc  with  different 
characteristics  are  used  in  treatment.  On  the  other  hand  is  external  beam 
radiotherapy, where the radiation source is at a distance from the patient. The 
most widely used external type of treatment is by photon beam. External photon 
beams fall into two categories depending on their origin, means of production 
and  energy.  The  first  categories  are  the  gamma  rays,  which  originate  from 
radioactive  nuclei  such  as  Cobalt 60  radiocative  sources  units.  The  second 
categories are the X rays which originate in a target bombarded with energetic 
electrons. The X rays are produced either in an X ray tube (orthovoltage X rays) 
or  in  a  linear  accelerator  (linac)  (megavoltage  X  rays).  Photon  and  electron 
beams  produced  by  linacs  are  the  most  commonly  used  beams  in  cancer 
treatments. A very small fraction of treatments are carried out by particles such 
as protons, neutrons and other heavier ions, but many of these are still under 
investigation.  This  study  was  conducted  with  external  photon  beams,  using  a 
Linear accelerator. 
 
       2 
1.2 Portal dosimetry and Equivalent Path Length 
The principal focus of this study is on portal dosimetry, which is defined as 
the extraction of quantitative dosimetric information from a portal image (image 
taken behind the irradiated object). Portal dosimetry can be done mainly with a 
film and electronic portal imaging devices (EPID);  limited information can  be 
obtained from using TLDs, diodes, etc. Portal dosimetry is subdivided into transit 
(where  photon  beams  pass  through  a  phantom  or  patient)  and  non transit 
dosimetry (where there is no attenuating material between the beam source and 
the  imaging  device).  EPID  portal  dosimetry  is  achieved  by  the  acquisition  of 
grayscale images and conversion to 2D dose maps in the plane of the imager. 
 
The presence in a patient’s body of many different tissues each with its 
own  density  and  chemical  composition  constitutes  a  big  challenge  in 
radiotherapy, since it would require simulating the ions traversals through all 
these  materials.  One  possibility  of  approaching  this  problem  is  to  apply  the 
concept of water equivalent path length (EPL), defined as the radiological depth 
between  a  source  and  a  any  other  point  of  interest  or  calculation  point,  as 
determined  by  the  linear  attenuation  of  each  material  in  the  path.  In  other 
words, if we consider a single radiation ray traversing several tissues of different 
thicknesses and densities, the EPL concept scales all these tissues to the depth 
of water which has the same attenuating effects. In this study we calibrated 
EPID images to determine the EPL, hence the term EPL is used to denote the 
water thicknesses at each EPID pixel location of the imaged phantom, measured 
via the transmission of mega voltage photon beams.  
 
1.3 Major structural components of a medical Linear 
accelerator 
Figure 1.1 shows a photograph of a Varian medical linear accelerator (Varian 
Medical Systems, Palo Alto, California, USA), showing the main structural 
components.   3 
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Figure 1- 1. Varian linear accelerator (Model ix) 
 
1.3.1 The gantry and treatment couch 
The beam is generated within the gantry, which rotates around the patient. The 
patient lies on a moveable treatment couch that can move in many directions 
including vertical (up / down), lateral (right / left) and longitudinally (in / out). 
Radiation can be delivered to the tumour from any angle by rotating the gantry 
and  moving  the  treatment  couch.  Alignment  and  precision  of  the  linear 
accelerator gantry and the treatment table are very important parameters in the 
quality of patient treatment. In operating a linear accelerator, the gantry and 
collimator rotate around the isocentre (a point in space where radiation beams 
intersect when the gantry is rotated), and laser (used to make sure the patient is 
in the proper position) alignment are important parameters for commissioning 
and quality assurance. The geometric gantry accuracy of 1.0 mm radius at the 
isocentre  is  required  to  deliver  a  precise  dose  distribution  in  conformal  and 
advanced treatment techniques such as intensity modulated radiation therapy 
(IMRT) image guided radiation therapy (IGRT) and stereotactic treatments. 
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1.3.2 The treatment head 
To make use of and control the produced radiation, all accelerators are designed 
with  a  treatment  head  which  provides  sufficient  shielding  against  leakage 
radiation, consisting of a thick shell of high density shielding material such as 
lead or tungsten. The treatment head contains many components and the major 
ones  are:  X ray  target,  primary  fixed  collimator,  scattering  foils,  flattening 
filter,  ion  chamber  dosimetry  system  (two  completely  independent  systems 
located directly under the x ray flattening filter which monitor delivered dose, 
dose rate and beam symmetry), secondary adjustable jaws and the multi leaf 
collimator (MLC) system that provides mechanically variable collimation. 
 
1.3.3 Electronic portal imaging device 
A  critical  requirement  in  radiation  therapy  is  accurate  day to day  treatment 
setup.  The  primary  objective  for  the  development  of  the  electronic  portal 
imaging devices (EPID) was to provide high quality portal images. A Portal image 
is obtained by positioning any 2D radiation detector such as film in the radiation 
beam, behind a patient while on treatment.  The primary purpose is to verify 
patient  position  under  actual  conditions  of  treatment,  which  is  an  essential 
component of a patients’ treatment. The EPID is mounted at the base of the 
treatment  machine  and  controlled  via  a  robotically  controlled  arm.  The 
retractable  arm  allows  quick  and  easy  set  up  of  the  image  detector  during 
clinical  operation  and  hence  saves  time.  The  EPID  retractable  arm  has  the 
capability  of  moving  the  radio sensitive  part  of  the  detector  to  any  desired 
vertical, horizontal or lateral position within its geometrical operating positions.  
 
 
1.3.4 On-board Imager 
The  On Board  Imager  (OBI)  device  is  used  for  verification  of  correct  patient 
position in relation to the isocentre and verification of the treatment fields in 
relation  to  assigned  landmarks  in  radiotherapy  treatments.  The  OBI  is  an 
automated system recently added to modern linacs, specifically to ease IGRT 
treatments by managing patient and target movement  both before and during   5 
treatments. The OBI is a kilovoltage X ray imaging system that improves tumour 
targeting using high resolution, low dose digital imaging in the treatment room. 
The  use  of  kV  imaging  means  lower  patient  dose  and  provides  better  image 
quality than megavoltage imaging performed with an EPID. Similar to the EPID, 
the OBI is mounted on the treatment machine via robotically controlled arms 
which operate along three axes of motion so that they can be positioned for the 
best possible view of the tumour. The OBI provides the tools to manage both 
interfraction motion (changes in position caused by day to day set up conditions) 
and intrafraction motion (changes in position during a treatment session because 
of normal respiratory, organ motion and patient movement). The system allows 
a number of imaging choices including: 2D radiographic, fluoroscopic or 3D Cone 
beam CT imaging modalities. 
 
1.3.5 Support systems 
A  medical  accelerator  has  several  ancillary  systems  that  include:  the  power 
supply system, cooling water system, dielectric gas system, interlock and control 
systems.  
·  The power supply system: The external power supply delivers the power 
required to operate the entire unit.  
·  The  cooling  water  system:  Cooling  is  necessary  in  order  to  maintain  a 
precise  temperature  control  for  stability  of  operation.  The  main  parts 
which  need  cooling  include:  microwave  generator,  accelerating 
waveguide  structure,  radiofrequency  isolators,  pulse  modulator,  high 
power transformers, beam focusing and steering coils and X ray target. 
For convenience, the same cooling system is used for all components to 
be  cooled,  requiring  water  to  be  supplied  at  a  fixed  flow  rate  and 
temperature.  
·  The dielectric gas system: The transition section between the Klystron (on 
dual  energy  accelerators)  and  transmission  waveguide  needs  to  be  gas 
filled and is operated at high pressure to prevent sparking. It is typically 
operated  at  twice  atmospheric  pressure  and  filled  with  Sulphur 
Hexafluoride (SF6) gas. The circulating water provides surface cooling for   6 
the dielectric load. Both gas filled sections of the microwave system are 
separated from the evacuated sections by the waveguide windows. The 
high pressure system is usually fitted with a gauge and pressure operated 
switch  which  provides  an  interlock,  inhibiting  the  operation  of  the 
modulator if the pressure falls bellow a pre set level. 
1.4 Radiation beam production 
Accelerators  used  in  radiotherapy  accelerate  bunches  of  electrons  either  by 
travelling or stationary electromagnetic (EM) waves to high energies through a 
disc loaded tube at frequencies in the microwave (» 3000 MHz, wavelength »10 
cm) region, in a vacuum. Radiotherapy accelerators accelerate electrons either 
by travelling or standing waves, and the main difference between the two is the 
design  of  the  accelerator  structure.  Travelling  wave  structure  requires  a 
terminating load to absorb the residual power at the end of structure preventing 
backward reflected waves. The standing wave provides maximum reflection of 
the waves at both ends of the structure such that the combination of forward 
and reverse travelling waves will give rise to standing waves. Figure 1 2 shows 
the block diagram of the main components commonly used in a medical linear 
accelerator,  adapted  from  Khan  (2003).  The  accelerator  structure  is  quite 
complex,  but  mainly  consists  of  an  evacuated  copper  tube  with  its  interior 
divided  by  copper  discs  of  varying  aperture  and  spacing.  Pulsed  microwaves 
produced  in  the  Magnetron  or  Klystron  are  injected  into  the  accelerator 
structure via a wave guide system and at the same instant electrons produced 
from the electron gun are also pulse injected into the accelerator structure. As 
the electrons are injected into the accelerator structure with an initial energy of 
» 50 KeV, the electrons interact with the EM field of the microwaves and the 
electrons gain energy from the sinusoidal electric field. After the electrons have 
been accelerated the full length of the wave guide, the electron energy will 
depend mainly on the wave guide design, power applied to it and the current in 
the wave guide.  
   7 
Power Supply
Modulator
Electron Gun
Magnetron 
or Klystron
Accelerator Tube Treatment Head
(Straight Beam)
Treatment Head
(Bent Beam)
Wave Guide System
Bending Magnet
Radiation 
Beam
Radiation 
Beam
Power Supply
Modulator
Electron Gun
Magnetron 
or Klystron
Accelerator Tube Treatment Head
(Straight Beam)
Treatment Head
(Bent Beam)
Wave Guide System
Bending Magnet
Radiation 
Beam
Radiation 
Beam
 
Figure 1- 2. Block diagram, illustrating the major components of the accelerator needed for 
the generation of the radiation beam (Adapted from Khan, 2003). 
 
The  high energy  electrons  emerge  from  the  exit  window  of  the  accelerator 
structure in a pencil beam » 3 mm in diameter. In the electron mode, this beam 
is made to strike a scattering foil in order to spread the beam and to get uniform 
electron fluence across the treatment field. In the photon mode, after electrons 
have been accelerated to relativistic velocities, they strike a target and forward 
peaked  photons  with  a  broad  energy  spectrum  are  emitted  due  to 
bremsstrahlung production. As a result of the collisions, high energy x rays are 
produced from the target. In this case the collimated beam then passes through 
the flattening filter whose main function is to modify the forward peaked X ray 
beam to a uniform beam and to filter the low energy X rays. These high energy 
x rays are directed to the patient’s tumour and shaped as they exit the machine 
to  conform  to  the  shape  of  the  patient’s  tumour.  The  beam  may  be  shaped 
either by moving jaws that are placed in the head of the machine, by a multi 
leaf collimator (MLC) that is incorporated into the head of the machine or a 
combination of both. 
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1.5 Physical properties of radiotherapy beams 
1.5.1 Electron beam properties 
A number of different types of particles e.g electrons, protons, neutrons and 
heavy ions are in use in radiotherapy and of these electrons and protons have 
gained wide spread use. The most clinically useful energy range for electrons is 
4 22 MeV (Khan, 2003) and at these energies the electron beam can be used for 
the treatment of superficial tumours less than 5 cm deep. Because electrons are 
charged,  they  rapidly  ionise  the  matter  through  which  they  are  passing  and 
therefore they are referred to as directly ionising radiation. In the process they 
lose energy, which falls off rapidly with depth in matter, hence their inability to 
deliver  high  dosages  to  deeper  tissues.  Typical  applications  for  electron 
radiation include the treatment of skin cancers, chest wall irradiation for breast 
cancers, para spinal lesions, some head and neck cancers and boosting dose to 
nodes. Although there are many similarities between the behaviour of electron 
and  photon  beams,  there  are  also  many  differences  and  chief  among  the 
differences are summarised below (ICRU report 42, 1987):  
1) One of the main features of the electron beam that makes it attractive for 
radiotherapy  is  the  steep  fall off  of  the  depth dose  curve  beyond  the  dose 
maximum.  
2) The broadening of the dose distribution with depth resulting in a bulged shape 
in the penumbra region. 
3) The complex behaviour of electrons in and around tissue inhomogeneities due 
to multiple scattering. 
4) The shape of the dose distribution particularly at depths greater than the 
electron beam range which is due to the bremsstrahlung produced mainly in the 
radiation head of the Linac and also irradiated material / patient. 
 
1.5.2 Photon beam properties 
Photons are often referred to as X rays (generated as a result of atomic process) 
or g rays which is a result of decay of radioactive sources (nuclear process). X 
radiation is mainly produced when fast moving electrons strike a high density 
target material and depending on the energy of incident electrons, either low or   9 
high (or a combination of both) energy X rays may be produced. Clinical X ray 
beams typically range in energy between 10 kVp and 50 MV (Podgorsak, 2005). X 
rays in the energy range between 10 – 50 kVp are used for diagnostic purposes. 
For therapeutic purposes the energy range is subdivided into superficial (50  200 
kVp), orthovoltage (200 to 500 kVp) and mega voltage (0.5 to 50 MV). The most 
commonly  used  photon  beams  in  radiotherapy  range  between  4  to  20  MV, 
produced from linear accelerators.  Because photons have no charge, they are 
often referred to as indirectly ionising radiation and this physical property plays 
a fundamental role in their interaction mechanism. When photons interact with 
matter, ionisation is produced as a secondary effect, and this reaches a peak 
value at a certain depth from the surface, resulting in relatively less dose to the 
surface. This phenomenon leads to a skin sparing effect observed when patients 
are irradiated. An important consideration in the use of mega voltage photon 
beams for the treatment of cancer is the amount of surface dose delivered to 
the patient (Petti et al, 1983). One of the main characteristics of a high energy 
photon beam is its ability to penetrate deep into tissue while depositing energy 
in the form of radiation dose, and because of this, photons are mainly used for 
the  treatment  of  deep  seated  tumours.  Principal  applications  for  photon 
radiation include the treatment of cancers of the prostate, cervix, oesophagus, 
lung, etc. 
 
1.5.3 Interaction processes 
The  most  important  phenomena  during  interactions  of  radiotherapy  photon 
beams are: 
   Attenuation of photons by scattering and absorption 
   Energy transfer to charged particles, i.e electrons and positrons 
   Transport of charged particles 
   Deposition of energy 
The three most important photon interaction types relevant at energies used in 
radiotherapy  (Metcalfe  et  al,  1997,  Cherry  et  al  1998,  Khan  2003)  are 
photoelectric,  Compton  and  pair  production  processes.  Other  interaction 
processes  are  the  coherent  (Classical  or  Rayleigh)  scattering  and  gamma n 
interactions, although their cross sections are small at radiotherapy energies. 
Figure 1 3 summarises the main interaction processes. The probability of each is   10 
determined by a cross section which depends on the photon energy and on the 
density and atomic number of the medium. 
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Figure 1- 3. Primary photon interaction processes with their secondary emissions 
 
 
1.5.3.1  Photoelectric absorption 
The  photoelectric  interaction  is  more  probable  at  low  photon  energies  and 
interactions occur with inner shell electrons e.g the K or L shells. All the energy 
of the incident photon (hn) is transferred to a bound electron, which is ejected 
from the atom with kinetic energy Ee = hn Eb, where Eb is the binding energy of 
the electron in the atom. A vacancy left in the shell after the ejection of the 
photoelectron  is  filled  by  electrons  from  outer  orbits,  and  in  the  process 
characteristic x rays are emitted. Auger electrons, which are mono energetic, 
are emitted as a result.   11 
1.5.3.2  Compton scattering 
Compton scattering is the dominant photon interaction process at beam energies 
used  in  Megavoltage  radiotherapy,  replacing  the  photoelectric  effect  as  the 
chief means of removing photons from the initial beam. It is the predominant 
interaction process in soft tissue at energies in the range of 200 kV to 2 MV. In 
these energy ranges, the energy of the incident photon is much greater than the 
binding  energy  of  the  atomic  electrons.  The  interaction  occurs  with  the 
outermost shell electrons that have negligible binding energies, resulting in the 
electron  and  scattered  photon  being  ejected  from  the  atom.  By  energy 
conservation,  the  incident  photon  energy  (hn)  is  equal  to  the  sum  of  the 
scattered photon energy and the kinetic energy of the ejected electron. The 
main outcome of the Compton scattering process is the ionisation of the atom. 
 
1.5.3.3  Pair production   
Pair  production  is  most  predominant  at  very  high  energies,  with  a  threshold 
photon energy of 1.022 MeV (equivalent to 2moC
2, where mo is the electron rest 
mass and C is the speed of light) required to supply the rest energy of the two 
particles.  At  high  energies,  the  incident  photon  escapes  interaction  with  the 
electron cloud and enters the strong field surrounding an atomic nucleus. The 
photon disappears totally resulting in the formation of two oppositely charged 
ion  particles,  a  positron  and  electron.  The  photon’s  energy  in  excess  of  the 
threshold is imparted to the ion pair as kinetic energy. That is, the total kinetic 
energy shared by the ion pairs is (hn   2moC
2). Annihilation radiation occurs when 
the positron comes to rest and combines with an electron. 
 
1.5.4 Attenuation of photons 
Figure  1.4  shows  an  experimental  arrangement  for  the  study  of  photons 
attenuated through an absorbing material. A collimated mono energetic photon 
beam  is  incident  on  an  absorber  of  thickness  Dt  and  a  radiation  detector  is 
placed  in  the  beam  direction  to  measure  the  number  of  photons  that  pass 
through.    12 
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Figure 1- 4. Attenuation of photon beam through an absorber 
 
It  is  assumed  that  if  a  photon  interacts  with  an  absorber  atom,  it  is  either 
absorbed  or  scattered  according  to  the  photoelectric,  Compton  and  pair 
production  processes.  The  intensity  of  the  beam  is  reduced  as the  absorbing 
material thickness Dt is increased. Neglecting scatter, the reduction in photon 
intensity (DI) is proportional to incident photon intensity (I) and to the thickness 
of  the  absorber.  Assuming  a  collimated  beam  where  there  are  no  scattered 
photons detected and also in the limit Dt ® 0, then Dt ® dt, thus 
Idt dI t I I m a - = ⇒ D D .                                                                          (1.1)  
Where the constant of proportionality m is the linear attenuation coefficient and 
the minus sign indicates that the intensity of photons decreases as the absorber 
thickness increases.  The solution of the equation is given by 
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Where It is the intensity transmitted through thickness t and Io is the incident. 
The equation indicates that the attenuation of a mono energetic beam follows 
an  exponential  law  and  a  plot  of  ln(It)  versus  t  gives  a  straight  line  with  a 
negative slope equal to m. The total attenuation coefficient is the sum of the 
attenuation  coefficients  due  to  photoelectric,  Compton,  pair  production  and 
coherent processes.  
 
1.5.5 Photon dosimetry 
Dosimetry is a process of measuring radiation dosages. Conventional radiation 
dosimetry  involves  measuring  doses  resulting  from  ionising  radiation  and   13 
modelling the particle interactions within tissue. Photons are indirectly ionising, 
that  is  they  bring  about  their  ionisation  by  a  two stage  process.  In  the  first 
stage, they interact with matter to produce electrons (and positrons) and these 
charged  particles  then  produce  ionisation  along  their  tracks.  The  energy 
transferred from the photon beam to the irradiated material depends on the 
photon  energy,  interaction  coefficients,  atomic  number  of  the  material  and 
electron density. The dose to a point in a medium is composed of the primary 
and scattered components. The primary dose component is composed of energy 
deposited by photons emitted from the source. The scattered dose component is 
the  result  of  the  scattered  radiations  from  the  collimator  and  irradiated 
phantom or material.  
 
1.5.5.1  Depth influence  
Several methods are available for calculating the absorbed dose to a point in a 
patient  /  phantom  (Podgorsak,  2005  and  Khan  2003).  These  methods  utilise 
either the percentage depth doses (PDD) or tissue phantom ratios (TPR) or tissue 
maximum ratios (TMR).  
The PDD distributions inside a phantom are usually normalised to Dmax=100% at 
the depth of maximum dose (dmax), hence 
max max
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where  
·  ) , , , ( E f A d PDD  is the percentage depth dose at depth d, due to field area 
A, source to surface distance (SSD) f and photon beam energy E.  
·  d D  and  d D
·
 are the dose and doserates respectively at a point at depth d  
·  max d D  and  max d D
·
 are the dose and doserates respectively at a point at 
depth dmax on the central axis of the phantom.  
However  the  dependence  of  PDD  on  SSD,  makes  the  ) , , , ( E f A d PDD   method 
cumbersome for isocentric techniques. This limitation is overcome by using the 
TPR or TMR concepts that are nearly independent of SSD or SAD.  
The TMR and TPR concepts are defined as    14 
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 where  
·  ) , , ( E A d TMR M  and  ) , , ( E A d TPR P are the tissue maximum ratio and 
tissue phantom ratio respectively at depth d , AP and AM are field 
areas defined at the isocentre for TPR and at a reference depth for 
TMR respectively and photon beam energy E. 
·  d D  and  d D
·
 are the dose and dose rates respectively in a phantom 
at an arbitrary point at depth d on the beam central axis. 
·  dref D   and  dref D
·
  are  the  dose  and  dose  rates  respectively  in  a 
phantom on the beam central axis, at a reference depth dref = 5cm 
or 10 cm (or any convenient depth) for the TPR and dref = dmax for 
the TMR. 
·  The  phantom  position  is  varied  such  that  the  arbitrary 
measurement point and the reference point are the same distance 
from the source. 
 
1.5.5.2  Effect of field size  
For a photon beam with small field sizes, the central axis depth dose is delivered 
mainly  by  the  primary  beam  component.  For  larger  field  sizes,  photons  are 
scattered to every location on and below the surface, including those along the 
central axis. The relative contribution of  scattered radiation  to the absorbed 
dose increases with depth because photon beams tend to be scattered in the 
forward direction. The radiation output for an accelerator then increases with 
increasing field sizes. Usually the outputs are measured for different field sizes 
ranging from the smallest to largest possible at a fixed depth for each field size. 
The obtained readings are normalised to that of the 10x10 cm
2 field area, and 
the  resulting  ratios  are  referred  to  as  output  factors  OF(A,E),  which  are  a 
function of field area A and photon beam energy E.  
For isocentric setup, the dose  ) , ( A d D  at a depth d for a field area A is 
then calculated according to the equation (Williams et al 2004)  
100
) , (
) , ( ) ( ) , (
A d TPR
x A d xD A MUxOF A d D ref ref =            (1.5)   15 
Where:   
·  MU is the number of monitor units given 
·  OF(A) is the output factor of field A relative to the reference field size 
( ref A = 10x10cm
2) 
·  ) , ( A d TPR  is the tissue phantom ratio at depth d and field size A 
·  ) , ( ref ref A d D  is the dose per MU (for linac, approximately 1cGy/MU) 
 
1.6 Objective of radiotherapy  
The main objective of radiotherapy is to deliver radiation that will maximize 
dose to the tumour and minimize dose to normal tissue and/or critical organs, 
thereby increasing the probability of cure and lowering normal tissue morbidity. 
Thus considerable effort is devoted to disease localisation, treatment planning, 
verification of patient setup and finally dose delivery to ensure that the most 
accurate treatment possible for the patient is provided. Due to the increased 
complexity
  of  treatment  planning  and  delivery  techniques, verification
  of  the 
dose  before  and  during  the  actual  patient  treatment
  is  necessary  since  the 
relationship  between  the  absorbed  dose  and  both  tumour  control  probability 
(TCP) and normal tissue complication probabilities (NTCP) is steep (Podgorsak 
2005, Metcalfe et al 1997).  Figure 1 5 illustrates the relation between TCP and 
NTCP.  
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Figure  1-  5.  Dose-response  curves  for  tumour  control  probability  (curve  A)  and  normal 
tissue complication probability (curve B) (adapted from Podgorsak 2005). 
 
The objective of radiotherapy is achieved by increasing the TCP while keeping 
NTCP to the minimum, a phenomenon known as the therapeutic ratio as defined 
in figure 1 5 above. There is a considerable amount of clinical evidence which 
indicates  that  a  high  degree  of  accuracy  in  dose  delivery  is  essential  for 
successful  outcome  of  radiotherapy  treatment  (Wambersie  et  al  2001).  A 
generally accepted criterion for dose accuracy which is developed on the basis 
of  clinical  and  dosimetric  experience  is  that  the  administered  tumour  dose 
should be within 5% of that specified by the oncologist (ICRU report 50 1993, 
ICRU report 62 1999). The striving for improved accuracy has led to tremendous 
developments in radiotherapy. 
 
1.7 Radiotherapy treatment planning 
Radiotherapy  treatment  planning  is  a  process  whereby  sources  of  ionising 
radiation are suitably arranged and combined to give a desired dose distribution 
in a particular region of the body. The goal of treatment planning is to produce a 
high and uniformly distributed dose throughout the target volume while keeping 
the dose to the surrounding normal tissues / organs at risk as low as possible. It   17 
is  usually  necessary  to  combine  a  number  of  external  beams  of  radiation 
entering the body from different directions to obtain the desired distribution of 
absorbed  dose  in  the  target  volume  and  to  minimise  unwanted  exposures 
elsewhere. The combination of beams necessitates two important parameters in 
treatment planning and these are beam weighting and dose normalisation. Two 
sets of data are needed for the initialisation and accomplishment of treatment 
planning (ICRU report 24, 1987) and these are: 
1.  Beam data: These characterise the radiation and implies measurement 
at  the  therapy  machine.  The  number  and  type  of  measurements 
depend on the model used for beam representation and the algorithm 
used to combine the information with patient data. 
2.  Patient data: These describe the patient’s anatomy  (geometry) in a 
form that can be combined with the beam data. These data include 
information on the external surface of the patient, the target volume, 
organ at risk and relevant tissue inhomogeneities.  
The  enormous  amount  of  beam  combination,  dose  distribution  and  patient 
information data necessitate the use of computers for planning. When a patient 
undergoes  the  necessary  procedures  involved  in  producing  a  treatment  plan, 
including imaging e.g CT scan, MRI, etc, a computer plan is generated which is 
used as a tool for the accurate beam direction on the linac. Instructions from 
the plan have to be carried out in order to reproduce the correct arrangement of 
treatment fields. The plan specifies the gantry position, collimator positions and 
orientation, field sizes, shielding, wedge information and source to skin distance 
pertinent  to  an  individual  patient.    The  plan  also  provides  a  contour  of  the 
patient’s  anatomy  giving  a  view  of  tumour  and  surrounding  normal  tissues  / 
critical organs. 
 
1.8 Treatment verification 
Radiotherapy treatment is complicated and involves a series of processes that 
result in a dose distribution to a patient. It is a complex process involving many 
steps before the actual treatment begins. Figure 1 6 summarises the chain of 
processes  involved  before  the  patient  is  treated  with  radiotherapy  (van  Dyk 
2005). A number of uncertainties are introduced at every step in the process of   18 
planning and delivery of treatment, which makes treatment verification a crucial 
step in ensuring accurate treatment delivery. 
 
 
Figure 1- 6. Steps in the radiotherapy treatment process, linked by a chain 
 
 
The process starts with the diagnosis and the decision to treat the patient with 
radiation  therapy.  This  is  followed  by  delineation  of  the  target  volume  and 
organs  at  risk,  usually  from  CT  or  MR  scans.  Next  is  dose  calculation  that 
includes beam energy selection, shaping and optimisation. Radiation fields are 
combined  in  an  optimal  manner  to  create  a  treatment  plan  for  a  particular 
patient to be given in one or an extended set of fractions. Each step in this 
treatment chain has one or more sources of error and it is therefore important 
that  each  single  step  is  executed  with  the  greatest  accuracy  possible.  The 
uncertainty in each step will influence the accuracy of subsequent steps and, 
therefore impact on the overall treatment result. Uncertainties in the treatment 
process may include: 
o  Uncertainties in the position and extent of the target volume 
o  Inaccuracies in dose calculation algorithms 
o  Inaccuracies in treatment machine calibration, mechanical alignment and 
machine settings 
o  Inaccuracies in patient setup and/or inter fractional patient movement 
o  Variability of patient’s internal anatomy 
The advancement and development of new procedures in radiotherapy demands 
a  stringent  verification  procedure  due  to  their  complexity.  The  high  dose   19 
gradients  in  these  complex  treatments  make  single  point dose  measurements 
inadequate  in  verifying  the  dose  distribution.  Radiotherapy  treatment 
verification  is  the  process  that  enables  the  tumour  volume  to  be  treated  as 
planned. A comprehensive treatment verification programme is necessary that 
includes positional verification, treatment parameter verification and dosimetric 
verification to ensure that the right radiation dose is given to the correct place. 
 
1.8.1 Positional (Geometric) verification 
The aim of geometric verification is to ensure that the geometric accuracy of 
radiotherapy is within the limits set by the uncertainty margin allowed in the 
treatment  plan.  This  is  achieved  by  comparing  information  from  the  delivery 
against  that  planned.  Verification  is  only  one  component  of  the  treatment 
process.  Accurate  and  reproducible  planning  procedures,  including  the 
acquisition  of  good  quality  reference  images,  are  essential  to  successful 
verification. Geometric verification is achieved by comparing 2D or 3D images 
(data)  of  the  treatment  delivered  with  that  planned.  In  many  instances  a 
reference  image  is  obtained,  which  shows  the  planned  geometry  of  the 
treatment field placement relative to internal or anatomical bones or markers. 
The  reference  image  can  be  digitally  reconstructed  radiographs,  simulator 
images or the entire volumetric planning data. Any of these may be used as the 
standard  against  which  treatment  images  are  assessed.  Before  the  start  of 
radiotherapy, a pre treatment verification (process that compares the reference 
images with the planned treatment) is done. 
 
1.8.2 Treatment parameter verification 
There are several control mechanisms  to evaluate  the  accuracy of  the  single 
steps  in  the  treatment  procedure.  These  checks  are  based  on  QA  of  the 
treatment equipment, including the Linac and treatment planning system, and 
on the data transfer among the various types of equipment, such as transfer of 
data from a CT scanner to the TPS and from the TPS to the linear accelerator. 
However,  human  procedures  are  subject  to  error  also  and  determine  the   20 
accuracy  of  the  actual  patient  treatment.  In  practice,  despite  these  control 
mechanisms random or systematic errors still may occur (Lavalle et al 2006). The 
dosimetric impact of these errors is unique for each case and depends on the 
proportion of fields in error and volume mistreated (Ramaseshan et al 2004). An 
additional  check  during  the  actual  treatment  delivery  provides  information 
about the actual dose delivery and gives the ability to correct the dose before 
the next treatment fraction, when dose errors occur. 
 
1.8.3 Dosimetric verification:  In vivo dosimetry 
Dosimetric  verification  is  as  crucial  as  the  field  placement  geometric 
verification,  considering  the  complicated  treatment  protocols  employed  in 
modern radiotherapy. Verifying dose is the most obvious method of assessing the 
accuracy of a patient’s treatment. Patient dose verification, in vivo dosimetry, 
serves as an important part of a QA programme in radiotherapy and has been 
recommended for quality improvement of patient care in radiation therapy by 
several organizations such as the European Society of Therapeutic Radiology and 
Oncology  (Ferreira  et  al,  2000)  and  the  Royal  College  of  Radiologists  (RCR) 
report No BFCO(08)1 “towards Safer Radiotherapy” (2008) . In vivo dosimetry is 
a tool to measure the radiation dose delivered to patients during radiotherapy. 
The  aim  of  in  vivo  dosimetry  is  to  compare  dose  measured  at  the  time  of 
treatment with the dose values specified by the radiation oncologist and  the 
dose values calculated by the TPS, to ensure that the accuracy of the prescribed 
dose to the target volume is within acceptable limits. In addition to the use of in 
vivo dosimetry for assessing the dose delivered to an individual patient for the 
detection  of  various  types of  errors  in  the  dose  delivery  process,  it  can  also 
serve as a tool to verify new treatment techniques in the clinic, after the initial 
validation of the procedure using phantoms, or as an indicator to assess the dose 
in organs at risk. It is recommended that in vivo dosimetry should be carried out 
on  all  patients  and  that  the  treatment  dose  delivery  should  be  accurate  to 
within  5%  (Huyskens,  et  al  2001,  ICRU  report  62  1999).  For  each  individual 
patient  the  deviations  between  the  delivered  dose  distribution  and  the 
distribution  according  to  the  treatment  plan  should  be  within  the  accepted 
tolerance limits. Radiation detectors that have been used for dose verification   21 
include  thermoluminescent  dosimeters,  diodes,  films,  and  most  recently 
electronic portal imaging devices (EPID).  
 
 
1.8.3.1  Entrance and exit dosimetry 
The most direct form of in vivo dosimetry is to physically place detectors inside 
the  patient  (Podgorsak,  2005),  however  this  is  only  possible  for  treatments 
where there are cavities inside the body such as the mouth, vagina and rectum. 
The most common method is to measure the entrance or exit doses directly on 
the surface of the patient. Entrance dose measurements are performed in many 
centres  during radiotherapy due  to  their simpler setup on the surface of the 
patient (Leunens et al 1990, Fiorino et al 2000). They are useful for identifying 
setup  errors  such  as  incorrect  patient  source  to  surface  distance.  Entrance 
dosimetry is commonly performed with single point dose devices such as diodes 
or Thermoluminescent detectors (TLDs) which unfortunately do not cover the 
entire radiation field, and possible errors may not be detected, more especially 
in IMRT treatments where there are numerous steep dose gradients occurring in 
the  combined  beam  segments.    In  addition  to  the  errors  above  that  can  be 
detected by entrance dose the exit dose, defined as the dose on the patient at 
the exit side of the beam, can be used to identify changes in tissue thicknesses 
and detect inhomogeneities via changes in dose transmitted through the patient 
(Broggi et al 2001).  
 
Figure 1 7 illustrates the exit and entrance calibration planes used in the in vivo 
dosimetry calculations (Heukelom et al 1991) and also recommended by ESTRO 
(Huyskens et al 2001). The entrance point is defined at the dose plane a distance 
dmax from the entrance surface of the phantom. The exit dose is defined at the 
dose plane positioned at a distance dmax, from the exit surface of the phantom. 
It should be noted that the exit dose and entrance dose do not refer to the exit 
surface dose and entrance surface dose. Figure 1 8 shows a typical depth dose 
curve  illustrating  the  main  differences  between  entrance  and  exit  doses  and 
their respective surface doses. The lack of appropriate back scatter results in 
reduction of surface dose.  
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Figure 1- 7. Illustration of the (a) entrance and (b) exit dose calculation planes 
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Figure 1- 8. Typical depth dose curve in water phantom 
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1.8.4 Modalities of treatment verification 
1.8.4.1  Film 
Film  dosimetry  can  only  be  used  for  pre treatment  dose  verification  and 
typically employs high resolution radiographic film combined with film density 
digitisation to get a 2D dose distribution (Ezzell  et al, 2003). The technique 
involves  placing  a  film  inside  a  solid  water  (dosimetrically  water equivalent 
plastic) flat phantom at the isocentre perpendicular to the beam axis. One film 
is used for each clinical field that is being verified. Film depth can vary from the 
depth of maximum dose (d
max) to any depth of interest in the treatment plan. 
Pinholes are placed in the film marking the location of the cross hair or points of 
registration. To calibrate the film used for the clinical fields, a set of calibration 
films, taken from the same batch of film, are exposed with known radiation field 
sizes, depth and doses to generate a calibration curve or exposure of one film 
with step and shoot MLC controlled field beam. The calibration curve is then 
used  to  convert  the  optical  densities  of  the  test  film  to  absolute  dose. 
Advantages of using film are that 2D dose distribution is possible and that the 
required equipment is commonly available in most radiotherapy departments. 
However, film dosimetry suffers from several drawbacks (Warkentin et al 2003):  
1) It is time consuming since it requires processing and scanning of the film, and 
needs a sensitometric curve to convert optical densities into absorbed doses. 
2) The dose response may be affected by the production batch and processing 
conditions, which are difficult to control 
3) Film verification of multiple fields is labour intensive 
4) Film requires digitisation for quantitative comparison 
5) Requires darkroom and processing facilities. 
6) Storage and archiving of film are inconvenient and labour intensive  
 
1.8.4.2  Thermoluminescent dosimeters 
Thermoluminescence dosimeters (TLD) can be used to measure the dose at the 
entrance  and/or  the  exit  side  of  the  patient.  The  fact  that  no  cables  are
 
required during the measurement allows the use of TLDs inside
 tissue equivalent 
phantoms to verify radiation doses delivered
 in new treatment techniques. These   24 
features  make TLDs  a good  in  vivo  dosimetry  tool  allowing  dose  assessments
 
directly on patients during therapeutic procedures. A drawback of this approach 
is that dosimetric information is only obtained at a single or a few points. The 
major disadvantages of TLD are that there is no instant readout and that the 
signal  is  erased  during  readout  and  hence  it  is  easy  to  lose  dosimetric 
information.  
 
1.8.4.3  Diodes 
Diodes  are  semiconductor  detectors  which,  when  connected  to  a  suitable 
electrometer,  offer  the  unique  combination  of  high  sensitivity,  immediate 
readout,  simplicity  of  operation  (no  external  bias  voltage),  small  size  and 
robustness against radiation damage. Silicon diodes can be made from either n 
type or p type silicon and in the boundary between two regions, one of p type 
and  another  of  n   type  silicon,  there  is  a  depletion  of  free  charge  carriers. 
Irradiation induces charge flow and due to defects in the crystal lattice some 
electrons are trapped and will consequently not contribute to the diode signal. 
The charge can be amplified and measured with an electrometer. Diode signal 
depends on many factors (Huyskens et al 2001) including: photon beam energy, 
dose rate, temperature, field size, source to surface distance, beam angulations 
and  the  presence  of  wedges  or  blocks.  For  this  reason,  diodes  require  many 
correction  factors.  Diodes  are  conventionally  used  for  treatment  verification. 
They are the most commonly used detector type for patient dose verification 
(van  Elmpt  et  al  2008;  Fiorino  et  al  2000).  However,  since  they  are  usually 
placed on the patient’s skin surface, they are used for point dose measurement 
and dose verification is usually limited to a number of superficial points. 
 
1.8.4.4  MOSFET 
Recently there has been an increased interest in the use of the metal oxide 
silicon  semiconductor  field  effect  transistor  (MOSFET)  for  in  vivo  dosimetry 
purposes (Ferreira et al 2000, Bloemen van Gurp et al 2007). The system uses 
miniature  non intrusive  MOSFET  semiconductor  radiation  dosimeters  (size  less 
than 4 mm
2). Other characteristics of MOSFET devices are the direct and simple 
dose  readout,  the  portability  of  the  system  and  the  recording  of  the 
accumulated dose of each detector. The output can be converted from mV to   25 
cGy by entering a calibration factor in the reader  for each single dosimeter. 
MOSFETs exhibit in addition a good linearity of their response (Ferreira et al 
2000,  Bloemen van  Gurp  et  al  2007).  These  studies  determined  important 
physical  characteristics  of  the  detectors  to  demonstrate  the  usefulness  of 
MOSFETs as clinical dosimeters; and measurements were performed at different 
sites  of  the  patient’s  body,  with  both  photon  and  electron  beams  of  various 
energies. 
 
1.8.4.5  Ionisation Chambers 
Ionisation chamber matrix detectors have been produced for measuring energy 
fluence  or  absorbed  dose  in  two  dimensions  (Amerio  et  al  2004,  Spezi  et  al 
2005). These detectors consist of a large number of ionisation chambers placed 
in a regularly spaced array or at specific points in a phantom. Matrix detectors 
can  be  attached  to  the  gantry  of  the  linear  accelerator  or  placed  on  the 
treatment couch. A quick verification of the beam is performed by comparing 
the output of these devices with a dose distribution predicted by the TPS. A 
drawback of these devices is that they have relatively few measuring points and 
therefore a low spatial resolution. This potentially limits their applicability to 
the verification of highly intensity modulated fields. 
 
1.8.4.6  Electronic Portal Imaging Devices 
Currently electronic portal imaging devices (EPIDs) are mainly used for patient 
setup verification during treatment, but several other geometric properties like 
beam  blocking  shapes  and  leaf  positions  can  also  be  determined.  Recent 
literature  indicates  an  increase  in  treatment  verification  with  portal  imaging 
(Topolnjak et al, 2010) and it is an effective means of reducing setup errors 
(Murthy et al 2008, Krengil et al, 2009). Furthermore, one of the most recent 
usages of EPIDs is portal dosimetry, which allows the possibility of dosimetric 
treatment verification. Pre treatment monitor unit verification is possible with 
high  accuracy  and also geometric parameters can  be  verified using  the same 
EPID  image.  The  acquired  images  are  available  for  on line  review  before 
commencement  of  treatment.  By  combining  geometric  and  dosimetric 
information,  the  data  transfer  between  treatment  planning  system  (TPS)  and 
linear accelerator can be verified. The EPID dosimetric capability is based on the   26 
presumption  that  the mean pixel value of the imager is dependent upon  the 
photon fluence incident upon the corresponding area of the detector. This in 
turn is related to the dose at the exit surface of a patient or phantom. Thus, 
radiation dose measured at the detector is related to the attenuation through 
the patient and input dose. If the detector is far enough away from the patient 
to  reduce  scatter  to  a  minimum,  then  the  EPID  image  should  produce  an 
accurate estimate of the radiological thickness of the patient (Kairn et al, 2007), 
which can be related to dose (Kavuma et al, 2010). 
 
 
1.8.5 Advantages of electronic portal imaging devices over other 
modalities 
The EPIDs have several advantages over the other detectors used for dose 
verification, and the major ones are: 
o  The device is in most centres already attached to the accelerator 
o  Fast image acquisition 
o  No film processing and need of cassettes 
o  The image is in digital format with high resolution 
o  Point and 2D dose measurements 
o  Possibility of 3D dose verification, reconstructed by back projection of the 
2D dose into a 3D image data from CT scan or cone beam CT 
o  Possibility of performing in vivo dosimetry on linac based treatments 
without the need for additional equipment  
o  Immediate  image  analysis  is  possible  and  review  can  be  done  at  any 
workstation 
 
The  past  2 3  decades  have  yielded  new  clinical  capabilities  and  substantial 
improvements in patient care. The greater complexity of today's radiotherapy 
practice creates considerable challenges for users. There is a general need to 
use a wide range of equipment features and clinical applications to improve the 
quality (e.g. reducing the radiation dose to patients’ non targeted areas) and 
effectiveness of the treatment. EPID has evolved because it provides real time, 
fast image archiving, retrieval and automated image analysis. This has prompted   27 
many research groups to study their use for radiotherapy dosimetry. However 
the  current  techniques  are  limited  to  pre treatment  verification,  where  the 
radiation fluence is only verified in the absence of a patient (non transit). The 
actual  day to day  treatment  verification  of  dose  received  by  the  patient  is 
imperative  to  keep  up  with  the  pace  of  the  increasing  complexity  of 
radiotherapy treatments. In vivo dosimetry using diode, TLD and/or MOSFET is 
commonly  employed  to  verify  the  dose  delivered  during  external  beam 
radiotherapy (Nijsten et  al 2007,  Piermattei et  al  2007). These measurement 
techniques,  however,  require  considerable  time  and  effort  to  implement 
routinely  in  busy  radiotherapy  departments  and  the  amount  of  information 
gathered is limited to a single or a few selected points.  
 
1.9 Portal Dosimetry Literature Review  
1.9.1 History of EPID usage for dosimetry 
One  of  the  first  uses  of  EPIDs  for  dose  measurement  was  developed  at  the 
Netherlands Cancer institute  and involved the  scanning liquid filled ionisation 
chamber (SLIC) EPID (Van Herk, 1991). Later in mid 1990’s, this technological 
development  led  to  PortalVision,  a  Varian  (Palo  Alto,  CA,  USA)  commercial 
portal dosimetry software system. One of the main limitations of the SLIC was 
the relatively long read out time (van Elmpt, 2008), such that the device could 
not  measure  dose  directly,  but  was  suitable  for  measuring  dose  rate.  The 
measured dose rate was converted to absolute dose by recording a continuous 
readout of the monitor chamber signal of the linac during image acquisition and 
the number of MUs delivered for the measured dose image. Chang et al (2000) 
investigated  dose  verification  using  the  liquid filled  ion  chamber  EPID  by 
comparing profiles and dose measurement at the isocentre.  The study reported 
an accuracy of 3% in central axis, better than the 5% requirement recommended 
by the Task Group 40 Report (Kutcher et al 1999) of the American Association of 
Physicist  in  Medicine  (AAPM)  for  independent  verification  of  the  dose  at  the 
isocentre.  Although  this  was  sufficiently  accurate  for  clinical  QA,  the  slow 
response detector memory effect and beam hold off effects (the withholding of 
linac beam pulses when MLC leaves are not in the correct positions), made the 
liquid filled ionising chamber EPID usage impractical for clinical use (Chang et   28 
al,  2002).  Mohammadi  et  al  (2007)  used  a  scanning  liquid filled  ionization 
chamber electronic portal imaging device (SLIC EPID) and extended dose range 
(EDR2)  films  to  evaluate  transmitted  dose  profiles  for  homogeneous  and 
inhomogeneous  phantoms.  Calibrated  ionisation  chamber  measurements  were 
used to convert the pixel values acquired from the electronic portal images to 
dose. For homogenous and inhomogeneous phantoms, more than 90% agreement 
was  achieved  using  gamma  criteria  of  2%  and  3  mm  and  3%  and  2.5  mm 
respectively. 
In the mid 1990’s, camera based EPIDs were invented and developed into 
commercial products by various vendors, among which was iView
TM, marketed by 
Elekta  Oncology  Systems,  Crawley,  UK  (Heijmen  et  al,  1995).  The  main 
advantages  of  these  systems  were  that  a  large  portion  of  the  field  could  be 
imaged  quickly  due  to  the  fast  read out  of  the  camera  and  they  had  a  high 
spatial resolution. The measured grey scale value was approximately linear with 
dose and did not depend on the absorber thickness placed in the beam (Pasma et 
al, 1998). The camera based EPID however, had a large field size dependence 
caused by scattered visible photons inside the optical system. Once the camera 
based  EPID  was  calibrated,  mainly  by  removing  the  influence  of  the  optical 
scatter effects, the device was suitable for performing portal dosimetry with 
deviations around 1–2% (van Elmpt, 2008). Pasma et al (1999) reported on the 
use  of  charged coupled  device (CCD)  camera  based  system  for  pre treatment 
dosimetric  verification  of  IMRT  beams  produced  with  a  dynamic  MLC.  EPID 
images were acquired for all beams and these images were then converted into 
2D dose distributions and compared with the calculated dose distributions using 
a commercial TPS. The dose profile measured with the EPID was also compared 
with ionisation chamber measurements. The agreement between the EPID and 
ion chamber was within 2%.  
The  amorphous silicon  EPIDs  (a Si  EPID)  or  flat panel  imagers  were  first 
described by Antonuk et al (1998) and currently are the most common type of 
EPID available. The panel consists of an X ray converter, light detector, and an 
electronic acquisition system for receiving and processing the resulting digital 
image.  The  dose–response  behaviour  of  the  three  commercially  available  a Si 
EPIDs has been described; the Elekta iView GT system, the Siemens OptiVue and 
the Varian Portal Vision a Si 500/1000 (McDermott et al 2004, McDermott et al 
2006).    29 
 
Munro et al (1998a, 1998b) investigated the dosimetric characteristic of a 
small (96x96 mm
2) a Si indirect flat panel detector; they measured the linearity, 
spatial resolution, glare, noise and signal to noise characteristics. The results 
indicated that the response of the sensor was linear and did not suffer from the 
glare phenomenon associated with camera based EPIDs.  This study concluded 
that a Si detectors are more suitable for dosimetric verification. El Mohri et al 
(1999) studied linearity response, dose rate dependence, sensitivity, long and 
short term reproducibility of a Si flat panel. This study investigated EPIDs in both 
the  indirect  and  direct  configuration  modes.  The  direct  detection  mode  was 
superior over the indirect mode in terms of linear response and good long term 
stability in pixel response. 
 
1.9.2 Dosimetric characteristics of a-Si electronic portal imaging 
devices  
The  dosimetric  characteristics  of  EPIDs  have  been  studied  by  several 
investigators.  McCurdy  et  al  (2001)  investigated  dosimetric  properties  of  a Si 
detector such as linearity with dose (±0.5%), reproducibility (±2%) and response 
variations in gantry rotation and source to detector distance. Greer et al (2003) 
investigated the dosimetric properties of an a Si EPID using continuous frame 
averaging acquisition mode for 6 MV radiation beam. The properties investigated 
included effect of build up, dose response, field size response, response to rapid 
MLC leaf speed, beam dose rate effect, memory effect and reproducibility. The 
dependence  of  response  on  EPID  calibration  and  dead  time  in  image  frame 
acquisition occurring every after 64 frames was measured. The results of this 
study  indicated  that  the  response  of  the  EPID  with  dose  and  dose  rate  was 
linear, and response to MLC motion (leaf speed of 2.5 cm/s) was also found to be 
linear. A field size deviation of » 5% relative to dmax ion chamber measurement 
was found. Memory effect was negligible at » 0.2% and reproducibility was good 
at » 0.8%. This investigation also reported on the relative dosimetry of an a Si 
EPID, where they measured the accuracy of the EPID in recording open and static 
wedge fields. EPID profiles through the central axis for the open field and in the 
wedged  direction  for  the  wedge  field  were  compared  to  ion chamber 
measurement and the agreement was within 3%.    30 
  Van  Esch  et  al  (2004)  performed  EPID  detector  saturation,  linearity, 
reproducibility,  ghosting,  field  size  dependence  and  portal  depth  dose 
measurements.  The  results  from  this  investigation  indicated  that  detector 
saturation may result in dosimetric errors in the range 0.35 to 1.4%, though it 
can be worse than this depending on type of detector. The EPID response for 
depth dose (dose measurements as a function of absorbing material, normalised 
to their maximum value) was within 1% compared to an ion chamber in terms 
inverse square law behaviour. Short term and long term detector reproducibility 
was found to be within 2% for static as well as dynamic field delivery. Ghosting 
was below 1% for 6 MV and 18 MV. The field size dependence for EPID and ion 
chamber measurements were similar for 6 MV and showed discrepancies of up to 
9% for the 18 MV beam. The dose maximum plateau region is wider for the a Si 
EPID with widths of » 1.5 cm and » 3 cm for 6 and 18 MV respectively.  
Winkler  and  George  (2006)  carried  out  an  inter comparison  of  eleven 
Elekta iViewGT
TM EPIDs from different institutions and reported on dose, dose 
rate, and field size responses among others. Chen et al (2006) and Nijsten et al 
(2007) reported the dosimetric properties for the Siemens EPID, mainly focusing 
on calibration methods for transit dosimetry. McDermott et al (2006) compared 
the  ghosting  effects  for  three  (Varian,  Elekta  and  Siemens)  a Si  EPIDs  and 
reported  on  their  signal to MU  ratios.  Several  articles  have  reported  on  the 
dosimetric characteristics of the Varian EPID (Greer et al 2003, Chang and Ling 
2003). 
One specific area where EPIDs have been successfully used for dosimetric 
purposes  is in  the  pre treatment  verification  of  IMRT  fields,  by  assessing  the 
accuracy of the intended fluence as used in the treatment planning system (TPS) 
for dose calculation and the actually delivered fluence (Greer et al 2003, Van 
Esch et  al  2004).    These  studies  investigated  the  application  of  a Si  for  pre 
treatment dose verification by comparing clinical EPID IMRT images with fluence 
maps predicted by TPS. Van Esch et al (2004) developed and evaluated a portal 
dose  prediction  algorithm  based  upon  the  pencil  beam  dose  calculation  as 
implemented in the CadPlan TPS. Measured and predicted portal dose images 
were compared by means of line profiles and gamma index criteria. Over 90% of 
points in the IMRT fields passed the gamma criteria at 3% dose difference and 3 
mm distance to agreement. Chang et al (2003) evaluated the use of a Si 500 
EPIDs  for  the  verification  of  IMRT  beam  delivery  using  synchronous  frame   31 
averaging  acquisition,  which  was  evaluated  on  25  prostate  IMRT  fields.  The 
acquired EPID images for IMRT fields were converted to dose using a dose profile 
calibration curve. The measured dose profiles compared with the planned were 
in good agreement with a mean error of 1.9% and standard deviation of 0.5%. 
The central axis dose agreement was better than 2.0 %. 
A major problem associated with a Si EPIDs for transit dosimetry is the 
presence of a phosphor layer, which can introduce large deviations from water 
equivalent  behaviour  due  to  energy dependent  response  and  visible  light 
scattering, though the effect caused by the latter may be negligible. During the 
present  work, Sabet et  al (2010) modified an a Si EPID to a  direct detection 
configuration by removing the phosphor layer, and the accuracy of using it for 
transit  dosimetry  measurements  was  investigated  for  6  and  18  MV  treatment 
beams  by  comparison  to  ion chamber  in  water  measurements.  This  study 
concluded that the direct EPID could perform as an ion chamber detector for 
transit dosimetry applications in all geometries. The major current limitation of 
the  direct  EPID  is  the  poor  image  quality  compared  with  the  clinical 
configuration.  This  study  suggested  that  the  practicability  of  interchanging 
between imaging and dosimetry setups should be investigated.  
 
1.9.3 Dose Verifications 
Several  authors  have  reported  on  different  ways  of  using  the  EPID  for  dose 
verification. Leunens et al (1990) and Terron et al (1994) combined entrance and 
exit  point  dose  measurements  to  determine  a  mid plane  dose  inside  the 
patients.  This  approach  has  been  shown  to  be  valuable  for  immediately 
identifying errors related to the inaccuracy of the TPS, especially for 2D dose 
calculation  algorithms,  setup  errors,  human  errors  and  fluctuations  in  Linac 
output. The limitation of the approach has been the simplicity of the algorithms 
used to determine the midplane dose, which are only effective under certain 
geometric and symmetric (phantom) conditions (Leunens et al 1990). Algorithms 
for determining the midplane dose at a single point were later extended to 2D 
(Dam  et  al  1992,  Ebert  et  al  1994),  by  correlating  the  2D  transmitted  dose 
measured with film at a certain distance behind the phantom (patient) with a 2D 
dose  at  the  exit  surface  of  the  patient.  This  was  then  used  to  predict  2D 
midplane  dose  distributions.  These  authors  reported  the  agreement  between   32 
exit doses derived from transmitted film and diodes measurements to be within 
5 8%. Discrepancies were attributed to scatter approximations for large phantom 
to detector distances and curvature in phantom geometry at the exit beam side. 
Under such conditions, the correlations in off axis ratios at the midplane and 
transmitted  dose  plane  deteriorated  due  to  the  decrease  in  contribution  of 
scattered  dose  relative  to  the  primary  dose  contribution.  This  was  shown  to 
overestimate the dose near the edges of the field calculated at the midplane 
relative to measurements or TPS calculations at the midplane (Dam et al 1992, 
Fiorino 2000).  
For  dosimetric  use,  portal  images  must  be  corrected  for  field  size 
dependence, energy dependency and ghosting effects (Herman et al 2001). This 
idea was used by several investigators, e.g. comparison of the measured and 
predicted portal dose for each treatment field (Pasma et al 1998 and Van Esch et 
al 2004), verification of leaf positions for intensity modulated fields (Greer et al 
2003 and Parent et al 2006),  reconstructing the dose to the patient using the 
exit image acquired during treatment (Piermattei et al 2007 and Wendling et al 
2006) and converting the image to a fluence distribution that is used as input to 
a dose algorithm to reconstruct a 3D dose to the patient (Renner et al 2005, 
Steciw et al 2005, Van Elmpt et al 2006 and Van Zijtveld  et al 2007). 
 
 
1.9.4 In vivo dosimetry with electronic portal imaging devices 
The advancement of radiotherapy technology resulted in the transition from 2D 
film  measurements  described  in  section  1.8.4.1  to  EPID  acquired  images  as 
described in section 1.8.4.6. Kirby et al (1994) were one of the first authors to 
use  an  EPID  for  determining  exit  doses  of  phantoms  and  patients,  using 
integrated images from a fluoroscopic EPID with 6 and 20 MV photon beams. 
They determined an empirical relationship between exit doses measured with 
diodes and transmitted doses measured with the EPID based on homogeneous 
phantom measurements for a variety of thicknesses and patient to EPID air gap 
distances. The empirical data were tested on a variety of irradiation geometries 
using  an  anthropomorphic  phantom  as  well  as  on  patients  undergoing 
radiotherapy and the agreement was within ± 7%. The limitation of the method 
was  its  failure  to  accurately  predict  the  exit  dose  under  asymmetric  scatter   33 
conditions  and  also  the  ±  7%  is  out  of  tolerance  compared  to  the  ±  5% 
recommended by ICRU report 62. 
The  earlier  2D  midplane  dose  calculation  methods  above  were  only 
accurate for small air gap distances » 10 cm between the exit surface of the 
patient  and  the  transmitted  dose  plane  and  did  not  take  into  account  the 
decrease in scatter contributions for larger sized air gaps. Furthermore if EPIDs 
are  to  be  used  for  exit  and  midplane  dosimetry,  such  models  need  to  be 
adjusted for the extended distances from the beam focus and patient for which 
EPIDs are installed. As a consequence, Boellaard et al (1997) developed a 2D 
back projection convolution  model  for  converting  transmitted  doses  to  exit 
doses more accurately at larger phantom to detector air gaps of » 50 cm. The 
idea was based on the separation of the total exit dose into the primary and 
scatter  components.  The  scatter  dose  at  the  exit  surface  was  calculated  by 
convolving  the  primary  exit  dose  with  an  exponential  spread  function,  from 
which they derived the scatter to primary ratio transmissions. The agreement 
between exit doses calculated with the convolution model compared with exit 
dose  measured  with  an  ion  chamber  for  an  8  MV  photon  beam  under 
homogeneous and inhomogeneous phantoms was within 2.5% (Boellaard 1997).  
Wendling  et  al  (2006)  extended  the  original  convolution  model  of 
Boellaard et al (1997) for a Si EPIDs. Additional kernels were applied to account 
for the unique response of the a Si EPID, corrections for lateral scatter effects 
occurring within the EPID itself and improving accuracy in beam penumbra. More 
recent  work  focused  on  extension  of  2D  convolution  models  into  a  3D  dose 
reconstruction applied in different targets and organs at risk (Louwe et al 2007). 
Modifications such as the inclusion of patient contour information were included 
and were found to significantly improve the results. 
Fidanzio  et  al  (2010)  used  a  generalized  set  of  correlation  functions 
F(TPR,w,L) and empirical factors f(TPR,d,L); where TPR is the Tissue Phantom 
Ratio,  w  is  the  phantom  thickness,  L  is  the  square  field  side,  and  d  is  the 
distance between the phantom mid plane and the isocenter to reconstruct the 
isocenter dose for 6, 10 and 15 MV photon beams. The in vivo dosimetry method 
was developed from previous work done by the same group (Piermattei et al 
2006 and Piermattei et al 2007). The function F(TPR,w,L) is defined as the ratios 
between the transit signals per MU, obtained by an a Si EPID positioned below a 
solid  water  phantom,  and  the  dose  per  MU  values  measured  along the  beam   34 
central axis at phantom mid plane coincident with the SAD. In the experimental 
set up they determined the mid plane doses per MU, and the transit signals per 
MU  for  different  phantom  and  field  sizes  measured  at  the  Source  to  EPID 
Distance. They used these data to determine the empirical factors f(TPR,d,L) 
that take into account the variations of the scattered photon contributions on 
the EPID due to the different phantom position with respect to the SAD. They 
reported tolerance levels that ranged between ±5% and ±6% depending on the 
tumour body location. 
Whilst EPIDs are in routine use in radiotherapy departments to verify the 
desired treatment geometry in relation to anatomical structures, their role as in 
vivo dosimeters is less common (van Elmpt et al, 2008). In  the past  decade, 
research and development has been undertaken which relates to their double 
utilisation as an in vivo dosimeter and field verification tool (Fiorino et al 2000, 
Broggi et al 2001, Piermattei at al 2007, McDerrmott et al 2007, van Zijtveld et 
al 2009). Within the last two decades, EPIDs based on amorphous silicon panels 
mounted  on  an  accelerator  gantry  have  been  introduced  for  patient  setup 
verification (Fielding et al 2002, Herman et al 2001) while more recently, dose 
verification became more possible (Chen et al 2006, Wendling et al 2006, Parent 
et al 2007). EPIDs offer the possibility of performing in vivo dosimetry on linac 
based  treatments  without  the  need  for  additional  equipment.  EPID  in vivo 
dosimetry is thus defined as the determination of a dose distribution inside the 
patient based on EPID images acquired during treatment, and is only possible 
with the transit method (Wending et al 2006, van Elmpt et al 2008).  In vivo 
verification of  the delivered  dose is  achieved by comparing  the  portal image 
acquired  during  treatment  to  a  predicted  transmission.  Such  comparison  can 
reveal problems in dosimetric performance of the linear accelerator, errors in 
the  treatment  plan  or  beam  modifying  devices  such  as  wedges  and 
compensators, and changes in patient anatomy. 
 
1.9.5 Portal dosimetry commercial Packages 
1.9.5.1  Varian's portal dosimetry system 
The current portal dosimetry package available, version 8.2.0, is a non transit 
package; hence it is used for pre treatment verification of IMRT plans only. The   35 
averaged grayscale image is converted into a portal dose image in the Dosimetric 
Workspace by summing all images taken over the beam on time. Commissioning 
of the portal dosimetry system starts with configuring the Varis / Vision system. 
The  portal  dose  image  prediction  (PDIP)  software  algorithm  first  has  to  be 
configured in Beam Configuration before it can be used in Eclipse 8.6. Among 
other things, an image of a test pattern has to be measured with the imager, 
and output factor tables of the imager have to be measured. This is analogous to 
the beam data measurements (water phantom) needed for configuration of 3D 
dose calculation algorithms. The processes inside the amorphous silicon imager 
are  rather  complicated  and  not  comparable  to  ionisation chamber  water 
dosimetry. Hence the terms "dose" and the corresponding unit "Gy" are avoided 
by Varian in the context of Portal Dosimetry. Instead they use Calibrated Units 
(CU), where 1 CU corresponds to 1 Gy at a reference depth.  
 
1.9.5.2  Dosimetry Check  
Math  Resolution  LCC  (USA)  developed  an  EPID  dose  verification  package 
“Dosimetry Check”, which was initially dedicated to non transit pre treatment 
dose verification,  but now is  extended  to  transit verification. In  the UK,  the 
“Dosimetry Check” software was first tested at the Edinburgh Cancer Center, 
Western General Hospital and evaluation of its suitability in different conditions 
was presented at the Scottish Radiotherapy Physics meeting (Nichol et al, 2010). 
The  analysis  of  the  results  of  the  presentation  concluded  that,  “Dosimetry 
Check”  can  be  used  as  either  a  pre treatment  verification  or  as  a  transit 
dosimetry tool with reasonable accuracy and that further studies are required in 
order to establish acceptable tolerances for different clinical sites. By the end of 
2010,  at  the  end  of  the  present  project,  the  Dosimetry  Check  software  was 
commercially available. This system works with input from the Varian, Elekta, 
and Siemens EPID in integration mode. 
 
1.9.5.3  EPIQA 
EPIQA is also a non transit commercial software that can convert a dosimetric 
image acquired by an EPID into a dose map, and to compare the dose map with a 
reference dose distribution. EPIQA was developed specifically for use with Varian 
a Si500 mounted on a Varian 6EX linear accelerator. The software can be utilised   36 
for  verification  of  static  as  well  dynamically  modulated  fields.  The  portal 
dosimetry image conversion to dose is based on the GLAaS algorithm (Nicolini 
and Fogliata 2006). It is a pre treatment verification tool, hence incapable of in 
vivo  verification.  The  main  goal  is  to  identify  potential  errors  either  in  the 
calculation or in the delivery process.  
 
1.9.5.4  EPIDose 
EPIDose (Sun Nuclear, Melbourne, FL) is a tool designed for the use of EPIDs in 
IMRT QA that uses raw MV EPID images (no additional build up and independent 
of gantry angle, but with dark and flood field corrections applied) to estimate 
absolute dose  planes normal  to the  beam axis in  a  homogeneous media (i.e. 
similar to conventional IMRT QA methods) (Nelms et al 2010, Varatharaj et al 
2010). EPIDose is a non transit package used for pre treatment verification of 
fluence by comparing the TPS and EPIDose dose distributions. EPIDose converts 
an EPID image to dose maps for analysis in the MapCHECK software (also a Sun 
Nuclear product), by performing a dose to dose comparison independent of TPS. 
Nelms et al (2010) evaluated its suitability by using the Varian EPIDs images (a 
Si500 and a Si1000) and Siemens EPIDs images (OptiVue500 and OptiVue1000).  
 
1.9.5.5  Elekta iViewGT and Siemens Optivue 
There is evidence in the literature suggesting that the Elekta iViewGT (Winkler 
et al 2007 and Cilla et al 2011) and Siemens Optivue (Fidanzio et al 2010) EPIDs 
were  calibrated  for  transit  and  non transit  dosimetry.  The  purposes  of  these 
studies were to develop, implement and validate methods for portal dosimetry 
with amorphous silicon EPID for a wide energy range. Analytic functions were 
applied  in  order  to  correct  for  nonlinearities  in  detector  response  with  dose 
rate, irradiation time and total dose. EPID scattering processes were corrected 
for by means of empirically determined convolution kernels. Unlike the known 
Varian  PDIP,  we  did  not  find  corresponding  commercial  portal  dosimetry 
packages from Elekta and Siemens. 
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1.9.6 Current drawbacks for the wide use of electronic portal 
imaging devices as a dosimeter 
Despite  the  positive  characteristics  of  EPIDs  over  other  modalities,  there  is 
limited  usage  of  these  devices  for  dosimetry  and  there  is currently  only  one 
commercial  transit  dosimetry  module  (section  1.9.5  above):  This  became 
available  only  near  the  conclusion  of  this  work.  An  appropriate  calibration 
method for the conversion of the EPID image to dose is one of the main setbacks 
for using the devices dosimetricaly. Electronic portal imaging devices have been 
calibrated either by conversion of grey scale pixel value to dose value using an 
ion chamber or by using Monte Carlo simulation methods (prediction of the grey 
scale pixel value). The drawback is that these calibration models are not robust 
enough  to  cover  all  treatment  techniques  and  irradiation  configurations  (van 
Elmpt et al 2008: see section 2.3.3.1). Some centres have developed in house 
packages, which require assessment before induction into routine clinical usage. 
It  is  desirable  to  use  a  single  piece  of  equipment  for  geometrical  and 
dosimetrical  verification  to  keep  operational  costs,  treatment  times  and 
maintenance work to a minimum. The general aim for this study was therefore 
to develop techniques for integrated transit in vivo dosimetry verification using 
an EPID.  
 
1.10 Aims of this study 
As can be seen from section 1.9.4, there was no clinically usable system for 
transit dosimetry (either commercial or non commercial) at the commencement 
of this project. The main aim of the study was to develop techniques for the 
transit dosimetric treatment verification using an a Si EPID. The four sub aims 
were: 
￿  To investigate the dosimetric characteristics of Varian a Si500 EPIDs by 
assessing  a  large  number  of  clinically  used  devices,  for  consistency  of 
performance and portal dosimetry implications. 
￿  To  develop  a  method  to  predict  portal  dose  in  different  radiotherapy 
(clinical) settings based on equivalent path length, measured with an EPID   38 
￿  To develop a method for dose verification by deriving the plane phantom 
/ patient dose at the exit from the portal dose measured with the EPID 
which is compared with intended dose from TPS and MapCHECK device. 
￿  To evaluate the developed  techniques by comparing the predicted and 
measured patient doses in homogeneous / anthropomorphic phantoms. 
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2  CHAPTER TWO: MEGA-VOLTAGE ELECTRONIC 
PORTAL IMAGING DEVICES: DEVELOPMENT 
2.1 Introduction to electronic portal imaging devices 
For nearly 30 years, electronic portal imaging devices (EPIDs) have been under 
development  by  accelerator  manufactures  and  individual  investigators.  In 
addition  to  the  imaging  system  developments,  there  has  been  an  extensive 
advancement  in  the  means  of  extracting  quantitative  information  from  the 
images  (Herman  et  al  2001,  Antonuk  2002).  These  include  extracting  the 
treatment  field  edge  to  establish  a  known  reference  image  and  registration 
techniques to compare reference images with the newly acquired portal images. 
Despite the considerable development of imaging technology and image analysis 
techniques, the clinical role of this technology is still evolving. Initially touted as 
replacements  for  portal  films,  these  systems  have  been  used  to  reduce 
systematic  errors  in  patient  positioning  for  on line  (i.e.,  immediate)  patient 
repositioning,  to  identify  the  location  of  radiopaque  markers  to  account  for 
organ  motion,  for  megavoltage  cone beam  CT  and  also  for  kilovoltage  cone 
beam CT. In addition to their use for imaging, these imaging systems are also 
being  used  for  pre treatment  verification  of  IMRT  fields  and  for  transit 
dosimetry. Clinical acceptance of the imaging systems is increasing but much 
remains  to  be  done.  Improved  methods  of  identifying  errors  in  patient 
positioning and automated methods to correct these  errors (e.g., moving the 
couch  or  changing  the  MLC  pattern)  will  be  required.  Radiation  therapy  is 
becoming an image guided therapy and portal imaging will become ever more 
important in the delivery process (van Elmpt et al, 2008).  
 
2.2 Types of electronic portal imaging devices 
2.2.1 Direct and Indirect radiation detection electronic portal 
imaging devices 
Electronic portal imaging devices are designed to operate between 1 and 20 MV 
(Boyer et al 1992). Images from the EPID are the result of a high energy x ray 
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beam passing through and interacting with the EPID sensitive layer. They detect 
low energy electrons resulting from Compton scattering of high energy photons. 
The differences in the attenuation of the photons due to varying densities and 
thicknesses in the object give rise to different grey scale or pixel values which 
form an image. The pixel value is proportional to the number of electrons or ions 
formed  as  a  result  of  interactions  of  the  attenuated  x rays  beam  with  the 
sensitive  medium  of  the  EPID.  With  the  technological  advancement  in 
electronics,  the  image  quality  of  EPIDs  of  various  types  has  improved 
significantly.  Imaging  devices  can  be  classified  into  directly  and  indirectly 
detectors  (Mayles  et  al,  2007),  as  illustrated  in  figure  2 1.  Direct  detection 
(figure  2 1  b)  incorporates  a  buildup  material  (photodetector)  to  produce 
electrical charges on detection of an x ray whereby the incoming photons are 
converted  directly  into  secondary  electrons  for  detection.  Indirect  detection 
(figure 2 1 a) incorporates a phosphor to produce visible wavelength photons on 
detection  of  an  x ray.  The  Indirect  detector  converts  incident  radiation  into 
secondary  electrons  which  are  converted  into  visible  light  for  detection.  The 
process is indirect because the image information is transferred from the x rays 
to visible light photons and then finally to electrical charge.  
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Figure 2- 1. Types of radiation detectors. Figure (a) is the Indirect detector while figure (b) 
show the direct detector mechanism. 
 
Both detectors have a build up layer, typically a piece of thin copper, to convert 
high energy photons to secondary electrons. This layer also serves to minimise 
the contamination electrons from the head of the linear accelerator treatment 
unit. In the indirect case, an additional phosphor layer is required to convert the 
secondary  electrons  to  visible  photons  (figure  2 1a).  Detectors  are  used  to   41 
detect the optical photons. For the direct detector EPID, detectors are placed 
directly beneath the build up layers (figure 2 1b). Upon collecting the secondary 
particles  in  both  the  direct  and  indirect  cases,  a  signal  is  generated  and 
transferred for analysis via a set of peripheral electronics located around the 
device. For any imaging system, the most important physical quantity that must 
be  determined  is  the  signal to noise  ratio  (SNR).  The  detective  quantum 
efficiency (DQE), which is defined as the square of output SNR divided by the 
input SNR, is the metric used to gauge the efficiency of imaging devices. DQE 
gives  the  SNR  transfer  characteristics  of  an  imaging  system  as  a  function  of 
spatial frequency. DQE gives a measure of how efficient the imaging system is, 
at transferring SNR (i.e. information) contained in the radiation beam on a 0 to 1 
scale (Boyer et al 1992). Low optical conversion efficiency from one layer to the 
next may result in decreased DQE of the imaging system. Commercially available 
systems consist of scanning liquid ion chamber EPIDs, camera based EPIDs and 
the  active  matrix  flat  panel  imaging  detectors  (Munro  et  al  1998b,  Antonuk  
2002). 
 
2.2.2 Matrix (Scanning liquid) Ion Chamber detectors 
The  matrix  ion  chamber  device  consists  of  two  sets  of  electrodes  that  are 
oriented  perpendicularly  to  each  other  separated  by  a  0.8 mm  gap,  which  is 
filled with a fluid (2,2,4 trimethylpentane) that is ionized when the device is 
irradiated. Each set of electrodes consists of 256 wires spaced 1.27 mm apart to 
provide an active area of 32.5x32.5 cm
2. One set of electrodes is connected to 
256 electrometers and the other set of electrodes is connected to a high voltage 
supply  that  can  apply  a  300 V  potential  to  each  electrode  individually.  As 
illustrated in figure 2 2, the matrix ion chamber array is read out by applying a 
high  voltage  to  each  of  the  high voltage  electrodes  in  succession  (for 
approximately 20 milliseconds) and measuring the signal generated in each of 
the 256 signal electrodes. The readings are read out via the electrometers which 
are multiplexed and sent to output via an amplifier.  
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Figure 2- 2. Schematic of a SLIC EPID. 
 
 
Several  authors  have  investigated  the  use  of  SLIC  EPID  for  dosimetry 
purposes Chang et al (2000), Mohammadi et al (2007). Advantages of these types 
of EPIDs are their compact sizes and their geometric reliability (images acquired 
with  the  system  have  no  geometric  distortions).  The  major  limitation  of  a 
scanning radiation detector is quantum utilisation, since only one high voltage 
electrode (out of 256) is active at any one time and the relatively long read out 
time (van Elmpt, 2008). 
 
 
2.2.3 Camera-Based detectors 
Camera based  systems  consist  of  a  metal  plate  and  a  phosphor  (gadolinium 
oxysulfide  (Gd2O2S))  screen  viewed  by  a  camera  using  a  45°  mirror.  A 
metal/phosphor  screen  is  used  for  converting  x rays  to  visible  light  which  is 
directed  to  the  camera  via  a  mirror.  When  irradiated,  high energy  electrons 
generated in the metal plate and the phosphor screen are converted into light in 
the phosphor screen and this light creates the video signal generated by the 
camera (figure 2 3). The video signal from the camera can be digitised and the 
digitised image can be viewed on a monitor located in the control area of the 
accelerator.  
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Figure 2- 3. Schematic of a video-based EPID  
 
The main disadvantages of Video EPIDs are the poor light collection efficiency of 
the  optical chain, which reduces  the image quality, and  optical glaring error 
which makes the use of these devices for dose verification difficult (Patridge et 
al 1999, Munro et al 1998). Since light is highly scattered within the phosphor 
screen, it is emitted from the rear of the screen in all directions with equal 
probability.  Only  those  light  photons  that  are  emitted  within  a  small  cone 
subtended  by  the  lens  of  the  camera  can  generate  a  signal  in  the  camera; 
typically only 0.1 0.01% of the light emitted by the phosphor screen reaches the 
camera. Two main reasons causing poor light collection efficiency (Herman et al 
2001):  
￿  If an x ray photon interacts in the x ray detector but none of the light 
generated by  this interaction reaches the camera,  then  no measurable 
signal is produced 
￿  If only a small signal is produced in the camera, then noise generated by 
the  pre amplifier  and  other  electronics  of  the  camera  may  be  large 
compared to the signal.  
As a result, the development of commercial camera based EPIDs has focused on 
increasing light collection efficiency. 
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2.2.4 Flat panel detectors 
Both  the  liquid filled  and  camera based  types  of  EPIDs  generally  produced 
images of inferior contrast and spatial resolution to those obtained using film 
(Antonuk  2002).  For  this  reason  amorphous  silicon  (a Si)  flat  panel  EPID 
technology has replaced the liquid filled and camera based EPIDs due to their 
superior  image  quality.  Flat  panel  detectors  are  currently  divided  into  two 
types, Silicon or photodiode systems and Selenium or photoconductor systems. In 
either case, the image quality from the flat panel devices is superior to that of 
the  liquid  ion  chamber  or  the  video  EPIDs.  The  most  common  type  of  EPID 
available today is the amorphous silicon EPID (a Si EPID) or flat panel imager, 
first described by Antonuk et al (1998). The panel consists of an X ray converter, 
light detector, and an electronic acquisition system for receiving and processing 
the  resulting  digital  image.  The  underlying  technology  behind  flat panel  a Si 
EPIDs is large area integrated circuits called active matrix arrays. Active matrix 
technology  allows  the  deposition  of  semiconductors,  like  amorphous  silicon, 
across large area substrates such that the physical and electrical properties of 
the resulting structures can be adapted for many different applications.  
 
 
2.2.4.1  Basic image formation theory for the indirect a-Si electronic portal 
imaging devices 
The amorphous silicon EPID consists of a copper plate, a gadolinium phosphor 
screen and an active matrix array light sensor coupled to readout electronics. 
These devices have pixel resolution of less than 1mm. As illustrated in figure 2 
4,  each  pixel  in  the  flat panel  light  sensor  consists  of  a  photodiode,  which 
detects  the  light  emitted  by  the  phosphor  screen,  and  a  thin  film  transistor 
(TFT), which acts like a switch to control the readout of the signal. The data are 
read out through the data line and the timing is controlled by the control Field 
Effect  Transistor  (FET).  The  bias  line  is  used  to  control  the  bias  to  the 
photodiode and the charge up line is used to control the opening and closing of 
the control FET. The intensity of the light emitted from a particular location of 
the phosphor is a measure of the intensity of the x ray beam incident on the 
surface  of  the  detector  at  that  point.  During  irradiation,  each  photodiode 
collects  visible  photons  generated  by  the  high  energy  x rays;  light  that  is   45 
generated in the phosphor screen discharges the photodiode, which has a 5 V 
bias  voltage  applied.  The  TFT  is  non conducting  during  this  period.  During 
readout, the TFT is made conducting and this allows current to flow between 
the photodiode and an external amplifier. The photodiode is recharged to its 
original bias voltage and the external amplifier records the necessary charge. 
This  charge  is  proportional  to  the  light  reaching  the  photodiode  during  the 
irradiation. This charge is stored in the pixel until the active matrix array is read 
out. By activating the TFT's one line at a time and by having all of the TFT's in 
one column connected to a common external amplifier, the signals generated in 
the flat panel light sensor can be read out one line at a time with a modest 
number  of  electronic  components.  Readout  frame  rates  of  up  to  30/s  are 
achievable.  This  sequence  continues  while  the  x ray  exposure  is  occurring, 
allowing real time images to be acquired.  
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Figure 2- 4. Figure (a) is a schematic illustration of an a-Si photo diode coupled to thin film 
transistor (TFT). Figure (b) is a schematic arrangement of photodiodes and controls used in 
the flat panel imager (Reproduced from Varian document library). 
 
 
The principle of operation of the a Si detector is shown schematically in Figure 
2 5. The photodiodes have a very poor DQE for high energy photons. To increase 
the DQE, there is an approximately 0.5 mm thick layer of gadolinium scintillator 
(Gd
2O
2S), and a 1mm thick copper build up plate between the photo diodes and 
the radiation source (Varian Portal vision 2000 and McCurdy et al 2001). The   46 
copper  plate  converts  the  high energy  photons  into  electrons,  which  produce 
optical light in the phosphor. These photons (Figure 2 5 b) are detected in the 
photodiode and stored as charge until the TFT is triggered to conduct the charge 
collected into the ADC in the readout electronics.  
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Figure 2- 5. Figure (a) shows the main layers making up the detector (b) Functional cross-
section of EPID 
 
The system efficiency is considered to be x ray quantum limited. The size of the 
pixel, in addition to light spread in the phosphor screen and electron spread in 
the copper plate are the main factors affecting spatial resolution (Antonuk 2008, 
Munro  1998b).  Glare,  which  is  defined  as  light  scatter,  is  insignificant  for 
imaging suggesting  that  a flat  panel EPID is capable  of producing high image 
quality (Antonuk 2002). About 50% of the light emitted from the scintillator is 
used to produce the useful image which is orders of magnitude higher than the 
camera based and scanning liquid ion chamber EPIDs. For dosimetry purposes, a 
1 2%  deficiency  in  signal  is  significant  enough  to  cause  inaccuracy  in  dose 
verifications (Warkentin et al 2003).  
 
 
2.3 General uses of electronic portal imaging devices 
The  current  primary  applications  of  EPIDs  include  treatment  machine  QA, 
patients’ treatment setup verification, assessment of target and organ motion,   47 
patient dosimetry and compensator design and verification (Herman et al 2001, 
van Elmpt et al 2008). 
 
2.3.1 Treatment setup verification 
The goal of radiation therapy is to accurately deliver a prescribed radiation dose 
to  the  tumour  and  spare  the  surrounding  healthy  tissues.  Treatment  setup 
verification can be divided into verification of the geometric configuration of the 
treatment unit and verification of the patient and target position with respect to 
the treatment geometry. The geometric accuracy of patient positioning relative 
to  the  treatment  beam  is  crucial  and  factors that  could  affect  this  accuracy 
include:  incorrect  patient  alignment  relative  to  the  treatment  beam,  mis 
alignment of the light field versus radiation field and the shift of skin markers 
and  patient  movement.  Portal  imaging  is  used  to  verify  the  accuracy  of  the 
patient  positioning  prior  to  treatment.  Proper  evaluation  of  treatment  setup 
involves  relating  the  information  in  a  portal  image  to  that  extracted  from  a 
reference  image  (simulation  film  or  DRR).  Information  compared  may  be  the 
field border, the anatomic landmark or the 3D models of the patient from CT 
data.  
 
Flat  panel  amorphous  silicon  (a Si)  detectors  are  now  standard  in  the 
construction of electronic portal imaging devices (EPIDs) used for positional and 
dosimetric verification in external radiotherapy practice (McGarry et al 2007, 
Greer  2007,  Berger  et  al  2006).  With  excellent  image  quality,  patient  setup 
verification  and  organ  motion  detection  is  readily  achievable  (Vetterli  et  al 
2004).  In  addition,  the  convenience  of  EPID  technology  has  led  to  growing 
interest  in  its  role  as  a  replacement  for  the  laborious  and  time  consuming 
methods of using x ray film in dosimetric and quality assurance measurement 
(Menon and Sloboda 2004, Nijsten et al 2007).  
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2.3.2 Electronic portal imaging devices as a physics tool for 
routine linear accelerator QA 
The digital format of the EPID image offers added advantages of using a Si EPIDs 
for routine physics QA instead of the traditional ionization chambers, solid water 
stacks, and film. EPIDs can be calibrated to check photon beam field flatness 
and relative doses during routine machine QA. EPID results are used as “relative 
standards” to which later EPID results should be compared. EPID signal values 
are  meaningless  by  themselves  unless  they  are  calibrated  against  another 
detector. EPID relative standards should be obtained after the treatment unit 
has  been  properly  tuned,  adjusted,  and  calibrated  by  using  a  conventional 
scanning water phantom and ionisation chambers. The major QA tests that can 
be done with EPIDs include: 
o  Verification of light field and radiation field coincidence or verification of 
light field and radiation field coincidence with field size dimensions 
o  Constancy check of radiation field flatness and symmetry 
o  Constancy check to compare day to day linac output   
o  Collimator isocentric accuracy check 
o  Cross hair tray isocentric accuracy check 
o  Gantry Isocentric accuracy check 
o  Enhanced dynamic wedge (EDW) constancy check by comparing profiles in 
the direction of jaw motion 
o  Dynamic  MLC  QA,  for  example  the  popular  Varian  picket  fence  and 
complex tests  
o  Constancy check of electron beam energies, by comparing beam in plane 
profiles (Beck et al, 2009). 
 
The  above  QA  procedures  suggest  that  the  EPID  performance  is  a  reliable 
medical physics tool. The main QA tests needed to be carried out on the EPID 
itself include: 
o  Positioning in the imaging plane 
o  Positioning perpendicular to the imaging plane  
o  Mechanical integrity and collision interlocks  
o  Spatial distortion and Noise 
o  On screen measurement tools of distances, angles and pixel resolution    49 
o  Contrast and Modulation transfer function 
o  Regular recalibration to ensure constant signal stability 
 
2.3.3 Dosimetric application 
Amorphous silicon flat panel detectors are used to acquire digital portal images 
with excellent image quality. The efficiency in the use of detected signal and 
the  improved  spatial  resolution  makes  the  a Si  EPID  better  suited  for  dose 
verification compared to SLIC and camera based EPIDs (Warkentin et al 2003). 
Their ease of use also makes them attractive for dosimetry applications, but the 
images must be corrected for non water equivalence of a Si material, non linear 
behaviour of the electronics, inhomogeneous pixel sensitivities, scattering in the 
detector and the panel's complex energy response.  
The EPID image resulting from the whole radiation delivery may be calibrated to 
obtain  a  quantity  that  may  be  compared  with  a  prediction  based  on  the 
prescribed dose. This may be the total fluence reaching the detector or the dose 
delivered, in which case this image is calibrated using a dosimetric model and 
the resulting dose image is compared with a theoretical dose image based on 
prescription. Van Elmpt et al (2008) gave a comprehensive literature review of 
electronic portal imaging for radiotherapy dosimetry citing  the advantages  of 
EPIDs as: fast image acquisition; high resolution; digital format; potential for in 
vivo measurements; point dose measurement; and 3D dose verification. This has 
prompted many research groups to study their use for radiotherapy dosimetry. 
 
2.3.3.1  Electronic portal imaging devices calibration for dosimetry 
The  use  of  any  EPID  for  dosimetric  verification  requires  implementation  of  a 
suitable calibration procedure to establish a relation between the pixel intensity 
and  either  fluence  or  dose  distribution.  Various  authors  have  used  different 
approaches  to  calibrate  the  EPID  detectors  for  dosimetry  purposes  including 
analytical  methods  involving  comparison  of  detector  grey  scale  value  with 
ionisation  chamber  response  and  Monte  Carlo  simulations.  The  first  approach 
utilises  empirical  (measurement  based) models by  comparing  grey scale  pixel 
values to measured dose using a calibrated ionisation chamber inserted into a 
water phantom (Chen et al 2006, Chang et al 2000). The second approach uses   50 
Monte  Carlo  simulations to  predict  the  relation  between  the  grey  scale  pixel 
values and dose (Siebers et al 2004, Chin et al 2003). However, a detailed model 
of the EPID is necessary for accurate simulations. Like many other Monte Carlo 
simulations, the calculation times are long and all the technical details regarding 
the construction and materials of the various layers are not always available. 
Hence the first method is simpler and faster than a Monte Carlo simulation and 
therefore more suited for implementation in clinical routine. The limitation is 
that  empirical  models  need  to  be  validated  outside  the  reference  conditions 
(van  Elmpt  et  al  2008);  in  particular  their  robustness  under  various  clinically 
encountered radiotherapy situations should be studied. 
 
 
2.3.3.2  Transit and Non-transit dosimetry 
Dosimetry verification techniques using EPIDs may be categorised according to 
whether the beams have passed through an attenuating medium e.g phantom or 
patient  (transit);  or  not  (non transit)  (Vial  et  al  2008,  Elmpt  et  al  2008, 
Piermattei et al 2007). In both cases the dose can be reconstructed either inside 
or outside a phantom or patient. 
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Figure 2- 6. Transit and non-transit 
 
The non transit (Figure 2 6(a)) approach is where the dose or fluence is acquired 
without any attenuating material (patient or phantom) in the beam. The method   51 
involves the determination of the dose in the detector or patient (phantom) or 
determination of the incident energy fluence, based on measurements without 
an  attenuating  medium  between  the  source  and  the  detector.  An  image  is 
acquired for each field without a patient (phantom) in the beam and compared 
with a predicted EPID response at the level of the imager. Alternatively the EPID 
image signal is reconstructed into dose inside the patients (phantom) as detailed 
above.  The  non transit  approach  is  mainly  used  as  a  pre treatment  dose 
verification method and hence is a valuable tool for performing quality control 
of treatment parameters related to dosimetric and geometric characteristics of 
the linac, independent of the patient. 
 
Transit  dosimetry  (Figure  2 6(b))  or  back  projection  is  where  the  EPID  is 
calibrated  to  predict  dose  based  on  the  radiation  transmitted  through  the 
patient or phantom. The technique involves the determination of the dose at the 
position of the detector or patient (phantom) or determination of the incident 
energy fluence, based on radiation transmitted through the patient or phantom. 
This approach is mainly used as a treatment dose verification method and offers 
the possibility of in vivo dosimetry. An image is acquired for each field with the 
detector  located  behind  the  patient  (phantom)  and  compared  with  predicted 
EPID  response  at  the  level  of  the  imager  or  behind  the  patient/phantom. 
Alternatively the EPID image primary signal is back projected and computed into 
dose inside the patient (phantom) CT scan by converting the image to energy 
fluence, using this as an input for the dose calculation algorithm and comparing 
to a plan calculated from the patient/phantom CT scan. The transit method has 
the potential of verifying both the treatment planning system (TPS) calculation 
of dose to the phantom or patient, and the delivery of dose by the Linac. 
 
Nijsten et al (2007b) proposed a two step global calibration model for a Si EPIDs 
for  transit  dosimetry  based  on  measurements  and  mathematical  convolution 
methods. First, dosimetric EPID characteristics like long term stability, build up, 
ghosting effects, and field size dependence were investigated to implement a 
dosimetric  calibration  for  open  fields.  Second,  the  model  was  extended  for 
transit dosimetry application by including an energy spectrum correction model 
that  corrects  differences  in  EPID  response  between  measurements  with  and 
without  an  object  in  the  beam,  field  size  dependence  kernels,  beam  profile   52 
correction derived for two photon energies and the conversion factor to absolute 
dose in water from EPID greyscale values.  
 
2.4 Overview of the Varian electronic portal imaging 
device detector system  
The EPID flat panel used by Varian is an indirect detection system and comprises 
three main components, namely: Image detection unit, Image acquisition system 
and computer control software. 
 
2.4.1 Image detection unit 
The first component is the image detection unit (IDU). It has the shape and size 
of  a  standard  film  cassette  and    is  positioned  in  the  imaging  plane  using  a 
robotic  controlled R arm or exact arm. It is connected by cables to the therapy 
control  area  from  where  image  acquisition,  processing  and  display  are 
controlled. Within the detector, a phosphor scintillator converts incoming x rays 
to visible photons which are sensed by an array of photodiodes implanted on the 
amorphous silicon panel. The photodiodes convert the incoming light to charge 
and  the  integrated  charge  is  transferred  to  the  read out  electronics  to  be 
counted  as  a  pixel  signal,  proportional  to  incoming  radiation  intensity.  The 
detector electronics allow the transfer of charges from the pixels to the read 
out electronics  by  activating  row  after  row  of  the  pixel  matrix  while  all  the 
columns (data lines) are read out thus forming an image. Radiation shielding of 
the electronics is required to avoid damage due to their close proximity to the 
detector (ie they are too near to the primary beam). Figure 2 7 shows a block 
diagram of a plan view of the IDU. Varian has two versions of IDUs, the older one 
is the IDU II and the more recent is the IDU 20. 
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Figure  2-  7.  Block  diagram  of  the  image  detection  unit  (IDU)  (Reproduced  from  Varian 
document library). 
 
 
2.4.2 Image acquisition system 
The image acquisition system (IAS) contains drivers and acquisition electronics 
for the image detection unit. The IAS interfaces to the IDU, the linac and the 
imager controller (the R Arm or the exact Arm). It is essentially a digital signal 
processor  that  provides  frame  averaging  capabilities  and  image  buffering.  It 
controls and reads the image detector and performs image corrections. Varian 
has two versions of IAS, the older one is the IAS2 and the more recent is the 
IAS3. 
 
2.4.3 Acquisition computer control software  
The  third  component  is  the  computer  control  software  that  maintains  the 
interfaces and controls the communication between the IDU and the acquisition 
unit. Image correction data and acquisition parameters are stored on the hard 
disk of this computer. The EPID image is the average of acquired frames in the 
integration mode.    54 
 
PortalVision
TM  is  a  Varian  software  system  supporting  the  acquisition  of 
electronic portal images before, during and after treatment and provides tools 
for quantitative portal image registration and review. Table 2 1 summarises the 
physical characteristics and specifications of the Varian imager.  
Table 2- 1. Specifications of the Varian imager (Varian PortalVisionTM aS500, 2001)  
4 25 MV
100 600 MU/min
3 frames / second
2  images / second
Energy range
Doserate range
Image acquisition rate
Image storage rate
n i p photodiode
384x512 (a Si 500) and 768x1024 (a Si 1000)
784 mm (a Si 500) and 392 mm (a Si 1000)
40x30 cm2
Pixel
Pixel format
Pixel pitch
Array dimensions
0.6 mm copper
Gadolinium Oxy sulphide
Amorphous Silicon
Detection Components
Metal plate
Phosphor screen
Photon detector
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2.4.4 Electronic readout of a-Si detectors 
There are 3 modes for electronic readout schemes used for image acquisition 
with the a Si EPID (Varian portal vision 2001). All three modes work towards a 
common goal of acquiring images with optimal Signal to Noise Ratio (SNR).  
 
2.4.4.1  Single (integrated) mode 
During single mode acquisition, the configured numbers of frames are readout 
prior to the start of irradiation. This cycle is called the refresh cycle; it clears 
the accumulated dark current and residual data. No readout occurs during the 
delivery of the radiation and the signal is integrated over the entire exposure 
period. The trailing edge of the Radiation on signal generates one trigger pulse 
initiating one frame readout and also the accumulated data of the pixels during   55 
the exposure interval. This readout scheme reduces the effects of readout noise 
and  eliminates  the pulsing  effects  of  the  linac on  the final image. Since  the 
signal is integrated during the exposure time and the readout is performed after 
the  exposure,  this  improves  the  signal to  noise  ratio  (SNR). The  single  mode 
acquisition  is  routinely  used  clinically  and  allows  the  acquisition  of  clinical 
images with exposures as low as 2 MU (Kirby et al 2006, de Boer et al 2000). 
 
2.4.4.2  Continuous mode - high dose imaging 
Continuous mode is primarily used for monitoring the patient during intensity 
modulated radiotherapy (IMRT) treatment. This acquisition mode includes movie 
images and the verification image (average of movie images). Implementation of 
this mode can be done with either the use of free running mode or external 
trigger  mode.  The  external  trigger  continuous  mode  synchronises  the  frame 
readout with linac pulses thus eliminating the pulsing artefacts. This not only 
improves the image quality of movie images but also increases the accuracy of 
dosimetric verifications for applications such as IMRT. The external continuous 
mode  can  be  further  divided  into  two  synchronisation  modes;  line 
synchronisation and frame synchronisation. In line synchronisation, each line can 
be triggered and readout individually. In frame synchronisation mode, the start 
of  frame  is  synchronised  with  linac  pulses.  The  sensors  are  forced  to  be 
discharged  prior  to  the  start  of  radiation on  to  eliminate  the  dark  current 
accumulation. The linac beam pulses are synchronised to the external trigger 
pulses  which  in  turn  are  synchronised  with  the start  of  each  frame  scan.  An 
offset correction image is used to correct the dark current of each pixel. During 
the gain correction, the median value of the pixel data of the whole sensor is 
evaluated and each individual pixel value is mapped to the median value. The 
final image is the average of the frame scan during radiation exposure.  
 
2.4.4.3  Cone beam mode (only available on linacs with OBI system) 
Cone beam acquisition mode is used to perform volume (multi slice) kilovoltage 
CT  (kVCT)  or  CBCT  in  the  cone  beam  geometry  to  visualize  3D  (three 
dimensional) anatomy during patient positioning. In this mode, image acquisition 
is  synchronized  with  the  linac  enabling  the  imager  to  remove  the  pulsing 
artefacts from the image while also improving the SNR.   56 
 
2.4.5 Imager calibration 
The  system  requires  a  set  of  calibration  images  for  each  combination  of 
acquisition mode, energy and dose rate parameters of the treatment machine 
used. An imager calibration set comprises two images, a dark field image and a 
flood field image. Each set is stored in the IAS database. Both images consist of 
up to 10 individual images taken in succession. PortalVision
TM uses the averaged 
result of all images for correction. 
 
2.4.5.1  Dark field image 
In the dark field image (DF), individual pixel by pixel values are measured by 
periodically  acquiring  an  image  without  radiation.  The  DF  correction  is 
synchronised with linac pulses. An average of several images measured in quick 
succession is taken for minimum noise. Its contents reflect array imperfections 
and  electrometer  offsets.  Figure  2 8  (a)  displays  a  typical  dark field  image 
exhibiting bright and dark vertical stripes. 
 
(a)   Dark-Field (b)   Flood-Field (a)   Dark-Field (b)   Flood-Field
 
Figure 2- 8. Dark-field and Flood-field images 
 
2.4.5.2  Flood field image 
The flood field (FF) image is also measured several times in quick succession and 
averaged  for  minimum  noise.  Its  contents  represent  the  field  homogeneity, 
individual cell sensitivities and electrometer gains. The sensitivity of each pixel   57 
is determined periodically by acquiring an image with radiation for a wide open 
field  without  an  object.  During  the  acquisition  of  the  FF  image,  any 
interferences in the radiation field or the dose rate at which the EPID is being 
calibrated,  will  lead  to  a  wrong  FF  correction  file.  The  flood  field  image, 
illustrated in figure 2 8 (b) exhibits vertical bands of varying brightness.  
 
These images are used to correct the beam on raw object image according to 
the equation 
mean FF *
j) , FF_image(i
j) , DF_image(i j) i, Raw_Image(
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

 -
=                (2  1) 
 
Where the offset correction is equal to the stored dark field image subtracted 
from  the  acquired  raw  image.  The  gain  correction  is  defined  as  the  offset 
corrected image divided by the stored normalised flood field image. FFmean is the 
mean value of the flood field image. The i and j notations in the equation above 
represent the i
th   j
th pixel values in the X and Y directions of the image. 
 
2.4.5.3  Main components of the Varian's portal dosimetry system 
The Varian portal dosimetry system has three main requirements, namely: 
1)  The portal Imager (a Si 500 or a Si 1000): Portal dosimetry software in 
addition to the image acquisition system (IAS) is also required for the EPID 
to  acquire  dose  maps.  A  special  license  is  needed  to  activate  the 
Dosimetry Workspace. 
2)  Portal dose prediction: Eclipse 8.6 treatment planning system algorithms 
are  required  to  enable  prediction  of  dose  maps.  These  predicted  dose 
images  (PDI)  are  compared  to  the  measured  dose  maps  for  dosimetric 
verification of treatment plans.  
3)  Portal dosimetry review workspace to evaluate the agreement between 
predicted and measured images. An evaluation module is required for the 
comparison  of  PDI  and  measured  dose  maps.  The  review  workspace  in 
Vision caters for this purpose. The software has tools for comparison and 
evaluation of dosimetric images e.g. gamma analysis, dose differences, 
etc. However, this is not a mandatory requirement as such analysis can be 
carried out using other analytical software.    58 
 
3  CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Dosimetric performance of a-Si500 EPIDs 
The department is equipped with eleven linear accelerators which are: 4 
Clinac 600 C/EX, 4 Clinac 2100 C/CD/EX and 3 Clinac iX series with 6MV, 10MV 
and 16MV, all equipped with EPIDs as detailed in table 3 1. Six of the detectors 
(A, B, C, E, F and H) use hardware/software IDU II/IAS2 while the other five 
detectors (D, G, I, J and K) use IDU 20/IAS3 (Varian Medical Systems, Palo Alto, 
California, USA). At the time of this study all the detectors were being used for 
clinical  imaging  only  apart  from  detector  I,  which  in  addition  had  been 
configured  /  calibrated  for  dosimetric  purposes.  For  simplicity  we  refer  to 
hardware/software IDU II/IAS2 as system I and IDU 20/IAS3 as system II (Table 3 
1). Both system I and system II used in this study are a Si500, though Varian has 
introduced a system II fitted with an a Si1000. The main difference between the 
a Si500 and a Si1000 is that the latter has a better pixel resolution compared to 
the former, as indicated in table 2 1. 
 
Table 3- 1. The different accelerator models with EPIDs, the EPID image acquisition system 
and their corresponding clinical use period in months.  
10 iX II IDU-20 / IAS3 K
17 iX II IDU-20 / IAS3 J
17 iX II IDU-20 / IAS3 I
32 6 EX I IDU-II / IAS2 H
32 21 EX II IDU-20 / IAS3 G
32 21 EX I IDU-II / IAS2 F
75 6 EX I IDU-II / IAS2 E
34 21 EX II IDU-20 / IAS3 D
82 2100 C/D I IDU-II / IAS2 C
86 600 C/D I IDU-II / IAS2 B
86 600 C/D I IDU-II / IAS2 A
Months in use Accelerator Model System Hardware / Software EPID
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32 21 EX I IDU-II / IAS2 F
75 6 EX I IDU-II / IAS2 E
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The  manufacturer’s  technical  specification  suggests  system II  has  lower  noise 
readout electronics, higher readout rates and faster data acquisitions compared 
to system I.  The EPID detectors in the two systems have active dimensions of 
0.4m x 0.3m and a resolution of 512x384 pixels yielding an effective pixel size of 
784 m. For system I, readout of the EPID amorphous silicon array is synchronised 
with the beam pulses and a fixed integration time of 320 ms was used for image 
acquisition.  System II  uses  the  asynchronous  mode  where  the  readout  is 
controlled by an internal clock. This setup, specifically designed for IMRT fields’ 
acquisition, is Varian’s default mode for the system II EPIDs, activated by setting 
the sync mode parameter to zero. For both systems portal images were acquired 
using AM maintenance (Varian portal imaging control software used to acquire 
EPID images) version 7.1. 
Table 3 1 also shows the length of time each EPID had been in clinical use 
within our centre at the time this study was conducted. System I detectors had 
been used for periods ranging from 32 to 86 (mean 66) months while system II 
detectors had been used for a period ranging from 10 to 34 (mean 22) months. 
All measurements were performed in the evenings after the detectors had been 
in clinical use to ensure warm up. In this study a nominal photon energy beam of 
6 MV was used in all measurements.  
 
3.1.1  Image acquisition 
For system I, parameter settings in AM maintenance were kept constant for the 
400  MU/min  dose rate,  e.g  number  of  rows  acquired  before  next  row 
synchronisation (Rows Per PVSYNC) = 9, synchronization delay = 350 s, IDU/ACPU 
Gain = 1, PV synchronisation frequency = 2400 Hz. For system II, Varian uses a 
standard set of acquisition settings from their own optimisation experiments for 
each  dose rate.  These  parameters  include  the  number  of  trigger  pulses  the 
system waits before acquisition begins, frame cycle time, number of rows to be 
acquired and subsequent number of frames between accelerator pulses. 
To ensure  uniform pixel response,  EPIDs  were calibrated for dark field 
(DF) to eliminate background and electronic noise. A flood field (FF) calibration 
was also used to correct for variations in sensitivity of individual pixels. While 
this eliminates variations in pixel sensitivity, it also has the effect of removing 
the  characteristic  horn shape  of  the  photon  beam  profile  downstream  of  the   60 
flattening filter. The number of frame averages for the DF and FF calibration 
fields  for  system I  were  60  and  30,  while  for  system II  it  was  30  and  30 
respectively. Detectors were calibrated at the maximum effective field sizes of 
28.6 x 21.4 cm
2 and 30.5 x 22.5 cm
2 for system I and system II respectively. Both 
detector systems have same area  of 30x40 cm
2 at the isocenter, but due to 
mechanical positioning limitations vertically, all the system I detectors could not 
attain the same effective field size at the imaging plane. All field sizes were 
defined at the source to isocenter distance of 100 cm, unless otherwise stated. 
The vertically downwards position of the accelerator gantry was ensured with 
the help of a spirit level. The IDUs were positioned at lateral = 0, longitudinal = 
0 and vertical = 40cm below the isocenter. For each EPID, the physical position 
of the detector was maintained on the central axis of the linear accelerator. The 
distance from the accelerator targets to the EPID surfaces was maintained at 
138±0.5  cm  aiming  the  distance  to  the  sensitive  layer  to  be  at  140.0  for 
calibration and subsequent measurements. Van Esch et al (2004) and Greer et al 
(2003) reported negligible ghosting effects on Varian EPIDs. A minimum period of 
1 minute was employed (Winkler et al, 2005) to minimise these memory effects 
even further since EPIDs of varying life periods were being investigated.  
Images were acquired in the integrated mode, whereby the accumulated frames 
are displayed as a single image after irradiation is complete. At each setting, the 
measurement was repeated 3–4 times to derive the EPID integrated response (IR) 
which was calculated as the average of acquired number of frames (ANF).  
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                                                           (3. 1) 
Where n is the total number of measurements done and MPV is the mean pixel 
value. 
 
3.1.2  Detector reproducibility and responses to a reference beam  
Each  detector  was  irradiated  with  a  reference  beam,  defined  as  a  50  MU 
exposure, at a fixed field size of 10 x 10 cm
2, 400 MU/min doserate and at a 
fixed SDD of 138±0.5 cm. The average pixel value in the 13 x13 central pixel 
region  was  obtained  for  ten  consecutive  irradiations  for  each  detector.  The 
mean (of the average pixel values) for the ten consecutive readings was used to 
compare the detector’s response to a reference beam and the percentage pixel   61 
deviation from the mean value was calculated for each detector from [(MPV 
Mean)/Mean]  x  100%,  where  MPV  is  the  mean  pixel  value  for  each  detector 
(obtained  as  the  average of  ten  consecutive  measurements)  and  Mean  is  the 
average values for the detectors for each system. The responses for system 1 
and  system II  acquisition  systems  were  analysed  separately.  Also  the  ten 
consecutive readings for each detector were used to calculate the short term 
reproducibility. The long term reproducibility was done by comparing the mean 
pixel value over a six month period.  
 
3.1.3  Dose-response behaviour / Linearity 
To assess the linearity of their dose response, each EPID was positioned at a 
fixed SDD of 138±0.5 cm and exposed at a constant dose rate of 400MU/min. 
Three integrated images of a 10x10 cm
2 open field were acquired. The linear 
accelerator monitor units used were 1, 2, 5, 10, 20, 50, 100, 200 500, and 1000. 
EPID  response  was  assessed  in  a  13  x  13  pixel  (approximately  1.0  cm
2  area) 
region of interest in the centre of the image. For all detectors, the signal to  
monitor  units  ratios  (SMUR)  in  the  range  of  1–1000  MU  were  calculated  by 
dividing the average EPID response by MU delivered. To ensure stability of the 
accelerators, MU variation measurements were monitored using an ion chamber 
(Wellhoffer Dosimetrie, Schwarzenbruck Germany) in a mini water phantom at a 
depth of 1.5cm, prior to measurements with EPIDs. The phantom was placed on 
the couch in the centre of the beam and the source to water surface distance 
was maintained at the same level as for each EPID detector.  Ionisation chamber 
measurements after temperature and pressure correction were compared with 
corresponding measurement with the EPIDs. 
The  effect  of  cumulative  response  was  investigated  by  comparing  an  EPID’s 
response to a single 20 MU exposure to a series of lower dose exposures with 
equivalent  MU.  The  total  response  given  by  ( ) ∑ ANF x MPV   and  the 
percentage deficit from the single 20 MU exposure were calculated. 
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3.1.4 Pixel uniformity-response across the entire detector panel 
The EPID uniformity across each entire detector was investigated by comparing 
their  response  at  specific  positions  relative  to  the  central  positions.  The 
radiation beam uniformity for each accelerator was monitored as part of general 
quality assurance. The mean response in a 13x13 pixel region surrounding each 
of the positions P0, P1, …, P8 was obtained for each detector in a 20 x 20 cm
2 (28 
x28 cm
2 at the detector level) field size and PL, PR, PG and PT in the penumbra 
region as illustrated in figure 3 1. The penumbra region is known to be sensitive 
to  detector  and  collimator  positioning,  a  critical  parameter  in  dosimetric 
applications.  During  irradiation,  scatter  in  the  imaging  detector  and  over 
response to lower energy photons, increases the pixel values in the periphery of 
the field. For each EPID, three images were acquired at the same monitor unit 
(50 MU) and doserate (400 MU/min). At the detector level, positional lengths 
are:  cm P P P P 0 . 7 2 0 1 0 = =   located  at  the  EPID  central  axis  along  the  left right 
direction  of the gantry.  cm P P P P 5 . 10 4 0 3 0 = = , located  at the  EPID central  axis 
along the Gun Target direction of the gantry.  cm P P P P P P P P 2 . 14 8 0 7 0 6 0 5 0 = = = = . 
Points P5, P6, P7 and P8 are 1.8 cm and 1.0 cm from the field edge in the left 
right  and  the  Gun Target  directions  respectively.  The  four  values  in  the 
penumbra  regions  were  averaged  (Pavr)  for  each  detector  such  that  any 
deviation/shift in one side is counterbalanced by the results in another. MATLAB 
(The MathWorks, Inc) was used to obtain the average of the three images and 
normalise the response to that of the central position P0. 
   63 
P5
P8
P1 P2 P0
P4
P7
P3
P6
PL PR
PT
PG
30 cm 7.0 7.0
10.5
10.5
14.2
14.2
14.2
14.2
40 cm
P5
P8
P1 P2 P0
P4
P7
P3
P6
PL PR
PT
PG
30 cm 7.0 7.0
10.5
10.5
14.2
14.2
14.2
14.2
40 cm
 
Figure 3- 1. Specific locations used to measure the uniformity with in a 20 x 20 cm
2 radiation 
field size in the EPID detector. Each of the positional points has an area of 13 x 13 pixels. 
Mean response for all the points were compared to the central axis (P0) reading of each 
EPID detector. The response of the points (PL, PR PG and PT) in the penumbra region were 
averaged (Pavr) for each EPID.  
 
3.1.5 Electronic portal imaging device’s relative dosimetry 
A physical step wedge with relative thicknesses of 0.25, 0.50, 0.75 and 1.00 was 
used  to assess relative response. The steps create  steep  dosimetric gradients 
similar  to  those  encountered  in  IMRT.  The  step wedge  was  positioned  at  the 
surfaces of the EPID detectors at the same source to surface distance of 140.0 
cm. The centres of the EPID detectors and step wedge were aligned using the 
isocentre  lasers  and  checked  with  the  central  mechanical  pointer  of  the 
accelerator. The field size was maintained at 1.0 x 7.5 cm
2.  EPID images were 
obtained with 6 MV, 50 MU and 400 MU/Min in both Right Left and Gun Target 
directions relative to the accelerator. The signals were normalized to the open 
field reading and standard deviations at different steps calculated. 
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3.1.6 Field size dependence  
With the EPID detectors at fixed distance of 138±0.5 cm, fields of various sizes 
were obtained at a constant doserate of 400 MU/min. Open field images were 
obtained at a fixed dose of 50 MU to field sizes of 2x2, 5x5, 10x10, 15x15 and 
20x20 cm
2. For each field size, response was measured in a 13 x 13 pixel region 
of interest (approximately 1.0 cm
2 area) in the centre of the image. Each field 
size response was calculated as indicated in equation 3.1. Field size responses of 
the different EPID were compared to ionisation chamber measurements acquired 
in water with a fixed source=surface distance maintained to the corresponding 
level  for each  EPID  detector.  Both  the  EPID  and ionization  chamber  data  for 
different field sizes were normalised to that of a 10 x 10 cm
2 and fitted to a 
second order polynomial equation,  
( ) ( )
2
2 1 0 FS A FS A A EF + + =    (3. 2) 
  
Where  EF is the EPID field size dependence factor (defined on the central axis 
and assumed to be a constant for all pixels for a given field size),  FS is the field 
size and A0, A1 and A2 are polynomial coefficients.  
 
3.1.7 Doserate influence 
The EPIDs were calibrated at accelerator dose rates of 100, 200, 300, 400, 500 
and  600  MU/min  utilising  identical  settings  (field  size/distances)  and  on  the 
same  day  to  minimise  the  day to day  variations  in  pixel  sensitivity,  beam 
symmetry  and  accelerator  outputs.  For  each  dose rate,  the  response  of  the 
EPIDs to 20MU and 100MU exposures at a 10x10cm
2 field size was evaluated.  The 
EPID responses were obtained as described in the previous sections and readings 
normalised to those obtained at 400 MU/min. It is common practice to fit the 
doserate (D
·
) response to a power potential function of the form  
D ·
= D k S   (3. 3) 
(Fowler and Attix 1966, Pardo et al 2005, Muhammadi et al 2006, Winkler et al 
2006).  Where  S  is  the  detector  read out  signal  or  detector  relative  read out 
signal, k is a parameter for detector sensitivity and   is a parameter related to 
the  non linearity  of  the  detector  response.  Equation  3.3  can  be  used  with   65 
absolute or relative (normalised) data. In particular   is less than one when the 
EPID shows an over response and greater than one if the EPID shows an under 
response. 
 
 
3.1.8 Directional dependence 
The EPIDs were exposed at varying gantry angles between 0
o to 360
o in 12 equal 
intervals, to assess the influence of mechanical stability on their response as a 
result  of  gantry  rotation.  Open  beams  of  10x10cm
2  field  size,  fixed  SDD  of 
138±0.5 cm, 25 MU exposures and doserate of 400 MU/min were used for this 
analysis.  At  each  gantry  angle  the  EPID  central  response  was  evaluated  as 
described  in  previous  sections.  Measurements  were  performed  at  collimator 
angles  0
o  and  90
o.  EPID  response  values  for  each  collimator  angle  were 
normalised to that obtained at gantry angle 0
o.   
 
3.1.9 Further image profile analysis and memory effects 
Images for open field sizes 2x2, 5x5, 10x10, 15x15 and 20x20 cm
2 at different 
doses  (MU)  were  obtained  and  analysed  with  MATLAB.  Profiles  through  the 
central image axis both in the Gun Target and Left Right directions relative to 
the EPID were obtained and compared. For each EPID, a 5x5 cm
2 field size was 
irradiated with 50 MU followed by a 20x20cm
2 field size irradiated with 3 MU to 
evaluate memory effects. The time interval between the two exposures ranged 
from 12 15 seconds. Another 3 MU image for a 20x20cm
2 field size was obtained 
approximately  5  minutes  later.  The  EPID  ghosting  effect  response  was 
characterised  as  the  difference in  the central axes profiles  between  the  two 
20x20cm
2 field size images expressed as the percentage increase in response at 
the centre of 5x5 cm
2.  
 
3.1.10  Electronic portal imaging devices ageing due to 
radiation 
Electronic  portal  imaging  device’s  ageing  due  to  radiation  could  be  another 
factor  that  might  cause  degraded  results.  Hee  et  al.  (2002)  reported  that   66 
radiation  damage  affects  the  leakage  current  of  photodiodes  and  the  effect 
showed a linear dependence on absorbed dose. This may decrease the whole 
system  performance, although it  also  depends on the  ageing effects of  other 
components. This effect was investigated further by extracting data from the 
“treatment field history” file of the Varis system for about 2.7 million treatment 
records of all our machines since 2001, when the first EPID was commissioned. 
The data were extracted using mySQL database software. The aim was to find 
out  if  there  is  correlation  between  the  EPID  cumulative  dose/age  and  its 
performance.  From  the  database,  the  actual  linear  accelerator  monitor  units 
delivered per treatment field when EPID images were acquired were obtained, 
from which the cumulative dose to the imagers could be calculated. 
 
3.1.11  Electronic portal imaging devices, as a dosimeter 
Electronic portal imaging devices were purposely developed for on line patient 
setup verifications. The acquired image information is however related to the 
dose delivered to the EPID, and they are currently used as dosimeters as well. A 
study  was  conducted  to  evaluate  the  EPID  as  a  dosimeter,  by  comparing  its 
response with that of an ionisation chamber. Both detectors were positioned at 
the same source to detector distance (SDD) and same field size of 10x10 cm
2, as 
shown  in  figure  3 2.  The  ionisation  chamber  was  positioned  at  depth  of 
maximum dose (1.5 cm build up for 6 MV) with appropriate back scatter. Both 
detectors’ signals were obtained at linear accelerator monitor units of 1, 2, 5, 
10, 20, 50, 100, 200 500, and 1000; and at the same doserate of 400 MU/min. 
The EPID response was measured as the mean pixel value in a 13 x 13 pixel 
(approximately 1.0 cm
2 area) region of interest in the centre of the image.  
The same setup was used to compare the EPID with the ion chamber in terms of 
photon beam intensity reduction, by measuring the dose variation as a function 
of  absorbing  material.  This  was  done  by  interposing  solid  water  materials  of 
increasing thicknesses between the source and the detectors. For each phantom 
thickness, both detectors were exposed to the same radiation conditions, (SDD = 
140 cm, FS = 10x10 cm
2 and 100 MU). Similarly, the EPID response was measured 
as the mean pixel value in a 13 x 13 pixel region of interest in the centre of the   67 
image. The data for each detector were normalised to that when there is no 
absorbing material (thickness = zero). 
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Figure  3-  2.  The  geometrical  setups  for:  (a)  EPID  image  acquisition  and  (b)  Ionisation 
chamber measurements. In both (a) and (b) the detectors (EPID and ion chambers) were 
kept at fixed SDD. The ion chamber was set with a 10.0 cm solid water backscatter and 
build-up equivalent to the beam dmax (1.5 cm). 
 
 
3.2 Water equivalent path length calculation from EPID 
images 
The  photon  beam  physical  property  of  intensity  reduction  with  increasing 
material thickness, as described in the last paragraph of section 3.1.11 above, 
was used to explore further the dosimetric capability of the EPID. The quadratic 
calibration method was used, a technique first proposed by Morton et al (1991) 
to convert any acquired EPID image into water equivalent path length (EPL).  
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3.2.1 Treatment unit and EPID detector  
All measurements for the EPID calibration for equivalent path length (EPL) were 
performed using photon beams from the Varian linear accelerators (Clinac 2100 
C/CD/EX and Clinac iX series) at 6MV and 16MV.  The images were acquired with 
the  Varian  a Si500  EPIDs,  hardware/software  IDU 20/IAS3  (Varian  Medical 
Systems, Palo Alto, California, USA). Details regarding this imager design and 
calibration,  image  acquisition,  and  dosimetric  characteristics  have  been 
described extensively in sections 2.5 and 3.1.1, and in the literature (McDermott 
et al 2006, van Esch et al 2004, Greer et al 2003, and Kavuma et al 2008). The 
EPID  imager  was  kept  at  a  fixed  distance  of  140  cm  from  the  source  for  all 
images. Detectors were calibrated at fixed field sizes of 30.5 x 22.5 cm
2 (i.e this 
study was only done with system II detectors) All field sizes were defined at the 
source to isocenter  distance  of  100  cm.  Two  approaches  were  used  in  portal 
image acquisitions: 
o  Using  the  Varian  AM  maintenance  control  software  version  7.1  in  the 
integrated  mode  where  frames  are  acquired  and  integrated  continuously 
giving a  single image (the  average)  at the end  of  exposure. The acquired 
images were exported as DICOM files for analysis. 
o  In the second approach, test plans with desired field settings (i.e field size, 
monitor  units,  MLC  shapes,  etc)  were  created  using  the  Varian  RT  chart 
software. The test patients were scheduled in the time planner, exported to 
the  accelerator  and  treatments  executed  in  the  clinical  mode,  acquiring 
single integrated images at the end of each treatment. The acquired images 
were  opened  using  the  Varian  portal  dosimetry  software  and  exported  as 
ASCII files for analysis. 
The  second  approach  was  mainly  used  because  the  images  are  automatically 
saved, test patients can be reused and image acquisition process is faster on the 
machine. Image processing and mathematical modelling were carried out using 
MATLAB v2008b (The MathWorks, Inc).  
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3.2.2 Measurements and Image acquisition for calibration  
This study is based on the premise that the EPID image in the integrated mode is 
ideally dependent of the number of monitor units used to acquire the image. 
EPID images for a set of solid water phantoms of thicknesses 5, 10, 15, 20, 26 
and 32 cm were acquired with a 21.5x21.5 cm
2 field size, for calibration. This is 
the reference field size and all irradiations were 100 monitor units (MU) at a 
doserate of 400 MU min
 1. Each phantom was positioned on the beam central axis 
on the treatment couch and the distance from the source to the centre of the 
phantom adjusted such that the source axis distance (SAD) was equal to 100 cm 
as shown in figure 3 3. 
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Figure 3- 3. The experimental setup for EPID image acquisition. The solid water phantom 
thickness (T) was symmetrically set about the isocentre and the EPID kept at a fixed source 
to detector distance (SDD=140 cm).  
 
The photon beam has spectral variations due to the flattening filter, scatter and 
beam hardening in the object irradiated and hence the pixel intensity at any 
point in the detector will not follow exponential attenuation (equation 1.2) with 
object thickness. Equation 1.2 is modified by adding another term quadratic in 
thickness, and the data are fitted  onto the resulting equation (Fielding et al 
2002). The calculation of equivalent path length using the quadratic calibration   70 
method was done following the same principle as above; and also described by 
Kairn et al (2008). In their work, they used Monte Carlo simulations to validate 
the use of EPID as gauge for patient or phantom radiological thickness, as an 
alternative to dosimetry.  
The relationship between intensity and phantom thickness for a pixel at location 
(i,j) in the detector is assumed to be a quadratic function of thickness, given by 
0
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Where the * symbol represents element by element matrix multiplication, M(i,j) 
is a 2D matrix of signals (i =1 to 384 and j =1 to 512) due to placing a thickness 
T(i,j)  in  the  radiation  beam  and  Mo(i,j)  is  the  matrix  image  signal  obtained 
without any material in the beam for each pixel in the detector. T(i,j) at each 
pixel can be calculated from an expression related to the physical thickness of 
the material and setup / geometry of the unit and is given by   
 
                                                                (3. 5) 
  
 
Where x and y denote the distance of the i
th j
th pixel from the central axis, SDD 
and To are the source to detector distance and physical thickness of the material 
on the central axis respectively. q(i,j) is the angle between the vertical axis and  
pixel (i,j) on the EPID is given by  
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The  quadratic  coefficients  A(i,j)  and  B(i,j)  are  related  to  the  attenuation 
coefficients of the material. All matrix multiplications and divisions are done 
element by element. The measured 2D signal array for each of the thicknesses 
above was fitted to equation 3.4 resulting in a set of 384x512x6 equations, linear 
in A(i,j) and B(i,j) of the form  
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Where M1(i,j), M2(i,j), M3(i,j) are the matrices resulting from the element by 
element squaring of T(i,j), T(i,j) and simplification of the logarithmic term of 
equation 3.4 respectively. These sets of equations were solved by means of the 
least square method to obtain matrices A(i,j) and B(i,j).  
Any other material imaged by the detector resulting into matrix signal M4(i,j) 
can be solved by inverting equation 3.4 and substituting the values of fitting 
parameters A(i,j) and B(i,j) such that, 
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Where Th(i,j) is a two dimensional matrix of thicknesses in cm which is equal to 
water equivalent path length (EPL) for the reference conditions. However if a 
patient / phantom is imaged at any other irradiation situation, other than the 
reference  condition,  the  signal  M4(i,j)    has  to  be  corrected  for  field  size, 
phantom scatter and monitor unit changes to determine the (EPL). It was found 
that the solution given by evaluating the negative route of 3.8 was unrealistic, 
and thus discarded.  
 
3.2.3 Measurement of correction factors  
3.2.3.1  Field size and phantom thickness 
Scatter  correction  factors (CF)  due  to  phantom  scatter  and  field  size  effects 
were used to correct for EPL calculations as described by Fielding et al 2002. 
These factors were determined experimentally for a range of field sizes with 
solid water phantoms of thicknesses 5, 10, 15, 20, 26 and 32 cm. Each phantom 
was  positioned  on  the  beam  central  axis  on  the  treatment  couch  and  the 
distance from the source to the centre of the phantom adjusted such that the 
SAD was equal to 100 cm. Figure 3 4 shows the setup used. The transit signals 
through the phantoms were detected either directly with the EPID (figure 3 4 a) 
or using an ionisation chamber positioned on the central axis at the EPID position   72 
(figure 3 4 b). For the EPID, the response was measured as the mean pixel value 
in  a  1  cm  region  of  interest  in the  centre  of  the  image.  For  the  alternative 
method, the ionisation chamber was inserted in a 30x30cm
2 solid water phantom 
slab,  with  appropriate  build up  (1.5  cm  and  2.5  cm  for  6  MV  and  16  MV 
respectively) and 1 cm solid water phantom for back scatter to simulate the 
EPID. Using Monte Carlo simulations, Siebers et al (2004) established that 9.8 
mm  of  water  slab  was  optimum  to  model  the  equivalent  EPID  (Varian) 
backscatter  material.  Similarly,  the  phantom  model  used  by  Warkentin  et  al 
(2003) was » 2.7 cm equivalent thickness for Monte Carlo simulation of the EPID. 
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Figure 3- 4. The experimental setups for (a) EPID and (b) ionisation chamber measurement 
of  scatter  and  field  size  correction  factors.  The  solid  water  phantom  thickness  (T)  was 
symmetrically set about the isocentre and the detectors kept at fixed source to detector 
distances (SDD = 140 cm). The ion chamber was set with a 1.0 cm solid water backup and 
build-up equivalent to the beam dmax (1.5 cm and 2.5 cm for 6 MV and 16 MV respectively).  
 
The total radiation signal (dose) reaching the EPID detector is the sum of the 
primary and scatter components (Swindell et al 1996). The scatter factor, SF(s,z) 
due to field size (s) and physical thickness (z) is the ratio of the total signal   
(TD) to the primary signal (PD) and is defined by   73 
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Where  SPR(s,z) is  the  scatter  to  primary  ratio.  The  CF  is  related  to  the SPR 
(Mayles et al 2007, Kairn et al 2008), by  
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Where ref is the reference field size (21.5x21.5 cm
2) and since the primary dose 
is  independent  of  field  size,  then  PD(z)ref  =  PD(z)s.  Thus  for  either  EPID  or 
ionisation chamber measurements, the correction factor CF(s,z) due to field size 
(s) and solid water phantom thickness (z) were obtained as the signal ratios for 
the reference field and the field size of interest (s). 
 
3.2.3.2  Monitor unit effects 
The product of  EPID pixel value  and  acquired number  of frames has a linear 
relationship with the MU (McDermott et al 2006, Greer et al 2003 and Kavuma et 
al 2008). However, the preliminary results demonstrated significant differences 
between EPL for EPID images acquired with lower monitor units and those with 
higher monitor units. The effect of varying MU and the influence it has on the 
calculated EPL was studied by irradiating solid water materials of thicknesses 10, 
20 and 32 cm for square field sizes of 5, 10 and 20 cm; at 20, 50, 100, 200, 300 
and 500 MU; and doserates of 400 MU/min and 100 MU/min. The signal (average 
EPID response in a 13 x 13 pixel (approximately 1.0 cm
2 area) region of interest 
in  the  centre  of  the  image)  versus  MU  plots  were  generated  for  the  three 
thicknesses.  Another  dosimetric  parameter,  the  signal to monitor units  ratio 
(SMUR) was calculated by dividing the same EPID signal above by the delivered 
number of monitor units. The main purpose of the SMUR calculation is to take 
into consideration the non linear response of EPID at lower MU. The data were 
normalised to those at 100 MU. From these results, correction factors dependent 
on the MU were determined and equation 3.8 above was modified to take into   74 
consideration the varying effect of MU on EPL. Hence the overall correction due 
to  phantom  thickness,  field  area  and  monitor  unit  is  given  by  
mu
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This correction factor ) , ( , , j i CF mu z s , becomes the coefficient of the M4(i,j)/M0(i,j) 
term in equation 3.8 (Mayles et al 2007, Kairn et al 2008). 
The  calculation  of  the  water  EPL  was  accomplished  using  an  iterative 
numerical method (Appendix A). An iterative algorithm was created to obtain a 
converged solution  ) , ( 1 j i xn+  and the thickness Th(i,j) calculated in equation 3.8 
is the initial approximate solution  ) , ( j i xn  given by  
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Matrices  A(i,j),  B(i,j)  and  the  ratios  M1(i,j)/M0(i,j)  are  constants,  but  the 
correction is included in the loop which makes matrix c(i,j) a variable at each 
iteration.  In  other  words  after  each  iteration,  a  new  correction  is  obtained 
depending on the previous solution. The solution  ) , ( 1 j i xn+  is the water equivalent 
path length or water equivalent thickness or radiological thickness. The solutions 
were  tested  for  convergence  for  selected  field  sizes  and  thicknesses,  i.e  the 
solution  xn+1  approached  a  steady  value as  n  ® large  (see  table  4.6,  section 
4.2.5.1).  Convergence  was  obtained  after  two  –  three  iterations;  hence  the 
algorithm was set to repeat itself five times. Bad pixels within the imager and at 
edges of the imager may cause imaginary roots or not a number (NAN) within the 
matrix.  NANs were replaced by zeroes wherever they were in the matrix and 
imaginary roots were converted into the real numbers using Matlab. The stability 
of the fitting parameters A(i,j) and B(i,j) was investigated with a monthly repeat 
of image acquisition over a four month period for both 6 MV and 16 MV. 
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3.2.4 Open fields 
3.2.4.1   Verification of equivalent path length from EPID images   
EPID images were acquired for a range of field sizes and known thicknesses of 
water and non water equivalent materials to verify the accuracy of calculated 
equivalent  path  length  as  described  in  equation  3.12.  To  investigate  the 
influence  of  varying  densities,  materials  of  low,  medium  and  high  densities 
representing lung, water and bone respectively were used.  
(a) Slabs of solid water, bone and lung materials were positioned in steps (figure 
3 5  (a)).  The  dimensions  of  each  slab  were  30x30  cm
2  with  thicknesses 
(relative electron densities) of 10cm (0.99) for solid water, 3 cm (1.3) for 
bone and 3 cm (0.34) for lung.  
(b) In the second setup, cylindrical materials (diameter 3cm and height 7 cm) of 
lung, solid water and cortical bone with relative electron densities of 0.4, 
0.99 and 1.66 respectively were sandwiched between two 5cm slabs of solid 
water.  The  cylinders  were  inserted  into  Styrofoam  slab  (relative  electron 
density 0.05) as indicated in (figure 3 5 (b)). The relative electron densities 
quoted here are from the manufacture and were engraved on each phantom.  
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Figure  3-  5.  Figures  (a)  and  (b)  are  schematic  cross  sectional  diagrams  for 
different phantoms of varying electron densities. 
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The phantoms were positioned on the table in the center of the beam axis such 
that the SAD=100 cm to the phantom centres. EPID images of 20x20cm
2 field 
sizes were acquired with 6 MV exposures with 100 MU for both cases in figure 3 
5.  A  theoretical  formula  by  Broggi  et  al  (2001)  was  used  to  compute  the 
radiological thicknesses (EPL) for the cases in figure 3 5, whereby for any given 
material of physical thickness Tm and relative electronic density rm, the EPL or 
radiological thickness is given by       
m mx T EPL r =    (3. 13) 
 
                                                  
3.2.4.2  Exit dose prediction for open fields from EPID images 
After  the  equivalent  path  length  calculation  from  the  EPID  image  had  been 
carried out as described above, the method was extended to dose prediction. 
The exit dose is defined at the dose plane positioned at a distance dmax, from 
the exit surface of the phantom. In cases where the phantom / patient do not 
have a flat exit surface, the exit dose is similarly defined at irregular locations, 
with distances dmax from the exit surface. The dose at a depth for a particular 
field size can be calculated from the given number of monitor units, appropriate 
depth dose  data,  output  factor  and  off axis  correction    (Williams  et  al 2004, 
Podgorsak  et  al  2005).  For  the  2D  EPID  image,  an  exit  dose  map  (Dext)  was 
calculated by relating the calculated EPL to the percentage exit thickness dose 
(PETD), which is defined as the ratio of the exit dose at a depth of z dmax to the 
dose at dmax (Appendix B), where z is the thickness of the phantom. Table 3 2 
explains the conversion process for selected points in a 2D EPID image matrix 
obtained at 12 cm
2 FS. Each point in the EPID generated EPL matrix (3 2 a) is 
converted into a corresponding exit thickness dose (3 2 c) using the PETD(z,s) 
table ( 3 2b) by interpolation (look up table) between depths (d) and field sizes 
(FS).  
Table 3- 2. Conversion process of EPL to dose using PETD table   77 
- - - - -
- 55.2 49.0 - 18
- 54.0 50.2 - 17
- 60.1 55.0 - 16
- 65.0 60.1 - 15
- - - - d
- 15 10 - FS
- - - - -
- 55.2 49.0 - 18
- 54.0 50.2 - 17
- 60.1 55.0 - 16
- 65.0 60.1 - 15
- - - - d
- 15 10 - FS
- - - -
- 17.6 16.8 -
- 17.2 15.5 -
- - - -
- - - -
- 17.6 16.8 -
- 17.2 15.5 -
- - - -
- - - -
- 48.8 52.7 -
- 50.7 59.5 -
- - - -
- - - -
- 48.8 52.7 -
- 50.7 59.5 -
- - - -
(a) EPL 2D matrix for 12 FS
(b) PETD table
(c) ETD 2D matrix for 12 FS
 
 
The  PETD  were  derived  from  tissue  phantom  ratios  (TPR)  according  to  the 
equation 
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Where  SAD  is  the  source  to  axis  distance,  TPReff  is  the  TPR  at  an  effective 
distance z dmax and dmax is the maximum depth dose for 6 MV photon beams. 
Similar to TPR, the field size (s) in PETD is defined at the isocenter. The TPR 
data generated from measured depth dose curves were imported from Eclipse 
8.6 TPS (Varian Medical Systems, Palo Alto, California, USA). Equation 3.14 is 
theoretically  justified  in  Appendix  B  and  was  experimentally  verified  by 
ionisation  chamber  measurements  for  selected  field  sizes  and  solid  water 
phantom thicknesses, as illustrated in figure 3.6. This was done for square field 
sizes of 5, 10, 15 and 20 cm; at varying phantom thicknesses of 10, 15, 20 and 32 
cm. At each setup, z/2 was always kept at SAD  and the ionisation chamber was 
located at distance z  dmax (z is the phantom thickness). 
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Figure 3- 6. The experimental setup used for ionisation chamber measurement of PETD 
 
Flood field calibration of the EPID, required by the manufacturer’s control 
software, has the effect of flattening the beam profile, thus improving imaging 
performance. However it has a deleterious effect on transit dosimetry because 
the process removes any in air / off center ratio in the EPID image caused by the 
flattening filter (Van Esch et al 2004, Greer et al 2007). The off axis doses were 
corrected by applying the open field envelope and boundary profiles (Storchi et 
al 1995, Storchi et al 1999).  The envelope profile Ep(r,z) is defined as the ratio 
of the dose at a point off centre relative to the dose on the field central axis at 
the same depth and describes the off axis ratio of each calculation point for an 
infinite uncollimated field. The boundary profile Bp(x,z,s) is defined as the ratio 
of the dose at a point off centre in a finite field relative to the dose at the same 
point in an infinite field and describes the effect of the edges of the collimator 
jaws for each field size. The data used in this study were imported from Eclipse 
8.6  TPS’s  (Beam  configuration  work  space)  pencil  beam  algorithm  that  is 
generated from measured beam profiles. 
The exit dose map is then calculated according to the equation  
 
) , , ( ) , (
100
) , (
) ( ) , ( s z x xB z r xE
j i PETD
x s MUxOFxB j i D p p ext =    (3. 15) 
    
Where:   
·  MU is the given monitor unit   79 
·  OF is the output factor of field s relative to the 10x10cm
2 
·  B(s) is a factor which corrects for reduced back scatter proximal to the 
exit surface (corrects dose in our setup to reference condition);  
·  Ep(r,d) is the envelope profile, a function of radial distance (r) from the 
field central axis and the depth (z) of point 
·  Bp(x,z,s) is the boundary profiles a function of distance (x) from the field 
central axis, depth (z) of point and field size(s).  
 
3.2.4.3  Entrance dose prediction for open fields from EPID images 
The entrance dose is the most commonly measured in vivo dosimetry parameter, 
which  is  usually  compared  to  the  expected  dose  predicted  by  the  treatment 
planning system. The entrance dose is defined at the plane, a distance dmax from 
the  entrance  surface  of  the  phantom.  The  entrance  dose  distribution  was 
determined using back projection techniques based on the inverse square law 
and attenuation. The entrance dose (Dent) was determined by projecting the exit 
dose maps back to the phantom entrance surface at depth of maximum dose 
(dmax) given by 
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ent =    (3. 16) 
  
Where Bp(x,dmax,s) and Ep(r,dmax) are the boundary and envelope profiles at the 
entrance respectively. PDDcorr is the percentage depth dose for each pixel’s EPL, 
corrected for changes in SSDs using the Mayneord factor 
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Where d is set to be EPL  dmax. 
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3.2.4.4  Verification of exit dose  
From  the  calculated  EPL  of  the  EPID  images,  exit  doses  were  calculated  as 
described in equation 3.15, and verified by comparison with corresponding doses 
calculated by the TPS. The exit doses were verified using the setup described in 
figure  3 5  (section  3.4.2.1)  for  verification  of  EPL.  In  addition,  an 
anthropomorphic  lower  torso  phantom  shown  in  figure  3 7  (The  Phantom 
Laboratory, Salem, New York, USA) was positioned on the treatment couch and 
anterior posterior  fields  were  delivered.  The  phantom  consists  of  natural 
human skeleton  lumbar  vertebrae,  pelvis,  upper  third  of  femur  and  a  hollow 
cavity (reproduces the sigmoid flexure and rectum) cast into Urethane (material 
with same effective atomic number as the body soft tissue).  
 
 
Figure 3- 7. Shows the lower torso phantom and the white central square in (a) 
shows the 20x20 cm
2 irradiated area. 
 
The phantoms were positioned on the table in the centre of the beam axis such 
that  the  SAD=100  cm  to  the  phantom  centres.  EPID  images  of  20x20cm
2  and 
10x10cm
2 field sizes were acquired with 6 MV and 200 MU exposures. 
 
                
3.2.5 Irregular fields 
Radiation  fields  that  are  not  square  or  rectangular  or  circular  are  termed 
irregular fields. An irregular field also has an equivalent square field that will   81 
yield  the  same  value  of  a  given  dose  function  as  does  the  irregular  field 
(Podgorsak 2005). 
3.2.5.1  Equivalent path length from EPID images for irregular fields  
The  dose  functions  of  interest  are  the  scatter  correction  factor,  CFs,z(i,j)  as 
described in equations 3.10 and 3.11 above, and the output factor (OF) due to 
an  irregular  area.  Field  area  and  resulting  phantom  scatter  are  essential  for 
predicting the EPL from an EPID image. In case of irregular fields, one option of 
determining  area  is  to  measure  it  from  the  EPID  image.  A  range  of  irregular 
shaped fields of known field area were designed using the multi leaf collimators 
(MLC) in the Eclipse 8.6 (Varian Medical Systems, Palo Alto, California, USA) TPS. 
The fields were defined by the MLC leaves while the collimator jaws opening 
remained  fixed  at  25x25  cm
2.  The  plans  were  exported  to  the  linac  and  all 
irradiations were done at 100 MU and dose rate of 400 MU/min. EPID images 
were acquired for these irregular shaped field apertures with 20 cm thicknesses 
of solid water materials to verify the accuracy  of  calculated  equivalent  path 
length and hence dose. The images for the computation of irregular fields were 
acquired using the RT chart fields, as described in section 3.2.1. Figures 3 8 (a f) 
show some of the various aperture shapes used in the study. The shape in figure 
3 8 (a) is commonly encountered whenever there is a need for partial blocking of 
the  beam  to  shield  a  critical  organ.  The  shape  in  figure  3 8  (e)  was  chosen 
because it is clinically similar to the  anterior posterior pelvic radiation fields 
used in the treatment of prostate and cervical cancers. The other shapes were 
chosen to test the abilities of the algorithm and the TPS. For the shape in figure 
3 8 (d), the Eclipse 8.6 TPS has  no  problem with MLC abutting in open field 
(Varian  solved  this  issue  with  the  introduction  of  the  Distributed  Calculation 
Framework (DCF) in Eclipse 8.1). 
A MATLAB code was written to read and detect the radiation field edges from 
the  EPID  acquired  images  shown  in  figures  3 9  (a f)  of  the  irregular  shaped 
apertures.  An  edge  detection  algorithm  based  on  searching  the  entire  EPID 
image and computing the approximate gradients of the image intensity function 
was  written.  An  edge  is  localised  at  those  points  where  the  gradient  is  a 
maximum.  A  mask  image  was  derived  in  which  pixels  at  the  edge  are 
characterised by ones and all other pixels elsewhere in the image are set to 
zero.   82 
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Figure  3-  8. Irregular  apertures of  varying  shapes and areas.  The  dimensions  are  in  cm 
measured at the isocentre. 
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Figure 3- 9. Respective EPID images for the apertures shown in figure 3.7 above 
 
 
By tracing the entire bounded region (irradiated area), edge polygons are formed 
as shown in figures 3 10 (a f).    84 
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Figure 3- 10. Respective field edges determined from the EPID images above 
 
The coordinates of the pixels of these polygons are searched and successively 
stored. If the X and Y coordinates of all vertices are known and entered in order 
of  successive  vertices,  then  the  area  of  the  polygon  at  the  isocentre  can  be 
calculated (Beyer 1987) using the equation    85 
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Where,  
·  n is the total number of pixels forming the edge polygon,  
·  i x and i y  ; i=1, 2, . . ., n are the x and y coordinates of each vertex pixel 
making the bound region;  
·  pix is the pixel size (resolution) = 0.784 mm and  
·  mag is the magnification.  
The equivalent square areas are approximately obtained from taking the square 
roots of the area in equation (3.18). The area calculation was also tested with 
other images acquired for square, rectangular and wedged fields. The calculated 
areas  using  the  equation  above  were  compared  with  the  expected  area  and 
percentage differences computed. The automatic calculation of area from the 
image facilitated the calculation of EPL, and hence dose for any irradiated field, 
including  conformal  shapes  of  unknown  area.  The  calculated  area  is  used  to 
establish  an  appropriate  scatter  factor  CFs,z(i,j),  which  is,  together  with  the 
correction coefficients A(i,j), B(i,j) and the image signal obtained without any 
material in the beam Mo(i,j) for open fields, used as described in equations (3.8) 
and (3.12) to predict the EPL. 
 
3.2.5.2  Exit dose from EPID images for irregular fields  
The area calculated above is used to establish an appropriate output factor (OF) 
and the exit dose calculated as described in equation (3.14). The EPL beneath 
the MLC shielded regions is too high (» 80 cm) compared to maximum depths for 
TPR table which was measured up to a depth of 40 cm. To facilitate calculation 
of doses in these regions, the TPR table was extrapolated to include values up to 
50 cm. For all calculated EPL greater than 50 cm, the TPR was set to the MLC 
transmission factor. The images for the computation of MLC transmission were 
acquired using fields created in RT chart, as described in section 3.2.1. The MLC 
transmission is defined as the EPID dose (signal) ratio at the central axis of a 
closed MLC measurement to an open beam, for the same field size of 10x10cm
2 
(Lorenz et al 2007). The mean pixel values in the 10x10cm
2 area were obtained 
for the open field and MLC closed field, that is   86 
013 . 0
_ _
_ _
_ = =
Field Open alue MeanPixelV
Closed MLC alue MeanPixelV
on Transimisi MLC  
To  verify  the  accuracy  of  calculated  equivalent  path  length  and  hence  dose, 
corresponding  doses  calculated  with  the  TPS  were  compared  with  those 
predicted by EPID.  
 
 
3.2.6 Enhanced dynamic wedge fields 
Enhanced dynamic wedge (EDW) dose profiles are computer controlled, 
created by sweeping one of the Y jaw collimators from starting (open field) to 
closed position (0.5 cm from the opposite fixed Y jaw), while both the X jaws 
remain  fixed  during  irradiation  (Varian  Medical  systems  1996,  Gibbons  1998, 
Prado et al 2002, Kuperman 2005). Because of the collimator motion, different 
parts of the field are exposed to the primary beam for different lengths of time, 
creating a wedged dose gradient across the field.  The wedged dose distributions 
are generated by means of a single golden segmented treatment table (GSTT) 
for the 60
o wedge angle for each beam energy, and the GSTT is used to control 
the position of the moving jaw versus the proportion of the delivered monitor 
units. The dose distributions for the other wedged angles (10
o, 15
o, 20
o, 25
o, 30
o 
and 45
o) used clinically are reproduced by combining the open and 60
o wedged 
data beams, (Pasquino et al 2009) and are contained in a unique dose versus jaw 
position table called the Segmented Treatment Table (STT). EDW comprises of 
two parts: the open field phase and a collimator sweeping phase, both governed 
by the STT which specifies the moving jaw position in equally spaced steps as a 
function of the cumulative MU. 
 
3.2.6.1  Equivalent path length from EPID images for EDW fields  
The  sweeping  of  the  moving  jaw  across  the  radiated  field  modulates  the 
radiation intensity passing through the phantom by varying the exposure time of 
any  given  point,  hence  the  signal  reaching  the  EPID.  The  images  for  the 
computation of EDW treatments were acquired using fields created in RT chart, 
as described in section 3.2.1.The edge detection and subsequent calculation of 
irradiated area method, described in section 3.2.5.1, was used for EDW fields.   87 
There  are  two  potential  approaches  for  verification  of  dose  for  EDW     using 
either the same set of correction coefficients A(i,j), B(i,j) and Mo(i,j) generated 
for open fields or generating another set of coefficients that involve the wedge 
motion in the field. The former approach has some limitations in predicting EPL 
especially for EDW angles above 30
0,(see section 4.3.3 in results and discussions)  
hence  in  this  study,  the  latter  approach  was  used.  We  tested  the  use  of 
correction coefficients A(i,j), B(i,j) and Mo(i,j) on EDW fields but because of the 
limitation described in section 4.3.3, the idea was dropped. 
All the fitting parameter measurements were performed using the Y1 IN 
EDW orientation. The wedged image signal without any material in the beam 
) , ( 0 j i M
q  was calculated for the largest field size of 20x20 cm
2 used in this study 
with moving jaw Y1= 10 cm, fixed jaw Y2=10 cm, and fixed length X = 20 cm; 
using  the  MU  fraction  calculation  methodology  with  GSTT  (Gibbons  1998  and 
Kuperman 2005). For simplicity, the GSTT was represented analytically as  an 
exponential function i.e  
 
) exp( ) ( 1 1 0 Y b a a Y GSTT + =    (3. 19) 
      
Where Y is the moving jaw position that ranges from  20 to 10 cm; the fitting 
coefficients  a0,  a1  and  b1  are  determined  from  the  Varian  published  values 
(Varian  Medical  Systems,  1996).  The  full field  segmented  treatment  table 
associated with wedge angle q  is given by (Kuperman 2005) 
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Where MU is the applied monitor units; GSTT(0) and GSTT(Y=9.5) are the GSTT 
at Y=0 and Y=9.5 respectively (9.5 is due to the fact that the Varian wedge stops 
0.5 cm from the fixed jaw position); K is a geometrical correction factor that 
scales the data from the isocenter to the EPID imager level; 
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The STT is a two entry table composed of 20 segments (21 instances), which 
gives  the  positions  of  the  moving jaw  versus  the  proportion  of  the  delivered 
monitor units for each field segment. To simplify data manipulation with the 
EPID, which is comprised of 384x512 pixels;  
·  First  linear  interpolation  of  the  ) (Y STT
F
q table  was  used  to  create  384 
points (in wedge direction), where all the points outside the desired field 
lengths are reduced to zeros.  
·  Secondly  this  row  of  384  pixels  is  replicated  512  times  to  constitute 
matrix  ) , ( 0 j i M
q . 
·  Lastly  the  generated  profiles  present  a  slightly  steep  effect 
(Papatheodorou et al 1998) towards the end position of the moving jaw. 
Simple averaging of adjacent values was used to smooth the data. 
 
To  establish  the  appropriate  coefficients  for  the  wedged  fields,  an 
additional measurement and subsequent derivation of Aw60(i,j) and Bw60(i,j) for 
the 60
o wedge was made. The correction coefficients for any other wedged angle 
q (Awq(i,j) and Bwq(i,j)) were obtained from those of the 60
o wedge and the open 
field  (Aw0(i,j)  and  Bw0(i,j)),  using  weighting  factors  obtained  by  the  ratio  of 
tangents in a way analogous to that applied to the GSTT (Prado et al, 2002). 
That is 
and j i A w j i A w j i A w w w ) , ( ) ( ) , ( ) ( ) , ( 0 0 60 + = q q    (3. 22) 
   
) , ( ) ( ) , ( ) ( ) , ( 0 0 60 j i B w j i B w j i B w w w + = q q      (3. 23) 
     
With all the necessary factors established, the EPL for the irradiated material 
can  be  calculated  as described  in equations  (3.8)  and  (3.12) above.  The  EPL 
predicted in this way is independent of wedge presence.   
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3.2.6.2  Exit dose from EPID images for EDW fields  
The exit dose can then be calculated as in equation (3.14) and this dose will be 
independent of the wedge effect. The wedge effect in the dose is recovered 
using the STT methodology where Y in this case is truncated to the desired field 
length (in the wedge motion direction) according to the equation  
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In this case GSTT(Ystop) is the GSTT at Y=Ystop, where Ystop = Y2 0.5. As described 
above STTq(Y) is converted into a 384x512 array to constitute a matrix STTq(i,j). 
It has been reported that EDW depth dose is almost identical to the open field 
depth dose (Papatheodorou et al 1999, Varian Medical Systems, 1996), hence the 
TPR for open fields can effectively be used in the conversion of EPL to dose.  In 
the presence of an EDW of angle q, the exit dose in equation (3.15) above is 
modified to  
) , , ( ) , (
100
) , (
) ( ) , ( ) , ( s z x xB z r xE
j i PETD
x s xOFxB j i MUxSTT j i D p p ext q =    (3. 25) 
 
Equation 3.25 above was tested by irradiating and subsequently acquiring EPID 
images for 20 cm solid water thickness with 15
0, 30
0 and 45
0 EDW at different 
field  sizes.  All  irradiations  were  done  at  100  MU.  Corresponding  plans  were 
generated with the Eclipse 8.6 TPS for comparison.  
 
  
3.2.7 Dose comparison with treatment planning system 
Cross  plane  profiles,  point  dose  differences  and  gamma  index  methods  were 
employed  in  dose  comparisons.  The  dose  distributions  obtained  for  different 
square, irregular and EDW field sizes were used in the evaluation of both the 
exit and entrance doses. All corresponding dose comparisons for TPS and EPID 
were absolute. Plane dose distributions at the exit (z dmax) and entrance (dmax) 
were calculated in the Eclipse 8.6 (Varian Medical Systems, Palo Alto, California, 
USA) TPS for each of the fields. The calculated plane dose distributions from the   90 
TPS  were  subdivided  into  a  512  x  384  matrix  and  imported  into  the  Matlab 
software for comparison with those determined from EPID images. Point dose 
comparisons between the TPS dose (DTPS) and EPID predicted dose (DEPID) were 
calculated at the centres of homogeneous phantoms. For both the TPS and EPID, 
the point doses at the exit were assumed to be the mean of 13x13 pixels (~ 1 
cm)  at  the  central  axis.  The  results  were  computed  using  the  TPS  as  the 
reference and percentage differences were calculated as  
 
% 100 / ) ( x D D D TPS EPID TPS -      (3. 26) 
                                                                       
In addition, TPS and EPID dose profiles (1D) were extracted from the centres of 
the irradiated fields and compared. Furthermore, the absolute dose matrix (2D) 
datasets were evaluated quantitatively by calculating the gamma index, which is 
a measure of the percentage of points passing a selected criterion. The gamma 
index combines both the dose difference (DD) and distance to agreement (DTA) 
into a single quantity normalised by the acceptance criteria. With respect to the 
dose distribution in the high dose gradient region, Low et al (1998) and Chen et 
al (2009) reported that the DTA is equally important to the differences between 
the measured and the calculated doses obtained from the TPS. The DTA is the 
distance between measured data points and the nearest point in the calculated 
dose distribution that exhibits the same dose. 
 
 
3.2.8 Further dose verification with MapCHECK 2 device 
To  obtain  additional  independent  verification  of  EPID  calculated  exit  doses, 
MapCHECK 2 (SUN Nuclear Corporation, Melbourne Florida, USA) was calibrated 
and used to measure directly the exit doses for solid water phantoms. According 
to the manufacturer, MapCHECK 2 is a 2D array of 1527 uniformly spaced diodes, 
active detector resolution area of 0.64 mm
2, diode diode spacing of 7.07mm and 
covering an area of 32x26cm at the isocentre. The device has a build up and 
backscatter to the active detectors region of 2.0 ± 0.1 and 2.75 ± 0.1 g/cm
2 
respectively.  Figure  3 11  shows  a  photo  of  the  MapCHECK  2  device.  For 
measurements,  the  device  is  connected  to  computer  software,  which  is 
controlled from the operators’ room. During exposure, each diode generates a   91 
charge which is proportional to the dose received at that location. The charge is 
integrated, converted from analog to digital form and sent to the computer that 
applies  the  necessary  correction  factor  and  stores  the  data.  The  MapCHECK 
device was first calibrated by positioning it on the couch, aligning its detector 
level with the isocenter.  It was then irradiated with a direct anterior (gantry 
angle zero) beam of 100 MU to a 10x10 cm
2 field size. The software allows the 
entry  of  a  specified  factor  (dose  corresponding  to  a  given  number  of  MU  at 
specific depth and field size) which is used to normalise the data to create a 
calibration  file  that  was  used  to  correct  the  dose  maps  for  all  subsequent 
measurements. 
 
 
 
 
Figure 3- 11: MapCHECK 2 device (SUN Nuclear Corporation, Melbourne Florida, USA) 
 
 
To avoid heavy weight above the MapCHECK device, it was positioned upside 
down;  on  top  of  15  cm  thickness  of  homogeneous  solid  water  (total  water 
equivalent material of MapCHECK and solid water is » 20 cm). The gantry was 
rotated to 180
0, such that the sensitive side of the MapCHECK device faced the   92 
beam direction, as illustrated in figure 3 12. The setup enabled simultaneous 
measurement with MapCHECK and EPID image acquisition. 
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Figure  3-  12:  The  setup  used  for  the  simultaneous  MapCHECK  measurement  and  EPID 
image acquisitions. 
 
 
The MapCHECK and solid water were CT scanned and images exported to the 
TPS. Corresponding plans were generated with the Eclipse 8.6 TPS for exit dose 
comparison.  The  above  setup  was  used  for  selected  open,  conformal  (MLC 
shaped) and EDW fields. The plans were exported to the Linac and exposures 
taken, acquiring EPID image and MapCHECK measurements at the same time. To 
compare the dose distributions from the MapCHECK device (sensitive region is 
2.75 cm) with the EPID exit dose (calculated at 1.5 cm), the doses from the 
former  were    adjusted.  The  MapCHECK  dose  map  was  resized  to  the  same 
number of 2D data points as those used for the EPID and TPS. The effect of 
resampling the MapCHECK data points was initially investigated to see if it had 
any adverse effect on the 2D dose map. All doses for EPID, MapCHECK and TPS 
are absolute, measured in cGy. 
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4  CHAPTER 4: RESULTS AND DISCUSSION 
4.1 Dosimetric Performance 
4.1.1 Detector reproducibility and response to a reference beam  
Table 4.1 shows that system II detectors have better short term reproducibility. 
Repeated  exposure  of  system II  EPIDs  showed  a  standard  deviation  ranging 
between 0.13%   0.71% compared to system I that ranged between 2.74%  4.93%.  
 
Table 4- 1 Percentage signal short-term reproducibility for the different EPIDs: 
System-I
System-I
System-I
System-I
System-I
System-I
System-II
System-II
System-II
System-II
System-II
System
3.39 IDU-II/IAS2 H
3.42 IDU-II/IAS2 F
4.07 IDU-II/IAS2 E
4.47 IDU-II/IAS2 C
2.74 IDU-II/IAS2 B
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Figure  4 1  shows  the  long term  stability  of  pixel  response  over  a  six month 
period for three system II EPID detectors. For each detector, the pixel responses 
at the central axis for the first month were compared for the readings in the 
next five subsequent months. The results show that the short term and long 
term reproducibility for system II detectors is within ±1.5%, in agreement with 
McCurdy et al (2001).  
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Figure 4- 1. Long term (six months) reproducibility for three system-II detectors  
 
 
Figure  4 2  shows  the  EPIDs’  responses  to  a  reference  beam.  System I  EPIDs’ 
showed a significantly wider pixel deviation of 17% compared to 8% for system II. 
The  error  bars  in  figure  4 2  represent  a  fixed  value  of  0.22,  which  is  the 
standard error of the mean. 
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Figure 4- 2. Pixel deviation from the mean for each EPID, after exposure to a reference beam 
(50 MU, 400 MU/Min doserate and 10x10cm
2 field size).  
 
The signal outputs from the central pixel region (» 1.0 cm) for the reference 
beam showed considerable variation from one detector to another, with system I 
EPID’s  having  wider  pixel  deviation  of  ±9%  compared  to  ±5%  for  system II. 
Comparing the responses in figure 4 2 and the period in months each EPID has 
been in clinical use (table 3.1) indicates that individually the EPIDs’ responses to 
the  test  beam  are  age  independent.  Winkler  and  George  (2006)  reported 
variations of up to ± 10% on Electa iView
GT EPIDs and observed no relationship 
with age. 
 
4.1.2 Dose-response behaviour / Linearity 
In  the  integrated  mode  setup,  pixel  intensity  increased  linearly  with 
applied  monitor  units.  Figure  4 3  (a)  shows  typical  accelerator  output 
measurements using an ionisation chamber. Measurements were done at 140 cm 
source to detector distance. The results indicate  that all accelerator  outputs 
were stable prior to measurements with EPID’s. The linearity varied with system 
II  detectors  showing  a  better  fit  with  measured  data  compared  to  system I. 
Figure  4 3  (b)  and  (c)  shows  the  signal  to  monitor  units  ratio  (SMUR)  of  the   96 
detectors normalized to 1000 MU as a function of MU. Ideally the SMUR should be 
unity (100%) regardless of how many MU are used at each exposure. System II 
detectors  showed  a  response  that  ranged  between  95%     97%  at  5  MU  and 
progressively increased with increasing MU. We found that the normalised SMUR 
for system II EPID deviated from unity by 3 5% for ≤ 10 MU. The linearity was 
within 2% for 20 MU and practically 1% for 50 MU and above. At 1000 MU the 
SMUR is about 1%–1.2 % higher than that at 50 MU for system II EPID’s. Generally 
the SMUR varied between 3% 5% in the system II group of EPID’s within the 5 
1000  MU  range.  System I  detectors  show  a  wider  inconsistency  in  the  SMUR 
response. Detectors B,C and F show a gradual increase in SMUR with increasing 
MU.  However  the  SMUR  for  detectors  B  and  F  at  5  MU  of  52%  and  38% 
respectively are too low compared to the expected values. Similarly their SMUR 
response at 1000 MU is 8% and 7% higher than that at 50 MU. The ionisation 
chamber responses were within 3% in the 5 1000 MU settings for these system I 
detectors.  
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Figure 4- 3. Figure (a) shows Ionisation chamber response as a function of monitor units for 
different  accelerators.  Figures  (b)  and  (c)  show  the  signal  to  monitor  units  ratio  (SMUR) 
variation with monitor units. The readings at various monitor units were normalised to 1000 
MU for the ionisation chambers and EPIDs.  
 
 
Ideally the dosimeter reading ( ) M  should be proportional to the incident fluence 
( ) Q  and the ratio 

 


Q
M  should be constant regardless of MU settings. System II 
EPID response across the panel became stable (within 0.2%) for MU greater than 
200  MU,  in  agreement  with  Greer  (2007).  The  system II  SMUR  responses  are 
similar to previous studies reported by Greer (2007) and McDermott et al (2006) 
for the Varian a Si EPIDs and Winkler et al (2005) for Elekta iView
GT. The results 
directly show that there is much more variation for the system I EPIDs compared 
to system II.  
Winkler and George (2006) reported an increase in detector sensitivity of 1.7 – 
2.8% for the Elekta iView
GT in the MU range from 30 to 500. At lower MU (< 20),   98 
all EPIDs  had reduced  sensitivity attributable  to instability in the accelerator 
doserate  and  energy  during  start up  (Winkler  et  al,  2005).  McDermott  et  al 
(2004) indicated that EPID frames within the first few seconds of irradiation miss 
dose and that the longer the irradiation time, the smaller the deficit. This is 
illustrated  in  table  4 2,  that  compares  an  EPID’s response  to  a  single  20  MU 
exposure to a series of lower dose exposures with equivalent MU. The results 
indicate variations in the cumulative response for multiple exposures compared 
to a single exposure. The cumulative response for 20 exposures of 1 MU each, is 
3% lower compared to a single 20 MU exposure.  
 
Table 4- 2. Comparison of EPID J (System-II) response to a single 20 MU exposure to a 
series of lower-dose exposures with equivalent MU.  
  0.92% 1.62% 2.54% 2.92% Deficit from single exposure (20 MU)
117179 116100 115280 114200 113760 Total response (S MPV x ANF)
20 10 5 2 1 Monitor units per exposure
1 2 4 10 20 Number of exposures
  0.92% 1.62% 2.54% 2.92% Deficit from single exposure (20 MU)
117179 116100 115280 114200 113760 Total response (S MPV x ANF)
20 10 5 2 1 Monitor units per exposure
1 2 4 10 20 Number of exposures
 
 
The slow rise in EPIDs signal (McDermott et al 2004), together with doserate 
instability  during  accelerator  start up,  accounts  for  the  under response  at 
shorter irradiation times. 
 
Inconsistencies in the SMUR for system I were much more significant than 
for system II. Dead time corrections as indicated by McDermott et al (2006) due 
to frame saturation after every 64 frames could not rectify all the results nor 
could it account for discrepancies at the lower MUs. Chang et al (2003) indicated 
that there is dead time of 0.27 sec every 7.10 sec (the time for acquiring 64 
frames) when accelerator operated at 400 MU/min. The deficit in performance 
in  relation  to  system II  is  demonstrated  clearly  in  the  pixel  reproducibility 
results:  system I EPIDs averaged 3.8 % compared to 0.3% for system II as shown 
in table 4 1. The pixel sensitivity reproducibility of the Varian EPID has been 
reported to be within 1% (Menon et al 2004, Greer et al 2003, Greer et al 2007). 
However the image detection hardware / acquisition software combinations and 
periods of the EPIDs in clinical use could not be established from these studies.    99 
 
4.1.3 Pixel uniformity-response across the entire detector panel 
Table 4 3 shows the relative pixel response across the EPID detectors, based on 
their locations as illustrated in figure 3 1. There are no significant differences 
between the two acquisition systems in measured pixel uniformity within the 
radiation field. Because of the Dark field and Flood field corrections, the beam 
profile is expected to be flat within the irradiated region. All the detectors show 
that  the  intensity  is  slightly  high  at  the  inner  beam  (P1–P4)  and  gradually 
decreasing towards the outer beam of the field (P5–P8), with the exception of 
EPID I whose central response is lower than at the field edges because it had 
been  configured  for  dosimetry  and  hence  the  typical  horn shape  in  its  beam 
profile. The trend in all other EPIDs is expected since a large field is used for the 
flood  field.  The  20x20  cm
2  field  used  in  this  experiment  suffers  a  reduced 
scatter and therefore rolls off faster than the large field. Variations from the 
centre ROI of 1.0%, 2.2% and 4.5% for square field sizes of 5.0 cm, 7.5 and 10.1 
cm were found. Assessments in the penumbra region (Pavr) show wider variations 
in  response  between  different  detectors  with  system I  having  an  average 
response of 28.3% compared to 13.5% for system II.  
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Table 4- 3. Detectors response at different points (figure 3-1) relative to their central position 
P0. Pavr is the average of four points in the beam penumbra region. The subscripts I and II 
indicate whether the detector is a system-I or system-II respectively 
0.290 0.968 0.968 0.968 0.975 0.990 1.001 0.997 0.996 H-I
0.192 0.965 0.969 0.965 0.962 0.992 0.997 0.998 0.996 F-I
0.160 0.983 0.979 0.983 0.961 1.003 0.993 0.994 0.998 E-I
0.425 0.955 0.957 0.955 0.963 0.989 0.990 0.990 0.999 C-I
0.362 0.971 0.974 0.971 0.973 0.994 1.001 0.996 0.997 B-I
0.271 0.971 0.985 0.971 0.982 1.005 0.992 0.993 1.005 A-I
0.153 0.957 0.966 0.957 0.957 0.993 0.986 0.994 0.994 K-II
0.145 0.959 0.970 0.959 0.955 0.997 0.978 0.997 0.995 J-II
0.022 1.020 1.032 1.021 1.020 1.050 1.045 1.034 1.036 I-II
0.191 0.962 0.970 0.962 0.955 0.991 0.997 0.997 0.996 G-II
0.164 0.957 0.967 0.957 0.959 0.997 0.987 0.994 0.998 D-II
Pavr P8 P7 P6 P5 P4 P3 P2 P1 Position 
EPID
0.290 0.968 0.968 0.968 0.975 0.990 1.001 0.997 0.996 H-I
0.192 0.965 0.969 0.965 0.962 0.992 0.997 0.998 0.996 F-I
0.160 0.983 0.979 0.983 0.961 1.003 0.993 0.994 0.998 E-I
0.425 0.955 0.957 0.955 0.963 0.989 0.990 0.990 0.999 C-I
0.362 0.971 0.974 0.971 0.973 0.994 1.001 0.996 0.997 B-I
0.271 0.971 0.985 0.971 0.982 1.005 0.992 0.993 1.005 A-I
0.153 0.957 0.966 0.957 0.957 0.993 0.986 0.994 0.994 K-II
0.145 0.959 0.970 0.959 0.955 0.997 0.978 0.997 0.995 J-II
0.022 1.020 1.032 1.021 1.020 1.050 1.045 1.034 1.036 I-II
0.191 0.962 0.970 0.962 0.955 0.991 0.997 0.997 0.996 G-II
0.164 0.957 0.967 0.957 0.959 0.997 0.987 0.994 0.998 D-II
Pavr P8 P7 P6 P5 P4 P3 P2 P1 Position 
EPID
 
 
The variations in relative pixel uniformity across the EPID detectors were 
less  than  5%  within  the  irradiated  field.  The  effect  of  over  response  to  low 
energy x rays by the indirect a Si EPID (Vial et al 2008, McCurdy et al 2001) is 
observed in the penumbra regions of the field, though it is twice as pronounced 
in system 1 than system II. 
 
4.1.4 Electronic portal imaging device’s relative dosimetry 
Figure 4 4 shows a typical step profile acquired from an EPID image with a step 
wedge  compared  to  the  actual  transmission  measured  with  the  MapCheck 
device. For system I, the standard deviation in relative signal measured by all 
detectors in the step cross plane profiles beneath the 0.25, 0.50, 0.75, and 1.0 
relative thickness in the Right Left (Gun Target) direction were 0.4 (0.9), 0.7 
(1.2), 0.8 (1.4), and 1.0 (1.5) respectively, while for system II, they were 0.3 
(0.4), 0.5 (0.6), 0.5 (0.9) and 0.6 (1.0) respectively.  Theoretically, the EPID and 
MapCheck  results  should  be  the  same  because  they  are  relative  values.  The 
agreement between the EPID and MapCheck measurements was within 2% in the 
flat  area  of  each  step  for  both  systems.  In  areas  of  steep  dose  gradient,  at  101 
transitions in the step depth, the maximum distance to agreement of the EPID to 
MapCheck  is  2  mm.  The  residual  longitudinal,  vertical,  lateral  and  rotational 
misalignment of the wedge with the EPID detector/MapCheck and the primary 
beam  direction  cannot  be  ignored.  Together,  these  may  account  for  the 
observed differences. 
 
Step-wedge axis Step-wedge axis
Step-wedge axis
Step-wedge axis Step-wedge axis
Step-wedge axis
 
Figure 4- 4. Figure (a) shows typical central profiles comparing an EPID acquired image 
(dashed line) and actual MapCheck transmission (straight line) with a four step-wedge. A 
relative signal of 100 indicates an open field transmission; creating a fifth step in the figure.  
The X and Y figures quoted in boxes of figure (b) and (c) are the numerical values on the 
horizontal and vertical axes for each point.      
 
                     
4.1.5 Field size dependence  
A  systematic  increase  in  the  average  pixel  intensity  was  observed  when 
increasing the field size from 2x2 cm
2 to 20x20 cm
2. For system I, the relative  102 
increase  in  detector  responses  ranged  from  13.6%  to  24.4%  while  system II 
ranged from 23.0%   23.4%. This pixel value  dependence on field size is also 
reflected  by  the  variation  in  the  EPID  scatter  factors  for  the  two  systems. 
System II EPID’s had almost identical values of coefficients (equation 3.2) and 
exhibited better data fit to the second order polynomial compared to system I 
that showed large variability. Table 4 4 shows the polynomial coefficients A0, A1 
and A2, and the 
2 R  values for the different EPIDs.  
Table 4- 4. Polynomial coefficients for different EPIDs described in equation 3.2 and the R
2 
value for the field size fit. 
0.877 13 0.037 0.815 System-I H
0.994 7 0.029 0.777 System-I F
0.890 7 0.022 0.830 System-I E
0.977 10 0.036 0.760 System-I C
0.975 12 0.037 0.743 System-I B
0.931 3 0.019 0.836 System-I A
0.999 6 0.027 0.788 System-II K
0.999 6 0.027 0.787 System-II J
0.999 6 0.027 0.789 System-II I
0.999 6 0.027 0.791 System-II G
0.999 6 0.027 0.787 System-II D
Field size polynomial 
fit (R2 value)
A2x(-10-4) A1 A0 System EPID
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0.890 7 0.022 0.830 System-I E
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0.975 12 0.037 0.743 System-I B
0.931 3 0.019 0.836 System-I A
0.999 6 0.027 0.788 System-II K
0.999 6 0.027 0.787 System-II J
0.999 6 0.027 0.789 System-II I
0.999 6 0.027 0.791 System-II G
0.999 6 0.027 0.787 System-II D
Field size polynomial 
fit (R2 value)
A2x(-10-4) A1 A0 System EPID
 
 
 
Figure 4 5 illustrates the relative signal variation with field size. For small field 
sizes, the EPID readings were slightly lower than the ion chamber readings, and 
when the field sizes is increased, the EPID readings were higher than the ion 
chamber readings, as illustrated in figure 4 5 (a). This effect is due to changes in 
scatter with increased field size. Scatter has a low energy component; its effect 
on the EPID’s phosphor response is enhanced (due to presence of high atomic 
number  component  in  the  phosphor  material)  compared  to  an  ionisation 
chamber (Van Esch et al 2004, Greer et al 2003). The results in figure 4 5 (b) for 
system I are affected by the poor detector reproducibility of pixel signal. 
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Figure 4- 5. EPID signal variations with field size. The data were normalised to a 10x10cm
2 
field  size  for  the  two  systems.  The  figure  also  includes  a  comparison  with  an  ionisation 
chamber of accelerator B and I for system-I and system-II respectively. 
 
4.1.6 Doserate influence 
The system II EPIDs show a general decrease in response to increasing doserates 
at both total monitor units values (20 and 100) used in the investigation. Figure 
4 6 (c) shows that the system II EPID’s sensitivity decreased by between 1.0%   
1.8% with increasing the doserates in the range 100 600 MU/min.  
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(a) 20 Monitor units
(c) Normalized data
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Figure 4- 6. System-II EPIDs response to varying doserates. Figures (a) and (b) show pixel 
values variation with doserate for total doses of 20 MU and 100 MU respectively. The original 
data (points) were fitted to a power potential function in equation 3.3 and the lines show 
the best fit for each EPID. Figure (c) shows data normalised to 400 MU/Min.  
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The doubling of the dose rate decreased the EPID’s response by 0.2% to 0.5%. 
After fitting the data to equation 3.3, it was established that the EPIDs’ non 
linearity parameter   were within  0.006±0.002 at both 20 MU and 100 MU for all 
detectors.  Figures  4 6  (a)  and  (b)  show  typical  pixel  value  variation  with 
doserate, obtained for system II detectors. Using the normalised data (figure 4 
6(c)), the EPIDs sensitivity parameter K were 1.048 and 1.034 for EPIDs I and J 
respectively, independent of monitor unit used. System I EPIDs did not show any 
consistent doserate response.  
Ideally,  the  response  of  any  dosimeter  

 


Q
M   at  two  different  dose  rates 
1


 


dt
dQ and 
2


 


dt
dQ should  remain  constant  (Podgorsak  2005).  In  reality,  the 
doserate may influence the dosimeter readings and appropriate corrections may 
be  necessary  if  the  detector  is  to  be  used  for  absolute  measurements.  By 
increasing  the  doserates  from  100  MU/min  to  600  MU/min  the  sensitivity 
decreased  by  up  to  1.8%  for  the  system II  detectors.  This  is  due  to  the 
synchronisation of the linear accelerator pulses and several preset parameters 
(described in section 3.1) in the IDU 20/IAS3 systems. The EPID response as a 
function  of  dose  rate  should  be  accurately  determined  especially  in  dynamic 
treatments. Therefore, the use of a single dose rate calibration curve cannot 
yield completely accurate results. Although it is well known that during IMRT 
delivery  the  accelerator  doserate  may  vary  and  the  EPID  response  will  vary 
accordingly, in reality, there is very little variation in dose rate at 400 MU/min. 
Beam hold offs that relate to the mobility of the MLC leaves to keep up with the 
beam should not be seen. Other studies assessing doserate effects on EPID have 
yielded varying results, suggesting that the response is dependent on individual 
vendor, detector and model. The Varian system II EPIDs studied here show less 
doserate dependency than has been reported for the Elekta iView
GT (Winkler et 
al 2006). They reported changes in detector sensitivity of between 5% 11% in the 
doserate range 50 540 MU/min. The work done by Mohammadi and Bezak (2006) 
on the Varian SLIC EPID indicated that EPID response increased with increasing 
doserates, in the range 50 – 600 MU/min, in contrast to the results described in 
this  work  for  the  Varian  system II,  that  shows  a  decrease  in  response  with 
increasing  doserates.  Similar  to  the  Varian  system II  detector,  the  Siemens 
Perkin Elmer XRD EPID exhibited response variations of » 1% measured between 
50 MU/min and 300 MU/min doserates (Chen et al, 2006).  106 
 
4.1.7 Directional dependence 
Figures 4 7 (a) and (c) show typical pixel responses at different gantry angles 
and collimator angles of 0
0 and 90
0 for two system II EPIDs. Figures 4 7 (b) and 
(d) show their respective data normalised to those at gantry angle zero. The 
relative sensitivity normalised to gantry angle zero ranged between 0.99 – 1.01 
(within 2%). These departures from the values at gantry angle 0
0 are sufficiently 
small, that they may be considered insignificant. The insignificant variation in 
sensitivity with gantry angle shown in the two cases was exhibited by all system 
II detectors. The work done by Parent et al (2007) and Moore and Seibers (2005) 
reported on how the mechanical parameters relative to the gantry can affect 
the response of the Varian a Si EPID. The variations were associated with the 
mechanical  response  of  the  EPID  to  changes  in  the  accelerator  gantry  angle. 
Clarke et al (2008) used a similar approach to measure MLC defined field sizes at 
varying  gantry angles using  an a Si EPID. All these  studies indicated  that  the 
deviations  from  those  at  0
0  were  not  differentiable  from  the  short  term 
variations and may be considered insignificant. 
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Figure 4- 7. Figures (a) and (c) shows pixel responses at different gantry angles for EPIDs G 
and J respectively, while figures (b) and (d) show their data normalised to those at gantry 
angle zero. 
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4.1.8 Further image profile analysis and memory effects 
Figure  4 8  shows  typical  post  irradiation  effect  on  the  EPID  image  profiles 
indicating the memory effect of the EPID, which manifests itself as an increase 
in pixel value for the 20 x 20 cm
2 field size in the region of a previous 5 x 5 cm
2 
irradiation field. The percentage difference for each EPID was calculated as the 
signal enhancement at the centre (5 x 5 cm
2) within the 20 x 20 cm
2 field size 
compared to the signal for a 20 x 20 cm
2 taken after five minutes. Measurement 
of the EPID detector memory effect for system I ranged from 1.1% to 1.8% with a 
mean of 1.4% while system II ranged from 0.3% to 1.4% with a mean of 1.0%.  
 
Figure 4- 8. Central image profiles indicating post irradiation effect on the EPID. The image 
profile (continuous line)  was  acquired  within  12 seconds after 50  MU to  a  5x5 cm
2 field 
(dashed line) taken earlier. The profile in the inset is the difference between the image 
profiles. The double arrow shows the signal enhancement at the centre (5 x 5 cm
2) within 
the 20 x 20 cm
2 field size 
 
The EPID memory effect results were independent of the two acquisition 
systems and in agreement with previous studies performed on Varian EPIDs by 
Greer et al (2003) and Van Esch et al (2004). These studies indicated a residual 
increase in the central irradiated region of about 1%. Winkler et al (2005) used 
similar  settings  (doses,  energy,  field  sizes  and  time  interval)  on  the  Elekta  109 
iView
GT to those we used. They indicated a local modification of EPID response 
of up to 6% that may rise up to 16% with increase in photon energy. 
Figure 4 9 shows integrated image profiles for different EPID detectors 
obtained at various monitor units, constant doserate of 400 MU/min and 10x10 
cm
2  field  size.  The  images  were  analysed  by  obtaining  the  mean  of  the  two 
central pixel arrays in the Left Right direction of the detectors.  It should be 
noted that the profiles shown in this figure are related to the mean pixel value 
parameter reported by the EPID system in its un calibrated state, and are thus 
not directly related to the SMUR data in figure 4 3. The SMUR is dependent on 
both  mean  pixel  value  and  on  the  acquired  number  of  frames.  All  the  EPID 
profiles  showed  varying  dependencies  on  MU  accelerator  settings.  System I 
images  showed  wider variations  compared  to  system II  images.  These  varying 
image responses emphasise the necessity of individualised calibrations for each 
EPID if they are to be used for dosimetry purposes in agreement with previous 
studies (Winkler and George 2006). 
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Figure  4-  9.  Typical  integrated  image  profiles  for  different  EPID  detectors  obtained  at 
different MU, constant doserate of 400 MU/min and 10x10 cm
2 field size at isocentre. The 
images were analysed in their absolute sense without taking into consideration the averaged 
number of frames at each set MU. 
 
There are some differences in EPID response visible for the low MU fields for 
both  systems  in  figure  4 9.  The  root  cause  is  the  under  response  at  shorter 
irradiation times together with ghosting effects. Other possible causes are the 
nonlinearity of the electronics and sensitivity variations between different EPID 
panels and differences in accelerator outputs. 
 
 
Figure 4 10 illustrates profiles of images acquired by the two systems at 5 and 50 
MU. Figure 4 10(b) shows a 15 25% tilt in the T G direction cross plane profiles at  111 
5MU for system I which is absent at 50 MU for the same detectors (figure 4 10d) 
or completely absent for system II, as illustrated in figures 4 10(a) and 4 10(c). 
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Figure 4- 10. Cross profiles images of four EPIDs acquired at 5 and 50 MU in the transverse (L-
R) and radial (G-T) planes of the linear accelerator20x20 cm
2 field size at isocentre. System-
1 profiles (b and d) show dose (MU) dependence in the G-T direction 
 
The results indicate limitations of system I in terms of dose linearity. The 
systems  acquire  data  rows  sequentially  starting  from  the  gun  side  scanning 
towards the target direction. At lower MU, the pulsed nature of the radiation 
delivered  causes  significant  fluctuations  from  one  frame  to  another. 
Accelerators start off at lower doserate and for lower MU; the start side of the 
readout  frame  (gun  side)  will  read  less  dose  accounting  for  the  gradients  in 
figure 4 10. It is possible that the acquisition speed of system I and the exposure  112 
duration at lower MU enhance the effect. Figure 4 10 suggests that the older 
(system I)  EPIDs  may  not  be  suitable  for  step and shoot  IMRT  verification  (an 
important  application  of  portal  dosimetry)  that  frequently  contains  low  MU 
segments.  
The  inconsistencies  in  SMUR  (figure  4 3)  and  the  imager  effect 
demonstrated in figures 4 10 were investigated further by extracting data from 
the  “treatment  field  history”  file  of  the  Varis  system  for  about  2.7  million 
treatment  records  of  all  our  machines  since  2001,  when  the  first  EPID  was 
commissioned. The aim was to find out if there is any correlation between the 
EPID cumulative dose/age and its performance. From the database, the actual 
linear accelerator monitor units delivered for each treatment field when an EPID 
image  was  acquired  were  obtained,  from  which  the  cumulative  dose  to  the 
imagers  could  be  calculated.  Table  4 5  summarises  EPID  dose  related  data 
extracted  from  the  “treatment  field  history”  file  of  the  Varis  system.  As 
expected the Linac and imager doses increase proportionally to the period the 
accelerator has been in clinical use. The percentage of dose delivered with the 
imager out, ranged between 12.2 – 18.7% with mean 14.2%.  
 
Table 4- 5. Different EPIDs, their use period (months) and corresponding approximate dose 
(only corrected for inverse square law) from the Varis system database 
0.17 1.7 2.7  16.5 10 K
0.18 3.1 4.9  32.8 17 J
0.14 2.4 3.8  25.4 17 I
0.12 4.0 6.2  44.9 32 G
0.20 6.7 10.5  78.8 34 D
0.17 5.5 8.6  70.7 32 H
0.15 4.9 7.7  56.9 32 F
0.15 11.3 17.6  137.4 75 E
0.13 10.9 17  188.1 82 C
0.27 23.5 36.7  222.3 86 B
0.30 25.5 39.8  212.9 86 A
Imager 
Dose/ 
Month
Imager 
Dose (corr. 
ISL)
Imager 
Dose (KGy)
Linac Dose 
(KGy)
EPID use 
(Months)
EPID 
0.17 1.7 2.7  16.5 10 K
0.18 3.1 4.9  32.8 17 J
0.14 2.4 3.8  25.4 17 I
0.12 4.0 6.2  44.9 32 G
0.20 6.7 10.5  78.8 34 D
0.17 5.5 8.6  70.7 32 H
0.15 4.9 7.7  56.9 32 F
0.15 11.3 17.6  137.4 75 E
0.13 10.9 17  188.1 82 C
0.27 23.5 36.7  222.3 86 B
0.30 25.5 39.8  212.9 86 A
Imager 
Dose/ 
Month
Imager 
Dose (corr. 
ISL)
Imager 
Dose (KGy)
Linac Dose 
(KGy)
EPID use 
(Months)
EPID 
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System I EPIDs ageing due to radiation could be another factor causing 
degraded results. Hee et al (2002) reported that radiation damage affects the 
leakage current of photodiodes and the effect showed a linear dependence on 
absorbed dose. This may decrease the whole system performance, although it 
also depends on the aging effects of other components. However the results for 
the imager dose and imager dose per month were inconsistent with the EPID’s 
reproducibility and SMUR and no conclusion could be drawn. 
The overall results indicate the superiority of system II, due to its lower 
noise  readout  electronics,  higher  readout  rates  and  faster  data  acquisitions 
compared to system I. The differences in the system synchronisation between 
the  two  systems  may  also  contribute  to  the  observed  differences  in  the 
dosimetric characteristics and performance, especially for the lower MU. Greer 
(2007) studied the effects of the two Varian acquisition modes at different MU. 
This study indicated that the EPID image profiles were similar at higher monitor 
units and differences were noted in profiles acquired with less than 10 MU. 
 
4.1.9 Electronic portal imaging devices as a dosimeter 
A prerequisite for any clinical dosimetric application is a detailed understanding 
of the detector’s dose response behaviour. Figure 4 11 shows one of the system 
II  EPIDs  (J),  comparing  the  pixel  value  response  with  ionisation  chamber 
measurements at varying monitor units. Results in figure 4 11 (a) are presented 
on linear scale where the abscissa represents the accelerator MU. The left and 
right  ordinates  represent  the  EPID  pixel  and  ionisation  chamber  responses 
respectively.  Figure  4 11  (b)  shows  the  same  data  on  a  logarithmic  scale, 
including the relative response (ratio of Ionisation chamber signal to that of the 
EPID). The EPID and ionisation chamber responses are parallel to each other and 
the  relative  response  is  practically  constant  at  all  monitor  units,  which  re 
affirms that the EPID image signal, if calibrated correctly, can be matched to 
that  of  the  ionisation  chamber.  The  ionisation  chamber  is  the  gold  standard 
radiation detector for measurement of absorbed dose. 
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Figure 4- 11. Comparison of EPID response with ion chamber as a function of MU 
 
The intensity of a photon beam is reduced as the absorbing material thickness is 
increased. Figure 4 12 shows the reduction in photon intensity measured with 
the  EPID  and  ion  chamber  responses  when  solid  water  phantom  materials  of 
various thicknesses were placed between the source and the detectors (EPID and 
ion chamber). At each phantom thickness, both detectors were exposed at same 
radiation conditions. Both the EPID and ion chamber signals were acquired on 
the central axis, and the data for each detector normalised to those when there 
is no absorbing material (thickness = zero).  115 
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Figure 4- 12 EPID versus ion chamber response with solid water thickness 
 
Increasing  the  solid  water  thickness  both  attenuates  and  hardens  the  beam. 
Because  the  EPID  is  more  sensitive  to  lower  energy  photons,  its  response 
decreases  more  rapidly  than  the  ion  chamber  as  a  function  of  attenuator 
thickness. Another possible explanation for this effect could be that low energy 
scatter (secondary photons) is generated in the attenuating material, affecting 
the EPID response. 
 
4.2 Water equivalent path length measured with an EPID 
4.2.1 Variations of the fitting parameters A and B 
Figure 4 13 shows profiles extracted from the fitting parameter matrices A(i,j) 
and B(i,j) along the left right direction of the EPID. The results in figures 4 13(a) 
and (b) show the symmetrical variations of B(i,j) and A(i,j) with off axis distance 
for  two  6  MV  and  16  MV  beams  respectively.  The  figures  show  that  the  116 
parameters are almost the same (within 1%) for two accelerators at the same 6 
MV beam energy and decrease when the beam energy is increased to 16 MV. The 
B(i,j) parameter, which is theoretically the linear attenuation coefficient, has 
minimum values of 0.052±0.001 cm
 1 and 0.024±0.0005 cm
 1 for 6 MV and 16 MV 
beams respectively. These minima occur in the centre of the field, with values 
of B(i,j) gradually increasing with increasing distance from the centre up to a 
relative value of 1.2 and 1.3 of their minima for both energies respectively. On 
the other hand, the parameter A(i,j) has its maximum values of  3.0±0.2 x10
 4 
cm
 2 and  0.2±0.03  x10
 4 cm
 2 for 6 MV  and 16 MV beams respectively in  the 
centre  of  the  field,  gradually  decreasing  with  increasing  distance  from  the 
centre.  
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Figure 4- 13. Profiles extracted from the fitting parameter matrices A(i,j) and B(i,j) along the 
left-right direction of the EPID. Figures (a) and (b) show the symmetrical variations of B(i,j) 
and A(i,j) with off-axis distance for two 6 MV and 16 MV beams respectively. The X and Y (at 
each point, the Y value is either the A(i,j) or B(i,j) value) quoted in boxes are numerical  
values on the horizontal and vertical axes for each  point. Figures (c) and (d) show a 3D 
visualisation of the B(i,j) and A(i,j) fitting parameters respectively. 
 
The parameter B(i,j) is the linear exponent of the expression describing 
the  attenuation  of  the  photon  beam  as  it  traverses  material  upstream.  It 
increases as the distance from the centre of the EPID orthogonal to the beam 
central axis increases. The trend of parameter B(i,j) is caused by the flattening 
filter being cone shaped. The central part of the beam travels through more 
material and is more filtered than the edges of the beam. Therefore the average 
photon  energy  through  the  centre  is  higher.  The  results  indicates  that  B(i,j)  118 
decreases with increasing beam energy from 6 MV to 16 MV. This is because of 
the  attenuation  coefficient  components  due  to  photoelectric  and  Compton 
(dominant interaction processes at radiotherapy beam  energies) effects  being 
inversely  proportional  to  energy  (Khan  2003).  Monthly  repeat  of  imager 
recalibration over a four month period indicated that A(i,j) and B(j,j) could be 
reproduced to within 2%, in agreement with Kairn et al (2008). The value of the 
attenuation coefficient, B(i,j) in our case at the centre of the EPID is within ±3% 
compared to other studies (Allen 1999, McDonough et al 1999 and Vanetti de’ 
Palma  et  al  2005).  Backscatter  from  components  of  the  EPID  support  arm 
downstream from the detector have been found to influence the signal by up to 
5% (Greer et al 2007, Ko et al 2004). In the derivation of the fitting coefficients 
A(i,j) and B(i,j) (equation 3.4), the EPID signals M(i,j) obtained after imaging 
solid  water  phantoms  are  divided  by  the  image  signal  obtained  without  any 
material in the beam M0(i,j). Also in equation (3.12), the image signals M1(i,j) 
whose EPL are to be established are divided with M0(i,j) term. This pixel by pixel 
division should theoretically eliminate the support arm effect; Figure 4 13 shows 
that the calibration coefficient profiles in both directions are not distorted due 
to  the  support  arm;  hence  the  support arm backscatter  correction  is  not 
required when using the quadratic calibration technique for EPID dosimetry.  
 
 
4.2.2 The phantom scatter and field size correction factors 
As  discussed  in  section  3.2.3  above,  scatter  and  field  size  corrections  are 
required  for  the  EPID  to  predict  thickness  at  any  other  field  other  than  the 
reference field.  Figure 4 14 shows the variation of correction factor CF with 
field size and thickness, measured with an EPID for a 6 MV beam. For any field 
other  than  the  reference  field  size,  CF  increases  with  increasing  phantom 
thickness. This study is limited to field size of 21.5x21.5 cm
2, as the maximum 
that can be imaged with EPID imager positioned 40.0 cm below the isocentre, 
without irradiating the electronic components of the IDU. 
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Figure 4- 14. Correction factor variations as a function of field size for phantom thicknesses 
5cm, 10cm, 15cm, 20cm, and 32 cm for 6 MV beam 
 
 
4.2.3   Monitor unit effects 
Figures 4.15 (a), (c) and (e) show the variation of applied MU with system II EPID 
response (linearity) for square field sizes of 5, 10 and 20 cm, measured at 400 
MU/min dose rate and thicknesses of 10, 20 and 32 cm respectively. The results 
indicate  the  generally  expected  trend,  where  at  any  particular thickness  the 
response  increased  with  increasing  field  size,  and  decreased  with  increasing 
phantom  thicknesses.  Figures  4.15  (b),  (d)  and  (f)  show  SMUR  variations 
computed for the same data used in figures 4.15 (a), (c) and (e) respectively 
that exposes significantly reduced values at lower MU.  Figures 4.15 (g) and (h) 
show a repeat of linearity and SMUR but measured at a reduced dose rate of 100 
MU/min  for  solid  water  thickness  of  20  cm.  The  linearity  response  at  100 
MU/min as expected remained unchanged because the total delivered doses are 
independent of doserates, but the SMUR significantly increased for lower MU by 
about 3% and remained practically the same at higher MU.  
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Figure 4- 15. Figures (a), (c) and (e) show system-II linearity for thicknesses 10 cm, 20 cm 
and  32  cm  measured  at  400  MU/min  respectively,  while  figures  (b),  (d)  and  (f)  are  their 
corresponding  SMUR.    Figures  (g)  and  (h)  show  linearity  and  SMUR  respectively  for 
thickness 20 cm measured at 100 MU/min. 
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The accurate determination of EPL is essential in the prediction of dose by EPID. 
For the EPID to predict dose effectively, it is desirable for the EPL to be precise 
and independent of delivered number of monitor units. Ideally the response of 
any  radiation  detector  should  be  proportional  to  MU  for  both  open  and  MLC 
blocked  beams  (Podgorsak  2005).  The  concept  of  linear  relationship  suggests 
that  two  quantities  are  directly  proportional to  each  other for  all situations, 
such that the ratios between corresponding entities are practically the same. 
However analysis of the SMUR for the same data used for the linear relationship 
results, revealed lower values at MU below 50, in agreement with McDermott, et 
al (2006). This implies that at lower MUs, the EPID response and MU variations 
are  not  perfectly  proportional.  These  results  can  be  correlated  with  that  in 
figure  4 9,  explained by  under  response  at  shorter  irradiation  times  together 
with ghosting effects. The SMUR at a lower dose rate (100 MU/min) was found to 
be more consistent than that at 400 MU/min, indicating that the effect may be 
due to dead time within the imager system. Dead time in frame acquisition can 
result in reasonable loss of signal (Greer et al 2003). The imager has start delay 
which is fixed and will cause a greater dead time effect at low exposures. Under 
practical consideration the SMUR measured at 400 MU/min dose rate was only 
dependent on MU but not field size and phantom thickness. Hence a single look 
up table depending on image MU was included in the EPL determination.  
 
4.2.4 Measured and calculated Percentage Exit Thickness Dose 
(PETD) 
Figure 4.16 shows a comparison of the measured and calculated (equation 3.13) 
PETD for square field sizes of 5, 10 and 20 cm and depths of 10, 15, 20 and 32 
cm.  As  expected  PETD  decreases  with  increasing  depth  and  decreasing  field 
sizes.  The  results  indicate  that  the  differences  between  the  measured  and 
calculated are within 2%. 
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Figure 4- 16. Comparison of measured (meas) and calculated (cal) PETD at selected field 
sizes (FS) and depths.  
 
 
4.2.5 Verification of calculation of the equivalent path length 
4.2.5.1  Equivalent path length for solid water phantoms 
Table 4 6 shows EPL convergence for selected thicknesses and field sizes after 
20 iterations. The first item in each column is the initial solution obtained by 
solving equation 3.8.  The values in the tables are the mean pixel value in a 1.0 
cm
2 region of interest at the center of image, stored after each iteration. Using 
equation 3.13, the expected EPL for solid water thicknesses of 10 cm, 20 cm and 
32 cm are 9.9 cm, 19.8 cm and 31.7 cm respectively. The results show that 
convergence to within ± 2mm of the final 20 iteration value was obtained after 
three – four iterations; hence the algorithm was set to repeat itself five times.  123 
Previous authors (Fielding et al 2002 and Kairn et al 2008) reported convergence 
in thicknesses after three – five iterations. 
Table 4- 6.  EPL convergence for selected thicknesses (Th) and field sizes (FS) 
 
 
Figure  4 17  shows  the  EPL  profiles  calculated  from  EPID  images  for  selected 
thicknesses of solid water phantoms. The images were acquired at same 100 MU 
at various field sizes. The profiles in figure 4 17 (a d), extracted in both the X 
direction  (solid  lines)  and  Y direction  (doted  lines),  were  acquired  with  solid 
water of thicknesses 5.0, 10.0, 20.0 and 32.0 cm; and field sizes of 10x10 cm
2, 
15x15 cm
2, 20x20 cm
2 and 15x15 cm
2 respectively. From equation 3.13, the EPL 
for these thicknesses would be 4.95, 9.90, 19.80 and 31.68 cm respectively. The 
results  in  this  figure  indicate  that  EPID measured  EPL  agrees  with  that 
calculated  using  the  known  physical  thickness  and  electron  density  (equation 
3.13) to within +/  2mm. Monthly repeat of imager recalibration and subsequent 
EPL recalculation over a four month period indicated that for a homogeneous 
solid water phantom, EPL could be reproduced to within +/  2mm (80% of the 
central field). Towards the field edges, the EPL tends to increase due to the 
beam penumbra. The sharp increase in EPL at the field edges, results in the 
expected decrease in exit dose in these regions.   124 
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Figure 4- 17. EPL profiles from EPID images for selected solid water phantom thicknesses 
and acquired at different field sizes. The X and Y (at each point, the Y value is the EPL) 
quoted in the boxes are numerical values at the centre on the horizontal and vertical axes 
for each point. 
 
4.2.5.2  Equivalent path length for solid water phantoms with varying monitor 
units 
Figure  4 18  demonstrates  the  EPL  for  different  thicknesses  of  solid  water 
calculated before and after MU corrections, at different field sizes. The results 
show that at 20 MU, variations in EPL of up to 12 mm can occur between the 
corrected and uncorrected values.   125 
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Figure  4-  18.  Pre-MU  (UnCorr)  and  post-MU  (Corr)  EPL  (calculated  before  and  after  MU 
correction respectively) for 10 cm, 20 cm and 32 cm solid water; and field sizes of (a) 5x5 
cm
2, (b) 10x10 cm
2 and (c) 20x20 cm
2.  
 
Comparison of the pre MU and post MU EPL (EPL calculated before and after MU 
correction  respectively)  in  figure  4 18,  revealed  that  the  latter  gave  better 
conformity with the expected EPL and were independent of both MU and field 
size. A deviation in EPL of »10 mm may result in an uncertainty in PETD of » 3 
5% depending on field size, and hence a discrepancy » 3–5% in the exit dose. 
 
4.2.5.3  Equivalent path length for solid water and non water phantoms  
Figure 4 19 shows profiles from the calculated EPL of various materials of known 
thicknesses and relative electron densities for which EPID images were acquired, 
as described in figures 3 5 (a) and (b), section 3.2.4.1.  
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Figure 4- 19. Profiles extracted from centre of EPL maps for (a) slabs of solid water, bone 
and lung materials positioned in steps, as illustrated in figure 3-5 a. (b) cylindrical lung, solid 
water  and  cortical  bone  materials  inserted  between  two  5cm  slabs  of  solid  water  as 
illustrated in figure 3-5 b. The X and Y (at each point, the Y value is the EPL) quoted in 
boxes are the EPID measured values on the horizontal and vertical axes for each point, while 
P1, P2, P3 and P4 are corresponding calculated values.  
 
Table  4 6  summarises  the  results  from  figure  4 19  obtained  after  the  EPID 
calibration in comparison to the calculated EPL using equation 3.17. From these 
results, the calculated and the measured EPL are within ± 3 mm, equivalent to 
2% or less in all cases. 
 
Table 4- 7. Summary of the EPL results from figure 4-19 comparing calculated (equation 
3.13) and those measured from EPID images 
9.9 0.99 10 Solid water
10.2 10.3
9.9 0.99 10 Solid water
0.35 0.05 7 Styrofoam
P3
21.2 21.5
11.62 1.66 7 Cortical bone
P4
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14.0 13.8
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Calculated and measured EPL are within ± 3 mm for all phantom materials 
and thicknesses. The uncertainty is comparable to Kairn et al’s (2008) Monte 
Carlo simulated results, where they validated radiological thicknesses measured 
with an EPID. The accurate determination of EPL is crucial in the prediction of 
dose by EPID.  An increase or decrease in EPL by ~ 1 cm results in a decrease or 
increase in PETD of ~ 3% and ~5% for field sizes 20cm
2 and 5cm
2 respectively in 
the thickness range 10 32 cm. Hence such variations in EPL may result in ~ 3 5% 
discrepancy in the exit dose (Kavuma et al, 2010).  
 
4.3 Dose comparison 
4.3.1  Exit and entrance dose comparison for open fields 
Figure 4 20 shows dose profiles for the homogeneous phantom extracted from 
the centre of the TPS calculated  dose and EPID measured  dose distributions, 
demonstrating  the  effect  of  PETD,  envelope  and  boundary  corrections.  The 
figure shows a comparison of TPS’s and EPIDs, entrance (figure 4 20 (a)) and exit 
(figure 4 20 (b)) dose profiles for a 20x20 cm
2 field, after a 20cm thick solid 
water  phantom  is  irradiated  with  200  MU  of  a  6  MV  photon  beam.  The 
uncorrected EPID profiles indicate that the dose at the centre of the field is 
predicted to within 1%, but remains flat in the entire irradiated region. This is 
expected experimentally because the EPL for the homogeneous phantom is also 
flat, but does not reflect the actual dosimetric situations as shown by the TPS 
profile.  
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(a) (b)
 
Figure 4- 20. Dose profiles at the centre of the EPID images and TPS demonstrating the effect 
of flood field before and after correction for a 20x20 cm
2 field, to a 20cm thickness solid 
water material with 200 MU and 6 MV beam. Figure (a) compares TPS and EPID entrance dose 
profiles and figure (b) shows TPS and EPID exit dose profiles. 
 
Figures 4 20 (a) and (b) indicate that the EPID predicts a higher dose outside the 
treatment  field  compared  to  the  TPS.  This  is  consistent  with  previous 
investigations, though the effect is more significant for the entrance than for 
the exit doses. Vieira et al (2003) indicated that EPID dose deviations of up to 
10% can occur in penumbra regions. For smaller fields, the EPID doses in the 
penumbra  regions  were  still  higher  but  the  differences  were  within  3%.  The 
penumbra  dose  difference  for  large field  (20x20  cm
2)  irradiations  could  have 
been  increased  because  of  the  field  size  nearing  the  reference  field  size  of 
21.5x21.5 cm
2. One of the limitation of the method is that it cannot predict dose 
beyond the reference field size, because the fitting parameters A(i,j), B(i,j) and 
the  open  fields  are  not  modelled  in  these  areas.  This  possibly  explains  the 
observed spikes and unexpected discontinuities at the field edges of figure 4 20 
for  the  EPID  predicted  dose.  Another  possibility  could  be  that  the  a Si  EPID 
detectors  are  known  for  their  over  response  to  low  energy  x rays  which  are 
common at field edges and penumbra regions (Vial et al 2008, McCurdy et al 
2001). On the other hand, the method we used for the scatter and field size 
correction  may  also  have  an  influence  on  the  results.  The  CF  correction  is 
measured on the central axis and applied everywhere in the EPID.  This would 
miscalculate the dose received by the EPID at the edge of a phantom where 
there is less scatter.   129 
 
Table 4.7 shows a summary of the point dose percentage differences between 
the TPS dose (DTPS) and EPID predicted dose (DEPID) calculated at the centres of 
the homogeneous phantom for a range of field sizes (FS) and thicknesses (T) at 6 
MV. The differences between TPS and EPID, at the exit appear to be increasing 
with field size. For small field size, the EPID predicted a higher dose compared 
to the TPS for all thicknesses while the trend is reversed at large field sizes. This 
is  in  contrast  to  the  entrance  dose  differences,  which  appear  to  be 
unsystematic, except for the 5x5 cm
2.  
 
Table 4- 8. Percentage differences at exit and entrance central points between TPS and EPID 
for different field sizes and solid-water thickness (T) for 6 MV beam 
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The in vivo determination of entrance and exit doses are useful in clinical QA 
programs because the former aim to check the accuracy of MU calculations and 
delivery, while the latter serve in addition to check the influence of the patient 
(presence of inhomogeneities) on the dose calculation. Comparison of central 
axis point doses in table 4 7, at the exit and entrance showed that the TPS and 
EPID predicted values agreed to  within 3%. These results show  that the EPID 
doses were generally higher and lower than those of TPS at square field sizes of 
5 cm and lower than those of TPS at square field sizes of 20  cm.  This was 
related  to  a  noticeable  trend  that  the  EPID’s  predicted  EPL  at  5x5cm
2  and 
20x20cm
2 were respectively lower and higher than expected values by ~ 1 2mm. 
This could possibly be due to a weakness in a field size dependent correction in 
our method.  
 
A  further  comparison  of  the  EPID calculated  and  TPS  dose  distributions  was 
carried  out  using  a  gamma  analysis.  Two  dimensional  measurements  in  130 
homogeneous  phantoms  show  that  the  in vivo  dose  at  the  exit  and  entrance 
could  be  predicted  to  within  3%  dose  difference  (DD)  and  3  mm  distance  to 
agreement  (DTA)  criteria.  The  results  of  our  in  vivo  exit  dose  prediction  are 
consistent with previous investigation (Zijtveld et al 2009, McDermott et al 2007, 
Nijsten et al 2007). The failed area (gamma index > 1) for square fields of 5, 10, 
15 and 20 cm was about 3.1 % (average) of all the points in the irradiated regions 
and for all thicknesses. In 90 % of the irradiated field, a gamma map comparison  
between the measured and calculated dose maps showed failed area < 1.5%. The 
proportion of points within tolerance was higher for exit dose than for entrance 
dose. In conventional in vivo dosimetry where direct entrance dose are taken, 
the reverse might be expected, however because the algorithm uses the exit 
doses  to  predict  the  entrance  doses,  then  any  systematic  errors  in  the 
calculation of the former will manifest in the latter. Hence this supports the 
notion that the use of exit doses is better than using entrance doses. 
 
Figure 4 21 compares the effect of data points resampling on the results. Figure 
4 21 (a) is the original (53x65) dose map and figure 4 21 (b) shows the same 
central  dose  map  covering  an  area  of  26x26  cm
2  resampled  to  356x356  data 
points.  Figure  4 21  (c)  shows  cross plane  profiles  through  both  dose  maps, 
indicating  that  the  magnitude  of  the  values  are  insignificantly  affected  by 
resampling the data.  
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Figure 4- 21: Effect of resampling the MapCHECK data points 
 
 
Figure 4 22 compares the exit dose, as illustrated in section 3.2.8 (figure 3 11), 
between the MapCHECK device measurement and EPID image acquired at the 
same time.  The  results  in  this  figure  shows  MapCHECK  (a),  TPS  (b)  and  EPID 
image (c) dose distributions, acquired with 20x20 cm
2 field size and 100 MU. The 
percentage of area in figure (4 22) where the gamma index (3% DD and 3mm 
DTA) failed were 2.5, 3.2 and 2.8 for the TPS vs MapCHECK, EPID vs MapCHECK 
and TPS vs EPID respectively. 
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Figure  4-  22:  Figures  (a),  (b)  and  (c)  compare  2D  absolute  exit  dose  (cGy)  distributions 
measured  with  MapCHECK  device,  calculated  with  TPS  and  those  from  EPID  images 
respectively, for a 20x20 cm
2 field size and 100 MU. 
 
Figures 4 23 and 4 24 show exit dose comparisons for the step and cylindrical 
phantom cases respectively as described in section 3.2.4.1. Figures 4 23 (a & c) 
and 4 24 (a & c) are TPS predicted dose while figures 4 23 (b & d) and 4 24 (b & 
d) are their respective EPID calculated dose. Figures 4 23 (e) and 4 24 (e) are 
horizontal EPID (dotted lines) and TPS (dashed lines) dose profiles, and EPL (solid 
lines) profiles computed from their respective EPID images. Figures 4 23 (f) and 
4 24  (f)  are  their  respective  gamma  evaluation  between  the  TPS  and  EPID 
predicted, calculated at 3% and 3mm DTA tolerance criteria.  
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Figure 4- 23. Exit dose comparison for case in figure 3.5(a) as described in section 3.2.1.1 
Figures (a) and (c) are 2D TPS predicted colour maps and contour distributions, while (b) and 
(d) are their  respective  EPID calculated  doses. Figure  (e)  shows  horizontal  EPL  and dose 
profiles through the centre of their respective EPID images. Figure (f) is the corresponding 
gamma distributions between the TPS and EPID.    
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Figure  4-  24.  Exit  dose  comparison  for  the  case  in  figure  3.5(b)  as  described  in  section 
3.2.4.1 Figures (a) and (c) are 2D TPS predicted colour maps and contour distributions, while 
(b) and (d) are their respective EPID calculated doses. Figure (e) shows horizontal EPL and 
dose  profiles  through  the  centre  of  their  respective  EPID  images.    Figure  (f)  is  the 
corresponding gamma distributions between the TPS and EPID.    
  
The comparison of dose (right ordinate) and EPL profiles (left ordinate) in figures 
4 23 (e) and 4 24 (e) clearly depicts the inverse relationship between the two. 
Both  these  figures  show  discrepancies  between  the  TPS  and  EPID  in  regions  135 
where there is a steep increase or decrease in dose due to a respectively steep 
decrease or increase in EPL. Gamma index failures are correspondingly seen in 
those areas as indicated in figures 4 23(f) and 4 24(f). 
 
 
Figure 4 25 shows exit dose comparisons for the anthropomorphic lower torso 
phantom  as  described  in  figure  3 6.  Figure  4 25(f)  is  the  EPID  image  of  this 
phantom obtained with 20x20 cm
2 field size and 200 MU.  Figures 4 25 (a) and 
(b)  are  TPS  predicted  and  EPID  calculated  dose  distributions.  Figure  4 25  (c) 
shows horizontal dose profiles from the TPS (dashed lines), EPID (dotted lines) 
and EPL (solid lines)  profiles computed from the EPID image. Figure 4 25 (d) 
shows the gamma evaluation between the TPS and EPID predicted, calculated at 
3% and 3mm DTA tolerance criteria. Figure 4 25 (e) shows the dose difference 
(DEPID DTPS) map. 
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Figure 4- 25. Exit dose comparison for the case in figures 3-6 as described in section 3.2.4.4. 
Figures (a) and (b) are the 2D TPS predicted and EPID calculated dose contours respectively. 
Figure (c) shows horizontal TPS dose (dashed) and EPID dose (dotted line) and EPL profiles 
through the centre of the EPID image. Figure (d) is the corresponding gamma distributions 
between the TPS and EPID. Figure (e) is a 2D dose difference map. Figure (f) is the EPID 
image of the irradiated 20x20 cm
2 field area of the phantom. 
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Figure 4 26 shows exit dose comparisons for the same anthropomorphic lower 
torso phantom as described in figure 4 24 above, but for a 10x10 cm
2 field size. 
Figures  4 26  (a)  and  (b)  are  EPID  predicted  and  TPS  calculated  dose 
distributions. Figure 4 26 (c) shows the dose difference (DEPID DTPS) map. Figure 
4 26 (d) is the EPID image of this phantom obtained with 200 MU. 
 
Figure 4- 26. Exit dose comparison for the case in figure 3-6, for 10x10 cm
2. Figures (a) and 
(b) are the 2D EPID predicted and TPS calculated dose contours respectively.   Figure (c) is a 
2D dose difference contour distribution. Figure (d) is the EPID image of the irradiated 10x10 
cm
2 field area of the phantom. 
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Similar to results in figures 4 20 (a) and (b), figure 4 25 (c) indicates that the 
EPID predicts a higher dose outside the treatment field compared to the TPS. 
The  air  in  the  hollow  cavity  representing  sigmoid  colon  and  rectum  of  the 
anthropomorphic phantom (figures 3 7 and 4 24(f)) results in an increased dose 
along its path and both the TPS (figures 4 25 (a)) and EPID (figures 4 25 (b)) 
demonstrate this effect. The gamma index map in figure 4 25 (d) shows failures 
in the transverse descending and descending sigmoid colon junctions. The EPID 
predicted a higher dose than the TPS in the failed areas as demonstrated by the 
dose difference map (figure 4 25 (e)). A similar trend, i.e discrepancies in dose 
distribution is observed in figure 4 26, for a smaller field size. This variation is 
most likely due to increased air spaces in this colon like structure. As much as 
our  EPID  dosimetry  algorithm  takes  into  account  inhomogeneities  at  the 
conversion to EPL, it does not take into account the effects caused by irregular 
and sharp edged surfaces on dose. This could be the main cause of discrepancies 
in some areas observed in figures 4 25 and 4 26.  The case scenarios in this study 
may not be identical to those encountered clinically, but they do indicate that in 
some  patient  anatomies  potential  dose  discrepancies  may  occur.  This  is 
supported  by  the  findings  of  Mcdermott  et  al  (2007)  who  indicated  that  gas 
pockets in the rectum may increase the failure percentage when comparing the 
planned and the EPID generated dose of prostate treatments. 
 
4.3.2 Irregular fields 
As  mentioned  in  section  3.2.7  above,  the  irradiated  field  area  and  resulting 
phantom scatter are essential for predicting the EPL from an EPID image and 
hence dose. Table 4 8 shows a summary of the areas calculated from the EPID 
images for the test cases of figure 3 7, compared to their respective expected 
areas.  The  percentage  dose  differences  were  calculated  as  
% 100
_
_ _
x
Area Expected
Area Calculated Area Expected
 


 
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The deviations between EPID predicted and the geometrically expected areas for 
all images used in the study including squares and wedged fields were within 
±1%.  139 
Table 4- 9. Comparison of expected and EPID calculated areas for square fields and cases 
described in figure 3.7 
-0.6 51.8 51.5 Case f
1.0 249.5 252.0 Case e
0.6 245.4 247.0 Case d
-0.5 323.6 322.0 Case c
0.7 135.1 136.0 Case b
-0.1 319.2 318.8 Case a
-0.3 433.5 432.0 21.6x20 (60o EDW)
-0.4 401.7 400.0 20x20 sq
0.5 99.5 100.0 10x10 sq
Deference (%) Calculated Area Expected Area Case
-0.6 51.8 51.5 Case f
1.0 249.5 252.0 Case e
0.6 245.4 247.0 Case d
-0.5 323.6 322.0 Case c
0.7 135.1 136.0 Case b
-0.1 319.2 318.8 Case a
-0.3 433.5 432.0 21.6x20 (60o EDW)
-0.4 401.7 400.0 20x20 sq
0.5 99.5 100.0 10x10 sq
Deference (%) Calculated Area Expected Area Case
 
 
The irradiated field areas can be accurately determined from the EPID image to 
within  ±  1%  uncertainty  in  all  cases.    Scattered  radiation  in  portal  images 
depends on beam energy, phantom/ patient thickness and field area (Swindell et 
al 1995, Mayles et al 2007, Kairn et al 2008). Accurate determination of field 
area, which is one of the paramount factors required in the establishment of 
phantom  /  patient  scatter  correction  and  hence  EPL  and  dose,  is  essential. 
Because there are no simple means to determine the equivalent square for an 
irregularly  shaped  field,  the  most  commonly  used  technique  to  predict  the 
scatter / output factor correction is the sector integration method (Sanz et al 
2001,  Podgorsak  2005),  where  the  irregular  field  is  resolved  into  sectors  of 
circular beams originating at the point of interest in the phantom or patient. In 
the proposed method, the EPID image pixel resolution is less than 1.0 mm, hence 
the irradiated areas can be calculated to a high degree of accuracy. However, 
the sector integration method has an additional advantage that it accounts for 
the distances to the point of interest whereas the area calculation method used 
in this study does not. The use of area alone for scatter correction could be 
another source for the discrepancies in our results. 
 
The EPL beneath the MLC shielded regions is too high compared to the maximum 
depths for TPR table which was measured up to a depth of 40 cm. Figure 4 27  140 
shows the EPL profile calculated from EPID image of figure 3 8 (d) (MLC aperture 
3 7 (d)). The figure shows that the EPL in the open beam is » 20 cm and rises to 
over 100 cm in the shielded regions. With MLC height (physical thickness) of » 
6.5 cm and electron density of Tungsten » 19.3 g/cc, then according to equation 
3.17, the EPL in the shielded region should be much higher than 100 cm.  This 
indicates that the EPL equation is not accurate at such large values, due to the 
A(i,j) and B(i,j) fitting parameters being optimized for the range 0 – 35 cm. In 
addition, it will be inappropriate to use A(i,j) and B(i,j) due to spectral changes 
and  scattering  caused  by  the  MLC.  Another  factor  is  the  difference  in  pair 
production probability between tungsten and water. 
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Figure 4- 27. EPL profile (along the Y direction) calculated from the EPID image of figure 3.8 
(d) 
 
To facilitate calculation of doses in these regions, the TPR was set to the MLC 
transmission factor.  013 . 0
_ _ _
_ _ _
_ = =
Signal EPID Field Open
Signal EPID Closed MLC
on Transimisi MLC  
The value of the MLC transmission factor measured with the EPID agrees with 
that  of  Lorentz  et  al  2007.  They  indicated  that  the  MLC  transmission  varies  141 
across the irradiated field ranging between 0.016 at the central axis to 0.012 
towards the field edges. 
 
Figure 4 28 shows the EPID and TPS exit dose comparison for the case of figure 
3 7 (a). Figures 4 28 (a) and (b) show the TPS and EPID dose distribution where 
the EPID doses in the shielded regions are calculated as described in previous 
sections. The gamma index (figure 4 28 c) computed from figures 4 28 (a) and 
(b) at 3% DD and 3mm DTA criterion, indicates that 5.8% of the points failed. 
This gamma map shows that most of the discrepancies between the EPID and TPS 
doses are in the shielded regions. Figures 4 28 (d) and (e) and corresponding 
gamma index (f) show the same case, but the doses in the shielded regions have 
been  zeroed.  This  was  achieved  by:  first  a  matrix  is  created  from  the  edge 
polygon, (say figure 3 10 (a) for this case) whereby all the enclosed pixels are 
filled  with  “ones”  and  “zeros”  elsewhere.  Secondly,  the  created  matrix  is 
multiplied (element by element) with the exit dose matrices. This automatically 
zeroes the doses outside the irradiated fields and the gamma index map (figure 
4 28 f) shows a decrease in number of points failing the criterion.  
 
 
Figure 4- 28. Comparison of TPS (a) and EPID (b) exit doses for case of figure 3-7(a), where 
the doses in shielded areas are compared. Figures (a) and (d) are the same TPS doses but 
the dose data in shielded areas have been zeroed. Similarly, figures (b) and (e) are the same 
EPID doses but the dose data in shielded areas have been zeroed. Figures (c) and (f) are the 
corresponding gamma index maps.   142 
 
Figures 4 29 (a) and (b) show the absolute 2D EPID predicted and TPS exit 
dose distributions respectively, for the cases of figures 3 7 (c). For the MLC 
shaped field in this figure, the difference between the EPID and TPS doses within 
the in field region was very small. Hence, the percentage of areas in this test 
case where the gamma index (figures 4 29 (c)) evaluated at 3% DD and 3mm DTA 
criterion, was greater than 1.0, was 4.5%. This is well illustrated in a histogram 
figure 4 29(d) showing the actual gamma indices distribution computed from the 
2D gamma index maps of figures 4 29. About 50% of the total points in this figure 
have  gamma  value  less  than  0.3,  with  maximum  gamma  index  of  9.9.  The 
observed errors at the edges of the MLC might be partially corrected in the same 
way  that  the  Varian  Eclipse  8.6  TPS  corrects  their  MLC  delivery,  by  slight 
adjustment of the field edges when defined by MLC (Vial et al, 2006). This leaf 
offset is about 1.5 2.0 mm (Varian MLC). The effect this leaf offset might cause 
on the field edge dosimetry, need to be investigated.  
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Figure 4- 29: Figures (a) and (b) show EPID and TPS 2D absolute exit dose distributions for 
the irregular shaped apertures in figure 3.7 (c).  Figure (c) demonstrates the gamma index 
map. Figure (d) is a histogram showing the gamma index values, computed from gamma 
map of figure (c). 
 
 
Figure 4 30 compares the absolute 2D dose distributions at the exit for the MLC 
shaped field in figure 3.7 (d) measured by MapCHECK (a), TPS predicted (b) and 
that calculated from EPID image (c). The percentage of areas where the gamma 
index (figures (d), (e) and (f)) evaluated at 3% DD and 3mm DTA criterion, was 
greater  than  1.0,  were  3.2%,  8.2%  and  7.6%  for  TPS  vs  MapCHECK,  EPID  vs 
MapCHECK and TPS vs EPID respectively.  144 
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Figure  4-  30:Figures  (a),  (b)  and  (c)  show  2D  absolute  exit  dose  (cGy)  distributions 
measured  with  MapCHECK  device,  calculated  with  TPS  and  those  from  EPID  images 
respectively  for  the  irregular  shaped  field  in  figure  3.7  (d).    Figures  (d),  (e)  and  (f) 
demonstrate the respective 2D gamma maps, evaluated at 3% DD and 3 mm DTA. 
 
In figures 4 30, the dose differences between the EPID, MapCHECK and TPS at 
the  centre,  where  the  left  and  right  MLC  banks  intersect,  is  much  higher, 
resulting  in  higher  gamma  values  as  shown  in  figure  4 30  (d f).  Most  of  the 
discrepancies are at the MLC defined edges as illustrated in the 2D dose and 
gamma index distributions of figure 4 30 (d f). More than 90% the points in the 
test cases for figure 3.7 (c) and (d) passed the gamma index evaluated at 3% DD 
and 3mm DTA criterion.  
 
Figures 4 31 (a) and (b) show the absolute 2D EPID predicted and TPS calculated 
exit  dose  distributions  respectively  for  the  case  of  figure  3 7  (e).  The  doses 
under the MLC shielded areas have been zeroed in this figure. Figures 4 31 (c) 
and (d) compare dose profiles extracted from the dose distribution in the X and 
Y directions respectively. The matching between these profiles in the irradiated 
field  was  within  1%,  indicating  little  or  no  systematic  error.  Figure  4 31  (e) 
shows a 2D percentage dose difference map between the EPID and TPS predicted  145 
doses,  which  demonstrates  that  most  of  the  discrepancy  is  towards  the  field 
edges, also indicated by the gamma index map, figure 4 31 (f). The differences 
between EIPD and TPS towards the radiation field edge are high, ranging from  
30% to 35%.  
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Figure 4- 31: Comparison of EPID and TPS for case of figure 3-7(e) 
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Figure 4- 32. Comparison of EPID and TPS for the cases of figure 3-7 (b) and (f) 
 
Figures 4 32 (a) and (b) compare 2D exit doses in colour wash predicted from 
EPID images and TPS respectively for the case in figure 3 7 (b).  Figures 4 32 (c) 
and (d) show the same data as dose contours. Figures 4 32 (e) and (f) compare  147 
2D exit doses in colour wash predicted from EPID images and TPS respectively 
for the case in figure 3 7 (f).  Figures 4 32 (g) and (h) show the same data as 
dose contours. Similar to previous cases, the dose matching between the two is 
excellent.  
The doses in the centres of the irradiated fields for all the irregular cases are 
proportional  to  the  areas  indicated  in  table  4 8.  In  other  words,  the  MLC 
shielding  of  certain  areas  within  a  radiation  field  not  only  reduces  the  dose 
behind the MLC shield, but also reduces the doses in the unshielded areas, in 
agreement with Boesecke et al (1985). Both the EPID and TPS doses convey this 
clearly. 
 
Figure 4 33 shows the exit dose comparison for the anthropomorphic phantom 
case in figure 3 6 as described in section 3.2.4.4, irradiated with an irregular 
field illustrated in figure 3 7 (c), to a dose of 200 MU. Figures 4 33 (a) and (b) 
are the 2D EPID predicted and TPS calculated dose contours respectively. Figure 
(c) shows the corresponding gamma index map and 91.7% of points passed the 3% 
DD and 3mm DTA criteria. Figure (d) is the acquired EPID image from which the 
dose  distribution  in  figure  (a)  was  calculated.  The  air  in  the  hollow  cavity 
representing sigmoid colon and rectum of the anthropomorphic phantom results 
in an increased dose along its path, as demonstrated by both the EPID and TPS 
(figures 4 33 (a) and (b) respectively) dose distributions. 
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Figure 4- 33.  Exit dose comparison for the anthropomorphic phantom case in figure 3-7 as 
described in section 3.2.4.4, irradiated with an irregular field illustrated in figure 3-7 (c). 
Figures (a) and (b) are the 2D EPID predicted and TPS calculated dose contours respectively. 
Figure (c) shows the corresponding gamma index (3% DD and 3mm DTA) map between the 
TPS and EPID.  Figure (d) is  the  acquired  EPID  image from  which  the dose  distribution  in 
figure (a) was calculated.  
 
Within  the  shielded  regions  and  at  the  field  edges,  the  percentage 
differences between the calibrated EPID and TPS calculated doses were much 
greater than in the in field regions. Observed percent differences ranged from 
−15% to as much as 35%. This was partially due to the low EPID signal level in 
these regions compared to TPS. However, the differences in these regions were 
still small in an absolute sense. Similar to the previous example for the square 
field, the air in the hollow cavity representing sigmoid colon and rectum of the 
anthropomorphic  phantom  results  in  an  increased  dose  along  its  path,  as 
demonstrated by both the EPID and TPS (figures 4 33 (a) and (b) respectively) 
dose distributions. The error at the edges of the MLC profile might be at least  149 
partially  corrected  the  way  that  the  Varian  Eclipse  planning  system  corrects 
their MLC delivery for the rounded leaf edge, by a slight adjustment of the field 
edge when defined by the MLC. This leaf offset is usually around 1.5 2.0 mm for 
the Varian MLC. The effect, this leaf offset might cause on field edge dosimetry, 
need to be investigated.  
 
4.3.3 Enhanced dynamic fields  
The  edge  detection  and  subsequent  calculation  of  irradiated area  method, 
described in section 3.2.5.1 is similarly effective with EDW fields. Figures 4 34 
(a f) show 60
0 EDW EPID images, acquired for 20x20 cm
2 (X = 20.0 cm, Y1 = Y2 = 
10.0  cm)  field  size,  total  delivered  MU  of  100.  Figure  4 34  (a)  was  acquired 
without any material and figure 4 34 (d) was acquired with 20 cm of solid water. 
Figures 4 34 (b) and (e) show their corresponding profiles extracted in the wedge 
motion direction, while figures 4 34 (c) and (f) show the field edges deduced 
from their respective EPID images. Figures 4 34 (g), (h) and (i) were acquired 
with same setup as figure 4 34(d), but with a 30
0 EDW. Despite the variations in 
beam  intensities  and  scattering  effect  reaching  the  imager  (due  to  different 
EDWs, with and without solid water phantom), the calculated areas were the 
same. The areas calculated from figures 4 34(c), (f) and (i) were 401.70, 401.89 
and  401.83  respectively,  which  is  within  0.5%  uncertainty  compared  to  the 
expected value. 
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Figure  4-  34.  Figures  (a),  (d)  and  (g)  show  EDW  EPIDs  acquired  with  different  setups.  
Figures (b), (e) and (h) show their respective profiles, while figures (c), (f) and (i) are the 
corresponding field edges determined from the EPID image. 
 
 
Table 4 9 compares segmented treatment tables calculated with the proposed 
algorithm using equation 3.24 and those printed out after EDW treatment at 100 
MU exposures. The system’s dynalog viewer files were retrieved after delivery, 
where the actual Y1 jaw (moving jaw) position and cumulative monitor units are 
recorded. The two tables on top were obtained using 30
0 EDW and field size  151 
20x20 cm
2 (X=20 cm, Y1=10 and Y2=10). The two bottom tables were for 45
0 
EDW and field size 15x15 cm
2 (X=15 cm, Y1=7.5 and Y2=7.5). The exposure to 
the  first  open  field  calculated  for  30
0  EDW,  with  the  algorithm  is  53.75  MU, 
which is equal to that from the dynalog viewer. For the 45
0 EDW, the exposure 
to the first open field with the algorithm is 45.89 MU, compared to 45.77 MU 
from the dynalog viewer.  
 
Table  4-  10.  Comparison  of  segmented  treatment  values  calculated  with  the  proposed 
algorithm using equation 3.24 and those printed out after EDW treatment from the linac. 
Dynalog Viewer – 300 EDW
Dynalog Viewer – 450 EDW
Derived using equation 3.24
Derived using equation 3.24
Diff (%)
Diff (%)
Dynalog Viewer – 300 EDW
Dynalog Viewer – 450 EDW
Derived using equation 3.24
Derived using equation 3.24
Diff (%)
Diff (%)
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The comparisons of the MU exposures at different Y1 jaw positions for both cases 
are  in  very  good  agreement.  The  last  column  in  the  table  shows  that  the 
percentage differences between the derived MU at different jaw positions and 
those from the dynalog file are within ± 0.5%. Results from this table indicate 
that  the  proposed  algorithm  can  very  well  replicate  the  exposure versus jaw 
position for the EDW. 
 
The sweeping of the collimator jaw across the irradiated field generates an EPL 
that varies with the EDW angle. Figure 4 35 shows the EPL cross plane profiles 
for EPID images obtained without any material between the source and detector 
at 100 MU and 400MU/min. The EPLs were computed using the set of correction 
coefficients A(i,j), B(i,j) and Mo(i,j) (only for figure 4 35) generated for open 
fields.  As  indicated  in  section  3.2.6.1,  using  parameters  for  open  fields  has 
limitations for calculation EPL for EDW fields; hence the main purpose for the 
results in figure 4 35 is to clarify on these drawbacks. For the open field, i.e. 
zero wedge (open in figure 4 35), the EPL measured across the entire field in the 
X and Y direction was 0±0.3 cm. For wedged beams, the EPL profiles in the Y 
(wedge  motion)  direction  are  higher  at  the  start  of  the  field  and  decrease 
gradually as collimator jaw sweeps across the field. For the zero wedge field the 
entire 100 MU is delivered to the entire field, while the EDW comprises of the 
open field  phase  and  a  collimator sweeping  phase.  From  the  STT  calculation 
when  a  total  100  MU  is  given,  the  proportions  delivered  to  the  open field 
segments  are  53.8MU,  35.2MU  and  15.6  MU  for  the  30
0,  45
0,  and  60
0  EDW 
respectively.  For  the  EDW  fields,  as  the  cumulative  MU  increases,  the  EPL 
gradually decreases. EDW treatments are optimised such that the intended total 
MU is delivered by the end of treatment field, explaining why the EPL in the Y 
direction  are  nearly  the  same.  These  results  clearly  depict  the  inverse 
relationship between EPL and MU (dose).  
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Figure 4- 35. EPL profiles in X and Y directions predicted from images obtained without any 
material between the source and imager for open field (solid lines), 30
0 (dash-dot lines), 45
0 
(dot lines) and 60
0 (dash lines) EDW angles. 
 
 
The EPL computed for EDW using the correction coefficients A(i,j), B(i,j) 
and  Mo(i,j)  generated  for  open  fields  from  EPID  images  is  not  due  to  the 
irradiated image alone, but also the influence of the sweeping jaw across the 
field. Cross plane profiles in figure (4 35) illustrate that EPL may rise beyond 20 
cm across field for 45
0 EDW. The limitation with these open field coefficients is 
that, for EDW angles above 30
0, the combined EPL contribution from the EDW 
and irradiated material (~ 20 cm solid water) is high, reaching levels beyond the 
optimised range of calibration values (0 35 cm). Hence EPL in such cases may be 
calculated inappropriately. In addition to that, if the combined EPL goes beyond 
the maximum depths for the TPR table, which was measured up to depths of 40 
cm, then the conversion of EPL to dose may be inaccurate as well. 
 
Figure 4 36 shows measured and derived (equation 3.20) profiles without any 
material in the beam  ) , ( 0 j i M
q  in the X and Y directions for 30
0 (figures (a) and 
(b)) and 45
0 (figures (c) and (d)) EDW angles. These profiles are compared to the 
measured 60
0 EDW shown in figures 4 36 (e) and (f). As expected the signal at  154 
the start of the moving jaw is much lower for the 60
0 EDW field and continues to 
increase  with  decreasing  EDW  angles.  Figures  4 36  (g)  and  (h)  show  a  3 D 
visualization  of  the  fitting  parameters,  for  the  EDW  30
0  and  45
0  angles 
respectively. The main reason why we derived the parameters is analogous to 
the methodology of the Eclipse TPS whereby, during EDW commissioning, only 
the 60
0 EDW and open field measurements are done. The rest of the EDW angles 
i.e 10
0, 15
0, 20
0, 25
0, 30
0 and 45
0 are generated from the 60
0 EDW and open field 
measurements (Varian medical Systems, 1996). 
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Figure  4-36.  Comparison  of  measured  (solid  lines)  and  derived  (dotted  lines)  profiles 
without any material in the beam  ) , ( 0 j i M
q  in the X and Y directions for EDW angles 30
0 
(figure 4-36 (a) and (b)) and 45
0 (figure 4-36 (c) and (d)). Figures 4-36 (e) and (f) show the 
profiles for EDW angles 60
0. Figures 4-36 (g) and (h) show a 3-D visualization of the fitting 
parameter for the EDW 30
0 and 45
0 angles respectively. 
 
The results were for a symmetric field size of 20x20 cm
2 (X=20 cm, Y1=10 cm 
and  Y2=10  cm).  The  comparison  between  measured  and  calculated  profiles  156 
shows that, in general, a good agreement has been achieved. The deviations 
near the fields’ edges were less than 3%.  
 
Figures 4 37 (a) and (b) show the variations of fitting parameter matrices Bwq(i,j) 
and Awq(i,j) along the Y direction of the EPID respectively for open field (q=0), 
30
0, 45
0 and 60
0 EDW fields. It should be reiterated here that the Bwq(i,j) and 
Awq(i,j)  parameter  for  60
0  EDW  (W60 meas  in  figure  4 37)  were  only 
experimentally determined; they were  used  to  determine  Bwq(i,j) and Awq(i,j) 
parameter for other EDW angles (i.e 45
0, 30
0 and 15
0). The results were for a 
symmetric  field  size  of  20x20  cm
2  (X=20  cm,  Y1=10  cm  and  Y2=10  cm).The 
results also compare the measured and derived data profiles (equations 3.22 and 
3.23) of Bwq(i,j) and Awq(i,j) for the EDW angles 30
0 and 45
0. As illustrated in the 
results, there are significant variations in Bwq(i,j) and Awq(i,j) for open field and 
EDW fields. Unlike the open field data, which are symmetric about the central 
axis, the wedged parameters tend to reflect the slope of the wedge. This is a 
direct  consequence  of  applying  equations  3.22  and  3.23  to  recalculate  the 
parameters for wedged fields. 
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Figure 4- 37. Figures (a) and (b) show the variations of fitting parameter matrices Bwq(i,j) 
and Awq(i,j) along the Y direction of the EPID respectively for open field (q=0), 30
0, 45
0 and 
60
0 EDW fields. The results also compare the measured and derived profiles for the 30
0 and 
45
0. Figures 4-37 (c) and (d) show a 3-D visualizations of the fitting parameters for 30
0 EDW 
field. 
 
 
The derived data using equations (3.19) – (3.24) were used for the exit dose 
(equation 3.25) calculations of EDW fields. Figures 4 38 (a) and (b) are 2D exit 
dose distributions for EPD and TPS respectively for a 15
0 EDW with 20x20 cm
2 
(X=20cm, Y1=10 cm, Y2=10cm) field size. Figure 4 38 (c) shows the gamma index 
map, calculated at 3% dose difference and 3 mm distance to agreement criteria. 
The percentage area (points) that failed gamma criteria was 4.2%. Figure 4 38 
(d) shows a 2D pixel by pixel percentage dose difference between the EPID and 
TPS exit dose distributions. The percentage dose differences were calculated as  158 
% 100
)
( x
D
D D
TPS
EPID TPS -
. Figures 4 38 (e) and (f) are their corresponding exit dose 
cross plane profiles in the X and Y direction respectively.  
 
Figure 4- 38. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 15
0 EDW with 20x20 cm
2. Figures (c) and (d) show their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figures (e) and (f) show the percentage 
dose difference map and gamma index (3% DD and 3mm DTA) respectively.  
 
The truncation of the GSTT profile to reduce it to a desired field size results in 
the  automatic  zeroing  of  EPID  doses  outside  the  irradiated  region;  hence  for  159 
comparison purposes the TPS doses are similarly zeroed outside the irradiation 
field.  
 
Figures 4 39 (a) and (b) illustrate colourwash 2D exit dose distributions for EPID 
and  TPS  respectively  for  a  30
0  EDW  with  15x15  cm
2  (X=15cm,  Y1=7.5  cm, 
Y2=7.5cm) field size. Figures 4 39 (c) and (d) are their corresponding exit dose 
cross plane profiles in the X and Y direction respectively. Figure 4 39 (e) shows a 
2D  pixel by pixel  percentage  dose  difference  between  the  EPID  and  TPS  exit 
dose distributions. Figure 4 39 (f) shows the gamma index map, calculated at 3% 
dose difference and 3 mm distance to agreement criteria. The percentage area 
(points) that failed gamma criteria was 5.5 %.  160 
 
Figure 4- 39. Figures (a) and (b) are 2D colourwash exit dose distributions for EPD and TPS 
respectively for a 30
0 EDW with 15x15 cm
2. Figures (c) and (d) show their corresponding exit 
dose cross plane profiles in the X and Y direction respectively. Figures (e) and (f) show the 
percentage dose difference map and gamma index (3% DD and 3mm DTA) respectively.  
 
Figures 4 40 (a) and (b) show EPID and TPS dose distributions respectively, for 
images obtained for the same setup as in figure 4 39 above, but images acquired 
at 200 MU. The calibration fitting parameters were all obtained for images at 
100 MU. The purpose of this figure is to reaffirm that the same parameters can 
be used to predict EPL for EDW and hence dose, for any other non reference MU. 
Figures 4 40 (c) and (d) also show the profiles dose difference. Discrepancies are  161 
noted at the field edges where there are highest dose gradients, with largest 
differences at the level where the Y1 jaw stops.  
(d) (c)
(b) (a)
(d) (c)
(b) (a)
 
Figure 4- 40. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 30
0 EDW with 15x15 cm
2 and 200 MU. Figures (c) and (d) show their corresponding exit 
dose  cross  plane  profiles  and  dose  differences  (dashed  lines)  in  the  X  and  Y  direction 
respectively. 
 
Figures 4 41 (a) and  (b) illustrate 2D exit  dose  distributions for EPD and TPS 
respectively for a 45
0 EDW with 10x10 cm
2 (X = 10.0 cm, Y1 = 5.0 cm, Y2 = 5 cm) 
field size. Figures 4 41 (c) and (d) are their corresponding exit dose cross plane 
profiles in the X and Y direction respectively. Figure 4 41 (e) shows a 2D pixel 
by pixel  percentage  dose  difference  between  the  EPID  and  TPS  exit  dose 
distributions while figure 4 41 (f) shows the gamma index map, calculated at 3% 
dose difference and 3 mm distance to agreement criteria. The percentage area 
(points) that failed gamma criteria was 7.6%.   162 
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Figure 4- 41. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 45
0 EDW with 10x10 cm
2. Figures (c) and (d) show their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figures (e) and (f) show the percentage 
dose difference map and gamma index (3% DD and 3mm DTA) respectively. 
 
Figures 4 42 (a) and  (b) illustrate 2D exit  dose  distributions for EPD and TPS 
respectively for a 60
0 EDW with 20x20 cm
2 (X = 20.0 cm, Y1 = 10.0 cm, Y2 = 10 
cm) field size. Figures 4 42 (c) and (d) are their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figure 4 42 (e) shows a 2D  163 
pixel by pixel percentage dose difference between the EPID and TPS exit dose 
distributions.  
 
Figure 4- 42. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 60
0 EDW with 20x20 cm
2. Figures (c) and (d) show their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figure (e) shows the percentage dose 
difference map. 
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The profiles for all the test cases described in figures 4 38 to 4 42 are practically 
superimposed  within  70%  of  the  irradiated  field.  The  largest  deviations  are 
towards  the  field  edges  (regions  of  steep  dose  gradients).  Results  in  figures 
comparing exit doses in cross plane and 2D dose distribution for EDW show a 
good matching between the EPID and TPS for different EDW angles and field 
sizes.  The  cross  plane  dose  comparisons  for  EDW  indicate  that  the  EPID  had 
slightly lower doses of 1 2% at the field edges compared to TPS. This could be 
linked to the  ) , ( ) , ( ), , ( j i A and j i B j i M w w o q q
q  data matrices in figures 4 36, 4 37 
(a) and 4 37 (b) respectively, which compare cross plane profiles of derived and 
measured  coefficients.  Towards  the  edges,  both  the  derived 
) , ( ) , ( j i B and j i M w o q
q  are lower than the measured, while  ) , ( j i Awq is higher. 
An interplay between these factors results in an increase in EPL and hence a 
decrease in dose towards the field edges. Another possible reason for the failure 
at the edges is the utility of the GSTT described in equation 3.20. It tends to 
break down for large fields and deviations of 2 4% between measurement and 
calculated  values  have  been  reported  (Gibbons  1998,  Prado  et  al  2002  and 
Kuperman 2005). The variations in dose rates during EDW dose delivery could be 
another factor that can affect EPID dose distribution, causing discrepancies. The 
readout of the a Si array are synchronized with the beam pulses, hence EPIDs 
are calibrated at each accelerator dose rate. The dark and flood field images 
are  different  at  each  doserate  due  to  variation  in  image  acquisition  timing. 
Doserate variations that occur during EDW treatments could potentially affect 
the EPID signal, where the system is calibrated at a fixed accelerator dose rate. 
Lastly, the disagreements are at the field edges (regions of steep dose gradients) 
where dose predictions may be inaccurate (Vieira et al 2003). 
 
Figures  4 43  (a)  and  (c)  compare  typical  profiles  from  EPID  images 
acquired for the YI IN and Y2 OUT for 30
o and 45
o EDW respectively. Figures 4 43 
(b) and (d) show the same data superimposed onto each other by flipping the Y1 
IN data. The images were acquired for 20x20 cm
2 with moving jaw Y1=10 cm, 
fixed jaw Y2=10 cm and X=20 cm at same SDD and 200 MU. The profiles were 
extracted  from  the  centres  of  the  images  in  the  EDW  motion  direction.  The 
results show that EPID pixel value responses for Y1 IN and Y2 OUT are practically 
symmetrical, implying that data for Y2 OUT jaw orientation can be created from  165 
that of Y1 IN jaw orientation by data mirroring, saving valuable re measurement 
time. 
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Figure 4- 43. Figures (a) and (c) compare EPID image profiles for Y1-IN (solid lines) and Y2-
OUT (dash lines) for 30
o and 45
o EDW respectively. Figures (b) and (d) show the same data 
superimposed onto each other by flipping the Y1-IN data. 
 
All the EDW coefficients data and test cases in this study were acquired 
with Y1 IN jaw orientations. Results from figure 4 43 which is also in agreement 
with Greer et al (2007), indicate that EPID pixel value response for Y1 IN and Y2 
OUT for the same radiation field settings are practically symmetrical. Hence the 
data  fitting  coefficients  for  Y2 OUT  can  be  created  from  the  Y1 IN  by  data 
mirroring, saving valuable time of re measurements.   166 
Figure  4 44  compares  EDW  dose  distributions  for  15x15  cm
2  symmetric 
field  size,  Y2 OUT  jaw  motion  and  100  MU.  The  EPID  data  used  for  dose 
calculation were obtained by data mirroring as described above. The difference 
between the TPS and EPID dose was calculated for each point within the 2D data 
matrix. The cross plane dose differences in figure 4 44 (c) (displayed as a dashed 
line) illustrates that most of the discrepancies are at the edges, similar to the 
Y1 IN jaw orientation. Figure 4 44 (d) shows the gamma index map, where the 
percentage of area (3% DD and 3mm DTA) failed was 6.9. 
 
 
Figure 4- 44. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 30
0, Y2- OUT, EDW with 15x15 cm
2. Figure (c) shows their corresponding exit dose 
cross plane profiles and dose differences (dashed lines) in the Y direction. Figure (d) is the 
gamma map (3% DD and 3mm DTA) computed from figures (a) and (b). 
 
 
Figure 4 45 shows another case were the Y1 IN data were used to calculate the 
exit  dose  for  an  EPID  acquired  image.  The  results  in  this  figure  compare 
MapCHECK (a), TPS (b) and EPID image (c) dose distributions, acquired with 45
0  167 
EDW, 15x15 cm
2 symmetric field size, Y2 OUT jaw motion, collimator angle 90
0 
and  200  MU.  The  EPID  data  used  for  exit  dose  calculation  was  obtained  by 
mirroring the Y1 IN data as described above. We used a rotated collimator angle 
in this example to show that the fitting data coefficients can be used at various 
beam orientation. The percentage of area in figure 4 45 where the gamma index 
(3% DD and 3mm DTA) failed were 5.5, 7.2 and 7.8 for the TPS vs MapCHECK, 
EPID vs MapCHECK and TPS vs EPID respectively. Reasonably large differences 
are at the field edges as illustrated by the EPID vs MapCHECK dose difference 
profile in figure 4 45 (d). However this is not due to using the Y1 IN data to 
compute dose for Y2 OUT, as results in figures 4 38 and 4 42 also show a similar 
effect at the edges. 
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(b)  (a) 
(c) 
(e) g - TPS vs MAPCHK (f) g - EPID vs MAPCHK (g) g - TPS vs EPID
(d) 
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(d) 
 
Figure  4-  45.  Figures  (a),  (b)  and  (c)  show  2D  absolute  exit  dose  (cGy)  distributions 
measured with the MapCHECK device, calculated with TPS and those from EPID images 
respectively, for a 45
0, Y2- OUT, EDW with 15x15 cm
2. The image was acquired with 200 MU 
at collimator angle 90
0. Figure (d) shows the corresponding exit dose cross plane profiles 
and  dose  differences  between  EPID  and  MapCHECK  profiles  (dot-dashed  line)  in  the  X 
direction. Figures (e), (f) and (g) demonstrate the respective 2D gamma maps, evaluated at 
3% DD and 3 mm DTA.Figure (d) is the gamma map (3% DD and 3mm DTA) computed from 
figures (a) and (b). 
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Figures  4 46  and  4 47  show  exit  dose  comparisons  for  the  anthropomorphic 
phantom case in figure 3 7(c) as described in section 3.2.6, irradiated with 30
0 
(Y1  IN, collimator angle 0
0) and 45
0 (Y2  OUT, collimator angle 90
0) EDW fields 
respectively.  The EPID images were acquired and TPS calculations were done 
with 100 MU and with 15x15 cm
2 symmetric field. Figures 4 46/4 47(a) and (b) 
compare 2D TPS and EPID dose contours respectively. Figures 4 46/4 47(c) and 
(d)  compare  TPS  and  EPID  cross  plane  profiles  in  the  X  and  Y  directions 
respectively.  Figures  4 46(e)  and  4 47(e)  are  the  respective  percentage  dose 
difference maps between the TPS and EPID. Figures 4 46(f) and 4 47(f) show the 
acquired EPID images from which the dose distributions in figures 4 46(b) and 4 
47(b)  respectively,  were  calculated.  The  EPID  and  TPS  dose  distributions 
illustrated  in  the  two  examples  above,  compare  favourably  well  in  low  dose 
regions, but significant deviations are noticed in high dose areas (towards the 
end position of the moving jaw).   170 
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Figure 4- 46. Exit dose comparison for the anthropomorphic phantom case in figure 3-7 as 
described in section 3.2.4.4, irradiated with 100 MU, 30
0 EDW, Y1- IN, collimator angle 0
0, 
with 15x15 cm
2 symmetric field. Figures (a) and (b) compare 2D TPS and EPID dose contours 
respectively. Figures (c) and (d) compare cross plane profiles in the X and Y respectively. 
Figure  (e)  shows  the  percentage  dose  difference  map  between  the  TPS  and  EPID  doses. 
Figure  (f)  is  the  acquired  EPID  image  from  which  the  dose  distribution  in  figure  (b)  was 
calculated. 
  171 
(f) (e)
(d) (c)
(b) (a)
%
(f) (e)
(d) (c)
(b) (a)
%
 
Figure 4- 47. Exit dose comparison for the anthropomorphic phantom case in figure 3-7 as 
described in section 3.2.4.4, irradiated with 100 MU, 45
0 EDW, Y2- OUT, collimator angle 
90
0, with  15x15  cm
2  symmetric  field.  Figures  (a)  and  (b)  compare  2D  TPS  and  EPID  dose 
contours  respectively.  Figures  (c)  and  (d)  compare  cross  plane  profiles  in  the  X  and  Y 
respectively. Figure (e) shows the percentage dose difference map between the TPS and 
EPID doses. Figure (f) is the acquired EPID image from which the dose distribution in figure 
(b) was calculated. 
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4.3.4 Comparison of exit dose results with other literature 
The  present  exit  dose  results  for  open  and  MLC  shield  fields  can  be 
compared to the work done by Parsaeia and El Khatib (1998), Pasma et al (2002) 
and Chen et al (2006). Parsaeia and El Khatib (1998) investigated the dosimetric 
characteristics  of  a  scanning  liquid filled  ionization  chamber  (SLIC)  EPID.  To 
assess the system’s response in relation to incident radiation beam intensity, a 
series of characteristic curves were obtained for various field sizes and nominal 
energies of 6 and 10 MV photons. This study indicated that the response of the 
imaging  system  was  dependent  on  incident  radiation  intensity  and  could  be 
described to within 1% accuracy on central axis using a square root function. 
They used attenuating homogeneous phantom materials with thicknesses ranging 
from 0 – 22.5 cm and field sizes 5x5 cm
2 and 10x10 cm
2. This study compared 
relative transmission dosimetry with ionisation chamber measurements. Portal 
dose measurements at the plane of the detector, on central axis of the beam 
showed  that  the  imaging  system  was  capable  of  measuring  the  portal 
transmission  dose  to  within  3%  of  the  ionisation  chamber  results  for 
homogeneous material. For 2D dosimetry applications, the system was calibrated 
with a 10 cm Perspex block used as beam flattening material on the detector 
cassette to correct for variations in individual ion chamber sensitivity and the 
effect of non uniform beam profiles produced by the flattening filter. Open and 
wedged dose profiles measured agreed with ion chamber measured profiles to 
within 3.5% accuracy. The main limitation of this study was the requirement of 
additional material (10 cm Perspex block) to be placed on top of detector, which 
can be an obstacle in lateral fields. The profile agreements are comparable with 
results from our study. 
Pasma  et  al  (2002)  used  a  fluoroscopic  CCD  camera  based  EPID  for 
evaluating portal dosimetry of static wedged fields, an extension of the method 
they had published for open fields Pasma et al (1998). Their methods are based 
on calculation of 2D functions, describing the transmission of a photon beam 
through a patient for both open and wedged fields. The transmission functions 
are used for the prediction of portal dose images (dose distribution behind the 
patient)  in  a  plane  normal  to  the  beam  axis,  which  are  compared  with  PDIs 
measured with an EPID. The calculations are based on the planning CT scan of 
the  patient  and  on  the  irradiation  geometry  as  determined  in  the  treatment  173 
planning process. Similar to work by Parsaeia and El Khatib (1998), these studies 
were  evaluated  by  computing  percentage  transmissions  (main  distinction 
between these studies and our study were we compare dose directly), measured 
with an ionisation chamber. The results indicated that for low and high energy 
photon beams of 6 and 23 MV, good agreement of approximately 1.2% (excluding 
points  at steep  dose  gradient) were found between calculated  and measured 
transmissions for homogeneous Perspex slabs (thicknesses of 10 30 cm) and a 
thorax phantom. The agreement in profiles for both open and wedged fields, 
shows noticeable large deviations at field edges, comparable to our results. 
The Chen et al (2006) group slightly modified a convolution calibration 
method that has previously been used to calibrate liquid filled ion and camera 
based  EPIDs,  to  calibrate  a  Siemens  Perkin Elmer  EPID  detector  for  exit 
dosimetry. The modified model utilised two convolution kernels: one to describe 
the  flat  panel  detector  and  one  to  describe  the  water  dose.  They  also 
represented the effects of the EPID energy response and the variations in the 
beam energy spectrum using a tabulated conversion function. The study limited 
itself  to  solid  water  phantoms  less  than  11  cm  in  thickness  and  the 
anthropomorphic  (head)  phantom.  This  is  in  contrast  with  the  present  study, 
where  exit  doses  for  thicknesses  in  the  range  of  5  to  32  cm  and  a  pelvis 
anthropomorphic  phantom  have  been  calculated.  For  the  centred  fields 
excluding the smallest, the Chen et al (2006) EPID profiles fell within 3.1% of the 
ionisation chamber measured dose. This is very much in agreement with the our 
results  where,  within  the  irradiated  regions,  the  average  dose  differences 
(computed for all cases and for 80% of the irradiated field) between the EPID 
and TPS is within 3%. The Chen et al (2006) study also indicated that, out of the 
field,  the  percent  difference  between  the  calibrated  EPID  and  ion  chamber 
measured signals was much greater due to the low signal level in this region. 
They observed percent differences ranging from −10% to as much as 65%; which 
is not much different from what we measured in the MLC shielded regions. The 
Chen et al (2006) exit dose verification study did not include wedged or EDW 
fields.  The  main  limitation  in  the  Chen  et  al  (2006)  study  was  the  frame 
acquisition  /  calibration  capabilities  of  their  EPID  detector,  which  restricted 
their analysis to single frame images of 2–4 MUs. The study concluded that to 
acquire clinical exit beam measurements, suitable multi frame acquisition mode 
would need to be implemented.  174 
In all the studies discussed above, the authors used static wedged fields, rather 
than  EDW  used  in  our  study.  There  is  scanty  information  in  literature  about 
portal dosimetry of EDW using EPID. The work done by Greer and Barnes (2007) 
only assessed the dosimetric performance of an a Si EPID for measurement and 
quality assurance of enhanced dynamic wedge profile and wedge factor. Similar 
work was done by Al Kattar (2009), and also addressed only quality assurance of 
enhanced dynamic wedge using the a Si500 EPID. This work therefore, provides a 
novel  assessment  of  the  use  of  EPID  to  predict  EPL  and  exit  dose  in  routine 
clinical treatments, including EDW fields. 
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5  CHAPTER 5: CONCLUSIONS AND FUTURE 
WORK 
5.1 Conclusions 
The  dosimetric  properties  of  eleven  accelerators  in  clinical  use  were 
examined.  The EPID age and image acquisition system showed influence on the 
results with the system II giving better data reproducibility and linearity fit than 
system I. Uniformity  was  within 95% and independent  of  detector. Dose rates 
and  EPID  field  size  factors  have  similar  curves,  thus  can  be  described  by 
analytical functions. Memory effects are system and age independent. System II 
performance  data  are  in  agreement  with  other  Varian  a Si500  EPID  reports. 
Deviations are seen with the system I which are attributed to detector age and 
acquisition software. Generally the results confirm the suitability of all the EPIDs 
for  quantitative  dosimetry,  though  there  is  a  significant  improvement  in 
uniformity  of  response  in  those  devices  using  software/hardware  versions 
IAS3/IDU 20 over the older IAS2/IDU II.  
 
The objective of radiotherapy is to deliver an absolute dose to a reference 
point with an uncertainty of ± 3%. The results obtained in this work show that 
detectors  with  software/hardware  versions  IAS3/IDU 20  have  a  degree  of 
accuracy well in excess of that required to allow their use in routine verification 
of delivered dose within this tolerance. However limitations in reproducibility 
and linearity mean that detectors with software/hardware versions IAS2/IDU II 
are less suitable for routine quantitative IMRT dosimetric verification. 
 
Various  authors  have  approached  portal  dosimetry  by  radiological 
thickness / EPL calculations to verify treatment delivery when correcting EPID 
image derived dose data. This work has proposed a simple means to convert EPL 
to estimated dose, using an analytical method for the accurate prediction of in 
vivo dose using an EPID. The PETD data, boundary and envelope profiles have 
been used to convert the EPL into dose information at the exit. The developed 
tool is capable of converting EPID images into 2D dose maps, thus giving a real 
time  measure  of  the  actual  patient  dose  delivered  during  each  treatment 
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fraction.   Following some simple commissioning measurements, the tool may be 
implemented on almost any radiotherapy unit with an EPID. This will allow in 
vivo dosimetry to become a routine part of radiotherapy quality assurance, thus 
improving patient safety in radiotherapy centres. The method takes into account 
inhomogeneities  at  each  pixel  in  the  process  of  establishing  the  EPL.  The 
determined  EPL  by  the  QCM  method  for  homogeneous  water  and  non water 
equivalent  materials  are  within  ±  3mm.  Furthermore,  the  evaluation  of  the 
method  at  two  different  beam  energies  provides  a  significant  extension  to 
previous work.  
It has been shown that the QCM, applied to EPID images of homogeneous 
solid  water  phantoms,  can  be  used  to  accurately  predict  2D  exit  doses  for 
conformal  and  EDW  fields.  The  inclusion  of  MU  correction  improved  the  EPL 
determination and hence exit dose for various field sizes and thicknesses. The 
irradiated field areas can be accurately determined from EPID images to within ± 
1%  uncertainty.  Good  agreement  between  the  EPID  predicted,  MapCHECK 
measured and TPS calculated dose distributions were obtained for conformal and 
EDW test cases, with more than 90% of pixels within the irradiated field meeting 
a gamma index criteria of 3% DD and 3mm DTA. But it should be emphasised 
that, for practical in vivo dosimetry, these areas  of reduced accuracy at the 
field edges are less important. 
The method requires the acquired EPID image, the delivered number of 
monitor units and angle of EDW (if used) as clinical input parameters to predict 
the equivalent path length (EPL) and exit dose. It is the author’s belief that the 
algorithm developed  here provides a clinically effective high resolution 2D in 
vivo dosimetry system for radiotherapy. It is concluded that the EPID QCM is an 
accurate and convenient method for online in vivo dosimetry and may therefore 
replace existing techniques.  
The pixel sensitivity reproducibility of the Varian EPID has been reported to 
be within 1% (Greer et al 2003, Menon et al 2004, Kavuma et al 2008). It was 
established that the fitting coefficients were reproducible to within 2% (section 
4.2.1) and also the EPL is reproducible to within ± 2mm (section 4.2.5.1). This 
consistency in response gives a high level of confidence in the sensitivity of the 
system for its intended in vivo dosimetry use. Grattan et al (2010) investigated 
the positional stability of the Varian EPID R arm and Exact arm support systems 
and concluded that the latter, which also is used in this study, provided more  177 
reproducible  positions  than  the  former.    This  study  indicated  that  the  mean 
misalignment error for the Exact arm was approximately 2.0 mm, which may not 
cause adverse dosimetric effects. 
It is indicated in the materials and methods (section 3.2.1) that test plans 
with desired field settings were created using the Varian RT chart software and 
that these  were scheduled in the time planner, exported to the accelerator and 
treatments executed in the clinical mode, acquiring single integrated images at 
the end of each treatment. The acquired images were then opened using the 
Varian  portal  dosimetry  software  and  exported  as  ASCII  files  for  analysis  in 
Matlab.  This  means  that  our  transit  dosimetry  algorithm  should  require  only 
minimal work to be integrated into the existing commercial Varian portal dose 
image prediction (PDIP) and other operating / clinical software. 
In the current study, we used the Varian a Si 500 with IAS3 (pixel format 
384x512  and  pixel  pitch  in  each  dimension  of  0.784  mm  x  0.784  mm).  The 
developed method can easily be adapted  to  the Varian’s imager system (a Si 
1000 with pixel format 768x1024 and pixel pitch in each dimension of 0.392 mm 
x  0.392  mm)  that  comes  with  TrueBeam  (Varian’s  new  brand  of  linear 
accelerators). It will require image acquisitions on linac with these new imagers 
to determine the correction coefficient matrices A(i,j), B(i,j) and the open field 
matrix M0(i,j). The rest of the algorithm will remain unchanged. A change in 
beam  characteristics  has  a  significant  effect  on  fitting  coefficients  and  as 
indicated in section 4.2.1, the flattening filter has a significant influence on the 
shape of the fitting matrices. For TrueBeam that has the option of producing 
flattened  and  unflattened  beams,  two  sets  of  data  will  be  required  for  dose 
verification. Alternatively, the effect of the flattening filter on matrices A(i,j), 
B(i,j) and M0(i,j) can be characterised, but this needs further investigation. 
 
 
5.2 Possible future direction 
Despite the promising Gamma Dose analysis, there is still work that needs to be 
done on developing the procedure. Often it is not straightforward to interpret 
the  compared  2D  dose  deviations  in  terms  of  clinical  implications  for  the 
patient. Therefore a method to derive 3D patient dose, based on EPL measured 
with  an  EPID  needs  to  be  established,  that  is  the  2D  EPID  dose  must  be 
translated to a patient dose. Several authors have investigated the translation of 
EPID dose to patient dose at points along the central axis (Chang et al, 2000);  178 
the patient dose at the midplane (Boellaard et al, 1998) and the full 3D patient 
dose distribution (Patridge et al, 2002 and Louwe et al, 2003). For an accurate 
dose determination in the target area, tissue density data of the patient during 
the  actual  treatment  fraction  is  essential.  These  data  can  be  obtained  by 
performing an additional cone beam CT scan just before the fraction in which 
the  dose  measurement  is  performed.  By  extending  the  current  procedure  to 
incorporate  Cone   Beam  CT  (CBCT)  images  of  the  patient,  taken  before 
treatment, the calculated exit dose from EPID can be back projected into the CT 
data,  and  this  will  permit  volumetric  (3D)  verification.  Since  the  current 
algorithm has been verified extensively, particularly for the EDW, it would be 
expected that the 3D result will be more generally applicable to a wider range 
of clinical situations, comparable to the work done by: 
1)  McDermott et al (2008), who use CBCT images to reconstruct a phantom 
for in vivo calculation. They use the EPID for transit dosimetry and then 
assumed that the CBCT based phantom is homogeneous and water like.  
2)  Chen  et  al  (2006),  whereby  in  their  procedure  they  reconstructed  the 
dose delivered to the patient based on treatment time portal images and 
pre treatment MV CBCT images of the patient. They calibrated the MV 
CBCT in terms of electron density and used this information together with 
dosimetric calibration of the portal imager for dose calculation. 
Predicting  the  transmitted  dose  based  on  cone Beam  CT  data  acquired  at 
treatment should ideally be performed in the future and this would improve the 
effectiveness and reliability of transit in vivo dosimetry techniques.  
Further work needs to be done to assess the algorithm in situations not 
involving normal beam incidence on the phantom / patient. More investigation is 
needed to extend the scope of the algorithm to model doses in asymmetric EDW 
fields. Gibbons (1998) and Prado et al (2002) indicated that although simple in 
approach,  the  MU  fraction  model’s  prediction  of  EDW  factors  accurately,  is 
limited in large or asymmetric fields. They suggested various means of modifying 
the  MU  fraction  model  to  generalise  it  for  both  symmetric  and  asymmetric 
beams,  based  on  beam segmentation  superposition.  These  beam  summation 
methods are however, difficult to implement in routine clinical MU calculation 
schemes.  Critical  parameters  and  factors  that  may  result  in  discrepancies 
between predicted and measured doses during clinical application may include  179 
SDD  variations,  patient  target  volume  variations,  etc.  These  need  to  be  well 
characterised.  
Once the 3D verification is complete, the QCM will then be applicable for 
all static, conformal and EDW delivery techniques. Further development of the 
procedure will be necessary to extend verification to techniques that involve 
dynamic motion of MLCs during treatment, e.g. IMRT and Rapidarc. To use the 
QCM for dynamic treatment verification will require further testing. First, the 
linearity  of  the  EPID  panel  response  with  respect  to  irradiation  time,  as 
determined by the moving MLCs, should be investigated. The fitting coefficients 
(A(i,j), B(i,j), Mo(i,j)) which are the pillars in the conversion of the EPID signal to 
EPL, need to be re examined for the case of dynamic MLCs. 
It may be possible to increase the EPID signal strength by changing the 
time between reset frames and imaging frames, and by decreasing the number 
of frames per sync pulse. Although the EPID dosimetric response will be raised, it 
may introduce more noise into the image. Hence this was not investigated as we 
attempted to keep the image acquisition set up conditions as close as possible to 
the clinical imaging conditions.  
Investigation in clinical situations is the subject of our continued work in 
order to demonstrate the usefulness, strengths and limitations of the current 
algorithm on actual patients. 
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Appendix A: Solving Quadratic Equations 
The solutions of the quadratic equation 
ax
2+ bx + c = 0                                                  A1 
where a, b and c are real fixed numbers, are given in exact form by the well 
known quadratic formula given by  
                                 
a
ac b b
x
2
) 4 ( 2 - ± -
=                                              A2 
However if a, b and c are optimised values as in the case for the derivation of 
A(i,j) and B(i,j) in section 3.2, giving rise to unreasonable roots, then continued 
fractionation (iteration) is used to approximate the solution. The idea is that a 
function is found that, given an approximation of the solution as input (xold), 
outputs a more precise approximation (xnew). If this function is used iteratively 
by recycling the values produced on each iteration, better and better solutions 
will  be  reached.  This  process  can  be  continued  until  the  required  level  of 
precision is reached. 
The iterative scheme given in section 3.2 comes from rearrangement of equation 
(1) obtained as follows.  
Starting with:                                                       ax
2+ bx + c = 0   
Taking c to the right side of the equation gives:     ax
2+ bx  = - c                     A3 
Adding ax
2 to both sides gives:                               2ax
2+ bx  = ax
2 – c              A4 
Take out a common factor:                                    x(2ax + b) = ax
2 – c            A5 
Divide through  
       
b ax
c ax
x
+
-
=
2
2
                                                          A6 
Set up the iterative scheme as  
         
b ax
c ax
x
n
n
n +
-
= + 2
2
1                                                        A7 
where xn is the old solution (xold) and xn+1 is the new solution (xnew), which is the 
second order iterative method scheme and converges quickly to the roots of the 
quadratic. 
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MATLAB ALGORITHM FOR DETERMINING THE EPL 
%Using Matlab we read EPID image and Open image data (EPID_data and OPEN) 
TRANS =  log(EPID_data./OPEN); 
 
% From equation 3.8 
Xn = ( B + sqrt(B.^2+4*A.*TRANS))./(2*B); % Xn is the initial solution 
Xn_c = mean(mean(Th_un(186:198,250:262))); %Xn_c is initial mean pixel value 
% in a 1cm ROI (first No in each coloum of Table 4 6) 
 
% Effect of MU correction 
MUs = [20 50 100 200 500]; 
MU_factor = [0.970 0.990 1.000 1.004 1.009]; 
SMUR = interp1(MUs,MU_factor,MU); % 1D Interpolation to get MU factor which  
%the image was acquired 
 
Thickness = [0 5 10 15 20 26 32 50]; 
FieldSize = [4.9 10 15 20 21.5]; 
          
% Table of correction factor  
CF = [1.216    1.281    1.368    1.447    1.523    1.640    1.739    1.840     
      1.097    1.152    1.218    1.268    1.325    1.393    1.445    1.550 
      1.046    1.076    1.116    1.138    1.178    1.206    1.249    1.350 
      1.009    1.016    1.033    1.037    1.043    1.048    1.060    1.070  
      1.000    1.000    1.000    1.000    1.000    1.000    1.000    1.000]; 
 
for i = 1:n % n is total number of times we want to iterate 
   corr = interp2(Thickness, FieldSize,CF, Xn, FieldArea*ones(384,512))/SMUR;  
   % 2D interpolation to find scatter correction (corr) due to thickness Xn, 
   % and field size (FieldArea). FieldArea is determined from EPID image 
   % using equation 3.18 
   Xn+1 = (A.*Xn.^2  log(corr.*data./OPEN))./(2*A.*Xn + B); % equation 3.12 
   Xn+1(find(isnan(Xn+1))) = 0.0; % Any value in data which is not a number 
%(NAN) is replaced by 0 
EPL_c = mean(mean(Xn+1(186:198,250:262)));%EPL_c is mean pixel value in  
%1cm ROI  
   
end 
   
Note1:  A,  B  and  C  are  fixed,  but  the  correction  (corr)  keep  on  changing, 
meaning that the coefficient of C keeps on changing, which enable the Xn+1 
values to change at each iteration. 
Note 2: corr is also a 384x512 matrix (i.e correction is applied for each pixel 
depending on the previously calculated value or EPL). corr is evaluated at the 
same area (FieldArea) of the irradiated EPID image. 
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Proof of the Convergence of the iteration 
 
According to Newton’s Method, a function xn+1 = g(xn), converges quadratically to 
r if g’(r)=0, where r is a fixed point of g, (that is g(r)=r). 
 
If we let f(x) = ax
2+ bx + c = 0 ,                                                                    A8 
Then the first derivative of f(x) is given by   b ax x f + = 2 ) (
'                             A9 
 
From equation A7, let  g(x)  = 
b 2ax
c ax
x
n
2
n
1 n +
-
= +                                                A10 
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APPENDIX B: Relation between TPR and PETD 
 
Consider the diagram below that relates the TPR and PETD for the same field 
area and phantom depth z. 
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The TPR at a point P1 located at an effective depth,  max d z d - = , is related to 
doses D(P1) and D(Po) at P1 and at dmax respectively by `                        
( ) ( )
( ) o P D
P D
P TPR
1
1 =                                                                                    B1 
The PETD for a depth d measured at point P2 is given by     
( ) ( )
( )
'
2
2
o P D
P D
P PETD =   B2 
Where D(P2) and D(P
’
o) are doses at P2 and at dmax respectively. The dose D(P1) is 
given by 
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neglecting the effect of appropriate back scatter at P’o and at P2.  
Combining equations B1   B4,                      184 
( ) ( )
( )
( ) 1 '
1
2
2 ) (
) (
P TPR
P D P D
P D P D
P PETD
o
o =         ( )
( ) ( ) 1
2
max 2
max 1
1 1
2 2
,
,
P TPR
d f
d f
f P PDD
f P PDD






+
+
=           B5 
 
Where f1, fo and f2 are respective SSDs as shown in the figure above.  
Using the Mayneord factor that relates PDDs measured at different SSDs, then 
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Equation B8 implies that PETD is TPR, corrected for inverse square law, i.e 
taking into account the shift in the calculation point away from the isocenter. 
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